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Abstract 
 
Oral contraceptives are of the hormonal contraceptives that prevent pregnancy through 
their action on hormones in the woman's body. They have high efficacy and their failure 
is due to discontinuation and inconsistence use. Compliance and continuation are 
important factors so that oral contraceptives exert their effects in high efficacy. Poor 
compliance to oral contraceptives affects the desired effects of oral contraceptives 
negatively and unwanted outcomes may result in. Improvement of oral contraceptives 
compliance is the responsibility of the health team side by side with the users.  
Knowledge about oral contraceptives helps provide good compliance and thus high 
efficacy. Provision of information to women using oral contraceptives is a very important 
issue that needs effort and focus in order to improve knowledge and increase compliance.  
Oral contraceptives are widely used in Palestine. Oral contraceptives are the second most 
used contraceptive method, whereby 50.6% of married women use the oral contraceptives 
in Palestine distributed as 55.1% in the West Bank and 43.0% in Gaza Strip. 
 
The study aim is to investigate compliance to oral contraceptives usage and its 
determinants among current users in the West Bank 
 
The study objectives are to evaluate level of women’s knowledge of oral contraceptives 
and how it affected compliance, examine the relation between compliance and oral 
contraceptives use pattern, examine the effect of women’s health status and maternal 
history on compliance to oral contraceptives and identify the effects of demographic and 
socioeconomic factors on compliance to oral contraceptives.  
 
This is a cross sectional study that was carried out at the Palestinian Family Planning and 
Protection Association in Bethlehem, Halhoul, Hebron, Ramallah and Tulkarem from 
December 1, 2007 to March 31, 2008.  All women visiting the association and were 
current users of oral contraceptives were asked to fill in the study questionnaire.  During 
the study period, 149 women filled in the study questionnaire.  
 
Women participating in the study were distributed as follows between districts: 39.60% 
from Halhoul, 32.21% from Hebron, 11.41% from Tulkarem, 10.07% from Bethlehem 
and 6.71% from Ramallah. As for distributions according to locality; 69.8% of the 
women were from cities, 29.53% were from villages and 0.67% were from camps.  Age 
of studied women was categorized into groups where 2% were younger than 18 years old, 
6.7% were between 19 and 23 years old, 24.2% were between 24 and 28 years old, 26.2% 
between 29 and 33 years of age while 40.9% were 34 years old or more. The mean (SD) 
of live children born to a woman was 4.19 (± 2.117) children; minimum number born was 
one child while maximum number born was 13 children. About 59.7% of women were 
using oral contraceptives to space between children, whereas 32.9% were using them to 
stop having children and 4.7% used oral contraceptives due to health problems. Nearly 
54.4% of the studied women had intension to stop oral contraceptives' use while 45.6% 
did not intend to stop oral contraceptives' use.  Concerning compliance to oral 
contraceptives, 89.3% were taking pills regularly all the time, 10.1% were taking the pills 
regularly most of the times and 0.7% of them were rarely taking the pills regularly.  In the 
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same context, 15.4% of the studied women were missing pills whereby 10.1% missed one 
pill monthly, 5.4% missed two pills monthly and 0.7% missed three or more pills 
monthly. The overall compliance in taking pills was described by women as high 
compliance (87.9%), moderate compliance (10.7%) and poor compliance (1.3%). 
Occurrence of pregnancy in women using oral contraceptives 4% of the studied women 
got pregnant while using oral contraceptives. The major source of information for studied 
women was the nurse (59.7%) followed by the obstetrician (34.2%). The majority of 
women (85.9%) described the received information to be clear and understandable.   
 
Results of the study showed that knowledge about oral contraceptives by studied women 
was general and shallow. Specific knowledge of different aspects of oral contraceptives 
was poor and need to be worked on. Compliance to oral contraceptives was high pointing 
to the real desire of women to achieve the contraceptive effect of oral contraceptives.  
 
As a result for the study, the researcher recommends that women using oral 
contraceptives need to receive more oral information in addition to written information in 
Arabic about oral contraceptives in a way covering all the important aspects women need 
to know. Educational programmes for oral contraceptives and other contraceptive 
methods are also recommended in order to help provide women with knowledge about 
available methods and choices for contraception. 
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في الضفة   لها الىساء الهسثخدهات بيو هىع الحهلأقراص  هحددات الالثزان ىحو أسثخدان
 الغربية 
 
 إعداد: إيناس إبراهيم خليل العمد.
 
 إشراف: د. عائشة الرفاعي.
 
 :همخص
 
يٌؼ اهضيل ُٕ يً ّؿبئل يٌؼ اهضيل اهِؼيٌّٖج اهخٕ خيٌؼ اهضيل يً علال اهؾيل ؽوٓ  أكؼاص
ب ٖؾّغ هلعؼ اؿخعغايِب ّ فشوِؿتة نفبءث ؽبهٖج ّ بهغِٖ ُػٍ الأكؼاص يؼأث.ها سؿىاهِؼيٌّبح فٕ 
 هخلّى أكؼاصِبيج اهؾّايل اه الاؿخعغاى اهيٌخغى ّاهيغاّيج ؽوَٖ يً الاؿخعغاى اهغٖؼ يٌخغى. ٖؾختؼ
 كوج الاؿخعغاى اهيٌخغى لأكؼاص يٌؼ اهضيلنفبءث ؽبهٖج. تئؽعبء ٌخبئسِب اهيؼسّث ّتيٌؼ اهضيل 
 خضؿًٖييب كغ ٖؤغٔ إهٓ ضغّد ٌخبئز غٖؼ يؼغّة فِٖب.  ؿوتًب ِبوٓ اٗذبؼ اهيؼسّث يٌٖؤذؼ ؽ
سٌتب إهٓ سٌة يؼ  اهفؼٖق اهضضُٕٕ يؿؤّهٖج فٕ اؿخعغاى أكؼاص يٌؼ اهضيل  ىالاٌخغب
ّتبهخبهٕ  اؿخعغاى يٌخغى أفظلؿبؽغ ؽوٓ خّفٖؼ خيٌؼ اهضيل  أكؼاصاهيؿخعغيًٖ. اهيؾؼفج ؽً 
سِغ  إهٓ يٌؼ اهضيل ُٕ كظٖج ُبيج سغا خضخبر ضّل أكؼاص حتيؾوّيب اهٌؿبء خؽّٖغنفبءث ؽبهٖج. 
يٌؼ اهضيل  أكؼاص خؿخعغى .خٌبّل الأكؼاص تبٌخغبىّؽٖبغث  جّخؼنٖؽ يً أسل خضؿًٖ اهيؾؼف
 ذبٌٕ أنذؼ ّؿبئل يٌؼ اهضيلنيٌؼ اهضيل  خؾختؼ أكؼاصّؽوٓ ٌعبق ّاؿؼ فٕ فوؿعًٖ. 
 ٪ يً اهٌؿبء اهيخؽّسبح يّؽؽج ؽوٓ اهٌضّ 6.05  ضٖد خؿخعغيِب ،اهيؿخعغيج فٕ فوؿعًٖ
 ٪ فٕ كعبػ غؽث. 0.34٪ فٕ اهظفج اهغؼتٖج ّ 1.55 اهخبهٕ: 
 
فضص يغْ اهخؽاى اهٌؿبء اهيؿخعغيبح لأكؼاص يٌؼ اهضيل تِب ّيضغغاح ُػا اهغؼاؿج إهٓ  خِغفّ
 .فٕ اهظفج اهغؼتٖج بحاهضبهٖ بحتًٖ اهيؿخعغي الاهخؽاى 
 
اهٌؿبء اهيؿخعغيج لأكؼاص يٌؼ اهضيل ّأذؼُب يؾؼفج  يؿخّْ خلٖٖى ُٕاؿجوغؼه الأُغاف اهؾبيج
غؼاؿج  ،يٌؼ اهضيل أكؼاصٌّيع اؿخعغاى  هخؽاىغؼاؿج اهؾلاكج تًٖ الا ،ؽوٓ الاهخؽاى تئؿخعغايِب
يٌؼ اهضيل  الاهخؽاى فٕ اؿخعغاى أكؼاصؽوٓ  الإٌسبتٕ هِب خأذٖؼ اهّظؼ اهضضٕ هويؼأث اهخبؼٖظ
 x 
 فٕ اؿخعغاى أكؼاص الاهخؽاىٖيّغؼافٖج ّاهؾّايل الاسخيبؽٖج ّالاكخضبغٖج ؽوٓ ّخضغٖغ اٗذبؼ اهغ
 .يٌؼ اهضيل
 
نل  اهفوؿعٌٖٖج فٕسيؾٖج خٌغٖى ّضيبٖج الأؿؼث  أسؼاؤُب فٕخى  يلعؾٖج ُػٍ اهغؼاؿج ُٕ غؼاؿج
 7002نبًٌّ الأّل / غٖؿيتؼ  1فٕ اهفخؼث يً  ّعّهنؼى الله ىهضى، ضوضّل، اهعوٖل، ؼاتٖح  يً
. نل اهٌؿبء اهيؼاسؾبح هوسيؾٖج ّاهلاخٕ نً ٖؿخعغيً أكؼاص يٌؼ 8002آػاؼ / يبؼؾ  13ٓ إه
اؿختٖبً  تخؾتئج ؿٖغث 941كبيح  ،غؼاؿجاهاؿختٖبً اهغؼاؿج. ّعلال فخؼث  خؾتئجاهضيل ُعوة يًٌِ 
 اهغؼاؿج.
 
ً ضوضّل ٪ ي06.93 اهخبهٕ:ؽوٓ اهٌضّ  ضبفغبحاهغؼاؿج تًٖ اهي اهيشبؼنبح فٕاهٌؿبء نبً خّؽٖؼ 
. ؼاى اللهيً  ٪ 17.6٪ يً تٖح هضى ّ 10.01عّهنؼى،  يً  ٪ 14.11 ،٪ يً اهعوٖل 12.23، 
٪ يً  35.92يً اهيغً ،  نً ٪ يً اهٌؿبء 8.96 هوخسيؾبح اهؿنبٌٖج:أيب تبهٌؿتج هوخّؽٖؼ ّفلب 
.خى خضٌٖف أؽيبؼ اهٌؿبء اهيشبؼنج فٕ اهغؼاؿج إهٓ يسيّؽبح ٪ يً اهيعٖيبح76.0اهلؼْ ّ
٪ خخؼاّش أؽيبؼُى تًٖ  7.6ؽبيب ،  81٪ خلل أؽيبؼُى ؽً  2 ؽوٓ اهٌضّ اهخبهٕ:  زبٌح اهٌخبئّن
 9.04ؿٌج يً اهؾيؼ فٕ ضًٖ  33-92٪ تًٖ  2.62ؽبيب ،  82-42٪ تًٖ  2.42ؽبيب ،  32-91
) 711.2± اٌضؼاف يؾٖبؼٔ ( 91.4هويؼأث  لالأعفب يخّؿع ؽغغ. نبً ؽبيب أّ أنذؼ 43٪ نبٌح
. 31تٌٖيب نبً اهضغ الأكضٓ هؾغغ الأعفبل  عفل ّاضغ هويؼأث هضغ الأغٌٓ هؾغغ الأعفبلا ، ّنبًلعف
تًٖ الأعفبل، فٕ  نبٌح خؿخعغيِب هويتبؽغث يٌؼ اهضيل اهيؿخعغيج لأكؼاص٪ يً اهٌؿبء  7.95ٌضّ 
يٌؼ  أكؼاصخؿخعغى نبٌح ٪ 7.4هّكف إٌسبة الأعفبل ّ ِب٪ يٌِب نبٌح خؿخعغي 9.23ضًٖ أً 
 يٌؼ اهضيل اهيؿخعغيج لأكؼاص٪ يً اهٌؿبء  4.45ؼة يً بيب ٖل. يشبنل ضضٖج اهضيل تؿتة
عضّص الاؿخعغاى ت .ِب٪ لا خؾخؽى ّكف اؿخعغاي 6.54تٌٖيب  أؼغً إٖلبف اؿخعغايِب فٕ ّكح يب 
٪ نً  1.01٪ نً ٖأعػً الأكؼاص تبٌخغبى عّال اهّكح ،  3.98اهيٌخغى لأكؼاص يٌؼ اهضيل، 
ّفٕ  ٌبغؼًا يب نً ٖأعػً الأكؼاص تبٌخغبى. يًٌِ ٪ 7.0يؾغى اهّكح ّ  ٖأعػً الأكؼاص تبٌخغبى
٪ يًٌِ  1.01٪ يً اهٌؿبء فٕ اهغؼاؿج نبٌح خٌؿٓ أعػ الأكؼاص ضٖد أً  4.51اهؿٖبق ٌفؿَ ، 
٪  خٌؿٓ  7.0أً ٪ خٌؿٓ أعػ كؼضًٖ شِؼًٖب، فٕ ضًٖ  4.5ًّ نً ٌٖؿًٖ أعػ كؼص ّاضغ شِؼٖب
 تشنل ؽبى، فئً الاؿخعغاى اهيٌخغى لأعػ أكؼاص يٌؼ اهضيل خى ب.أعػ ذلاد أكؼاص أّ أنذؼ شِؼٖ
 7.01( اٌخغبى يخّؿع٪) ،  9.78( غبى ؽبهٕخاٌ يً كتل اهٌؿبء ؽوٓ اهٌضّ اهخبهٕ:  ّضفَ اهٌؿبء
ضغّد اهضيل فٕ اهٌؿبء اهلاخٕ ٖؿخعغيً ضتّة يٌؼ اهضيل نبً  ٪). 3.1( ّاٌخغبى ظؾٖف٪) 
 ix 
غؼاؿج ضغد هًِ ضيل تٌٖيب نً ٖؿخعغيً أكؼاص يٌؼ اهضيل. فٕ اه٪ فلع يً اهٌؿبء  4 كوٖلا؛
عتٖة اهوِٖب ٖ )٪ 7.95اهييؼظج (هوٌؿبء فٕ اهغؼاؿج نبٌح  هويؾوّيبح اهيؽّغ اهيضغؼ اهؼئٖؿٕ
اهيخولبث  يؾوّيبحاه ً٪) ّضف 9.58غبهتٖج اهٌؿبء ( ٪). 2.43( أعضبئٕ أيؼاط اهٌؿبء ّاهخّهٖغ
 .ّاظضج ّيفِّيجت
 
يؾؼفج اه. ّؿعضٖج ؽبيجنبٌح يؾؼفج  يٌؼ اهضيل صاهٌؿبء تأكؼا يؾؼفج أو غؼاؿجختًٖ يً ٌخبئز اه
ؾيل. اه يؽٖغ يً تضبسج إهٓ ح يخّاظؾج ّيٌؼ اهضيل نبٌ ضّل أكؼاصيعخوفج اهسّاٌة اهغكٖلج هو
فٕ اهضضّل ضلٖلٖج هويؼأث اهؼغتج اههٓ تبؿخعغاى أكؼاص يٌؼ اهضيل نبً ؽبهًٖب ُّػا ٖشٖؼ إ ىالاهخؽا
 بئز اهيؼسّث ُّٕ يٌؼ اهضيل ٌخٖسج لاؿخعغاى الأكؼاص اهيبٌؾج هوضيل.ؽوٓ اهٌخ
 
ضبسج تيٌؼ اهضيل  أكؼاصّضٕ تأً اهٌؿبء اهوّاخٕ ٖؿخعغيً خ ج، فئً اهتبضذٌخٖسج هِػٍ اهغؼاؿج
يٌؼ  أكؼاصتبلإظبفج إهٓ يؾوّيبح ينخّتج تبهوغج اهؾؼتٖج ضّل شفِٖج وضضّل ؽوٓ يؾوّيبح ه
تؼايز  ّٖضٓ أٖظًب تؾلغ .بيؾؼفخِهاهيؼأث  اهخٕ خضخبر اهسّاٌة اهِبيجاهضيل تعؼٖلج خغعٕ سيٖؼ 
 خؾؼٖفأكؼاص يٌؼ اهضيل ّغٖؼُب يً ّؿبئل يٌؼ اهضيل يً أسل اهيؿبؽغث فٕ خؾوٖيٖج ضّل 
 ّاهعٖبؼاح اهيخبضج هيٌؼ اهضيل تسيٖؼ اهّؿبئلاهيؼأث 
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1.1 Background 
 
Birth control and family planning are of the major public health hot issues discussed 
worldwide. Literature showed that there are several birth control methods that have 
different directions, mechanisms, effectiveness and both human and material costs. Birth 
control methods are usually classified into: physiologic methods, chemical barrier, 
mechanical barrier, intrauterine devices, subdermal implants and systemic hormonal 
control (Dunnihoo, 1992). Contraception was defined as the prevention of unwanted 
pregnancy and can be achieved by various means (Martin, 1996). The practice of 
contraception has been recognized by people since ancient times and different 
contraceptive measures have been used; some of these methods are counted to be natural 
while some are considered artificial (Dunnihoo, 1992).  
 
The first hormonal contraceptive that was approved for marketing was in the United 
States in year 1960. This contraceptive was consisted of an estrogen and a progestin in 
tablet form designed to be taken orally by women (Petitti and Sidney, 2005). In the 
United States, the Food and Drug Administration has approved the use of different birth 
control methods starting with over the counter methods, passing by prescription 
medications up to surgical options. The choice of birth control methods depends on 
different criteria of which the most important are: woman’s health, age, will to have 
children in future in addition to income (FDA, 1997).   
 
Oral contraceptive or “pill” is a preparation consisting of synthetic female sex hormones 
taken by women to prevent conception (Martin, 1996). There are two types of oral 
contraceptives: combinations of estrogens and progestin, usually called “the pill”, and 
progestin only tablets without the addition of estrogen, usually called “the mini pill” 
(Katzung, 2004). A large number of preparations are now available for oral 
contraception. When these medications are taken properly, the risk of conception is 
small; pregnancy rates are 0.5-1 for 100 women at risk (Katzung, 2004).   
 
Like any other medication, oral contraceptives have side effects some of which are mild 
and reversible while others are severe and could be irreversible. Mild side effects are like: 
nausea, headache and breast tenderness. Moderate side effects include: break through 
bleeding, weight gain, increased skin pigmentation, acne, hirsutism, urethral dilation, 
vaginal infections and amenorrhea. Severe side effects are: vascular disorders like venous 
thrombosis or myocardial infarction, gastrointestinal disorders, depression and cancer 
(Kalant and Roschlan, 1998).  Nevertheless, oral contraceptives have beneficial effects 
especially when using the low dose forms. These benefits include: reduced risk for 
ovarian cancer and benign breast tumor, lower incidence of ectopic pregnancy, decreased 
premenstrual symptoms, decreased menstrual cramps and bleeding and decreased risk for 
anemia and iron deficiency (Katzung, 2004). 
 
In conclusion, since oral contraceptives are widely used and have benefits, adverse 
effects and risk factors; family and personal history of women using them should be 
completely attended to. Equally important is their provision with complete information 
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and instructions about them so as to prevent problems and overcome them in case of 
occurrence (Katzung, 2004). 
 
The Palestinian Central Bureau of Statistics conducted a study using qualitative research 
methods on Palestinian Maternal and Child Health between February and December 
1999. Results showed that the most popular methods of birth control used were the intra 
uterine devices (IUD) followed by oral contraceptives (PCBS, 1999).    
 
According to Palestinian Ministry of Health, the percentage of oral contraceptives used of 
the total contraceptive in governmental family planning clinics is 33.2% (35.6% in GS 
and 31.9% in WB) (MOH, 2004). 
 
Despite this fact, women’s knowledge about oral contraceptives'; exact benefits, side 
effects, or directions remain notably limited. Uncontrolled missed doses often result in 
unwanted high-risk pregnancy when pills are being taken long before pregnancy has been 
ascertained.  
 
1.2 Problem Statement and Study Justification 
 
Since oral contraceptives are widely used and their use is on the rise, women using them 
should be well informed with every detail concerning them including : dosage, directions, 
benefits, side effects, interactions, precautions, risk factors and costs. 
 
Smith and Whitfield conducted a study in 1995 to determine the factors associated with 
women’s knowledge on how to take oral contraceptives correctly and then to examine 
improvement in their knowledge after providing them with leaflets about oral 
contraceptives and how to take them correctly so as to decrease the number of unplanned 
pregnancies in the United Kingdom. Data collected and analyzed revealed the 
improvement in women’s knowledge and the possibility of reducing the number of 
unplanned pregnancies and abortion following the provision of information for women 
on oral contraceptives (Smith, 1995). 
 
In 1994, Monash University at Box Hill Hospital in Victoria, a study was conducted to 
investigate whether medical practitioners were giving women important instructions 
concerning oral contraceptives as well as simple instructions. Results showed that 
information provided were mainly about: what to do if a dose was missed, if antibiotics 
were taken and if vomiting or diarrhea took place (Kovacs and Murtagh,1994). 
 
According to Townsend  (Network, 1993), the 70 million women in the world using oral 
contraceptives could be more if some regulations, medical practices or attitudes do not 
prevent them to.  These regulations and practices are not scientifically justified and 
hinder even unrisky women from using oral contraceptives. Guidelines for oral 
contraceptives contraindications were put by WHO and other agencies, e.g., smoking 
women older than 35 years are at risk for using oral contraceptives and progestin-only 
tablets are the ideal ones for lactating women (Townsend, 1993). 
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In 1999, Sydney Centre for Reproductive Health Research conducted a study about 
interactions between oral contraceptives and antibacterials/antifungals. The findings 
indicated that women taking both antibacterials and oral contraceptives should be 
informed of their interaction and of the precaution steps to take (Weisberg, 1999). 
 
Despite the fact that oral contraceptives are considered the most reversible birth control 
method used, they still have the possibility for the occurrence of unplanned pregnancy. A 
pilot study at the family planning centers in Australia revealed that the most common 
reasons for these pregnancies were missed doses, drug interactions or malabsorption due 
to vomiting or diarrhea. Results obtained from the study confirmed the effects of the 
mentioned factors on oral contraceptives effectiveness and the need for additional 
contraceptive method along with the first seven tablets taken to eliminate the possibility 
of decreasing the oral contraceptives effectiveness by the mentioned factors (Kovacs, 
1998). 
 
Due to the specific and difficult situations of the Palestinian people as a result of 
occupation itself and its consequences over years, the interests of Palestinian people and 
government differ from those of other countries. Other countries have adopted specific 
population policy while Palestine is categorized as a state without population policy. It is 
well noticed that countries adopting population policy have accomplished development 
by controlling population growth to meet their limited resources. In Palestine, fertility is 
high, resources are limited and health conditions are improving so that life expectancy 
has been increased. These factors resulted in delaying progress in the development 
process as revealed in demographic and health surveys (PCBS, 2004). 
 
Knowledge is a very important factor in the use of family planning methods since 
absence of knowledge limits the adoption of such methods. In Palestine, knowledge of 
family planning methods is high and was 99.4% in 2004 distributed as 99.3% in the West 
Bank and 99.6% in Gaza Strip. Variations of knowledge are seen with increasing level of 
education of women whereas place of residence barely showed a difference. The 
percentage of knowledge about intra uterine devices was 99.3% in 2004 while knowledge 
about oral contraceptive pills was 98.7% (PCBS, 2004).  Although knowledge of family 
planning method in Palestine is high, 73.9% of ever married women ever used a family 
planning method. Reasons for not using family planning methods are varied including:  
 
 desire to have children  
 objection from in-laws 
 religious reasons (9%) 
 fear from side effects (9.5%) 
 not convinced in family planning methods (5.3%) 
 
These reasons show how the social attitudes and beliefs are the major reasons for not 
adopting family planning methods. In other words, about quarter of the stated reasons can 
be reduced by education and increasing awareness based on scientific information so as 
to increase family planning methods use (PCBS, 2004). 
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As seen in different demographic and health surveys, the intra uterine device is the most 
widely family planning method used in Palestine. Reasons for using the intrauterine 
device more are its convenience, its long term effectiveness and because it does not affect 
sexual relation (PCBS, 1998). In general, women depend on medical advice for choosing 
the contraceptive method which means that health care providers need to promote other 
methods in addition too the intrauterine device. Refusal to use oral contraceptive pills or 
injections is due to beliefs that they cause infertility. Other reasons behind that are that 
women believe that oral contraceptives cause obesity, nervousness, headache, swelling, a 
decrease in breast milk, irregular menstruation and cancer.  (PCBS, 2000).   
 
Regarding the perception of Islam to family planning, Palestinian religious leaders have 
stated in mosques and via mass media that contraception to ensure adequate child spacing 
and to ensure mother’s health is supported by Islam (PCBS, 2000). 
 
This study is concerned in exploring the level of knowledge women using oral 
contraceptives have. Women current users of oral contraceptives who obtain their pills 
from the clinics of The Palestinian Family Planning and Protection Association (PFPPA) 
will be surveyed to determine the quantity and quality of information they have on 
various aspects of oral contraceptives with particular reference to the ones they currently 
use. This is in addition to the adherence levels and motives of the women themselves. 
This way, gaps are detected and employed as grounds for determining suggested 
interventions. Anticipated deficits are expected to relate to: incomplete information by 
doctors, unclear instructions given by pharmacists and nurses or poor adherence and 
compliance by the women themselves. 
 
1.3 Study Setting 
 
Clinics of the PFPPA in Bethlehem, Halhoul, Hebron, Ramallah, and Tulkarem.  
 
1.4 Aim of the Study 
 
Investigate determinants of compliance to oral contraceptives usage among current users 
in the clinics of the PFPPA in Bethlehem, Halhoul, Hebron, Ramallah, and Tulkarem. 
 
1.5 Objectives of the Study 
 
1.5.1 General Objectives: 
 
 Examine women’s knowledge concerning oral contraceptives’ use and its 
effect on compliance. 
 
 Examine the relation between oral contraceptive use patterns and 
compliance.  
 
 Explore the effect of women’s general health status on compliance to oral 
contraceptives’ usage. 
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 Explore the effect of women’s maternal history on compliance to oral 
contraceptives’ usage. 
 
 Identify the effects of demographic and socioeconomic variables on 
compliance to oral contraceptives’ usage. 
 
1.6 Study Assumptions 
 
 Compliance problems are due to poor knowledge. 
 
 Poor knowledge is related to women's fear to communicate their problems or 
concerns with the health care team. 
 
1.7 Study Limitations 
 
1. Small sample size. 
 
2. The study can not be generalized to the whole community since it only covered 
certain association and also because certain districts were covered. 
 
3.  Reaching Tulkarem are by the researcher was difficult, so data were collected 
their by the PFPPA. 
 
4.  The questionnaire used in the study was composed of nearly 90 questions; filling 
it in needed a long period of time.  
 
5.  Filling in the questionnaire depended mainly on respondents’ memory leaving 
the researcher with the recall effect.  
  
 1.8 Thesis Structure 
 
The thesis is presented in six chapters listed as follows: 
 
Chapter One 
 
This chapter contains background, problem statement and study justification, study 
setting, aim of the study, study objectives, research questions, study assumptions, study 
limitations and description for the study chapters. 
 
Chapter Two 
 
This is the literature review chapter in which studies about contraceptive use in general 
and coral contraceptive use in specific are discussed. Different studies are included from 
different regions. International, Arab and Palestinian statistics concerning contraception 
use and family planning are stated. This chapter also contains religion’s point of view 
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towards family planning and contraception. In addition, oral contraceptives are discussed 
from different aspects like: their action and efficacy, factors behind their use, different 
behaviors and attitudes towards oral contraceptives use, the definition of compliance and 
how it affects oral contraceptives use and finally oral contraceptives related mortality. 
 
Chapter Three 
 
Terms used in the study are defined in this chapter in addition to conception and 
contraception definitions. Different contraceptive methods are also discussed in this 
chapter. Model used in the study according to which variables were connected and thus 
analysis was made is found in this chapter. 
 
Chapter Four 
 
This is the methodology chapter that talks about the study design, sample determination, 
inclusion and exclusion criteria, research field, ethical consideration, research tool, the 
pilot study, data collection, research obstacles and data analysis. 
 
Chapter Five 
 
This is the results chapter in which data analysis results are presented. Data analysis was 
made in two parts: descriptive analysis and univariate analysis. In the descriptive 
analysis, nearly all variables asked for in the study were analyzed into counts and 
percents and results were shown in tables and figures. Concerning the univariate part of 
the analysis, cross tabulation was made and Pearson chi square was the test used.    
 
Chapter Six 
 
This chapter includes discussion of the main results of the study. Comparison between 
findings of the study and findings of some regional and international studies are included in 
this chapter. The chapter also includes conclusions of the study and recommendations for 
future research plans. 
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2.1 Introduction 
 
The issue of contraception is not a new one; it is considered to be as old as humanity. It 
has been practiced in its different forms throughout history. Reasons for contraception 
have been mainly classified as economic or political (Tindall, 1987; Dunnihoo, 1992).  
 
Since ancient years, history has witnessed the use of different methods. Coitus interrupts, 
douches, vaginal insertion of some animal extracts have been used long ago. In a1350 
B.C., Egyptians developed penile sheaths which were used till 1504 A.D. Afterwards, in 
the nineteenth century, rubber condoms became widely available. Around the beginning 
of the century, appeared the concept of family planning and population education in this 
issue became a career. By 1915, diaphragms and cervical caps were introduced into use.  
In 19650, contraceptive hormones were developed where the first study on contraceptive 
pills appeared in 1956. In 1960, the pill was approved by the FDA and then Searle 
Pharmaceutical Company marketed the first oral contraceptive pill (Dunnihoo, 1992).  
 
As time goes on, the world population increases and thus humanity is put in challenge 
with the scarcity of resources. In the last century, there has been great development in the 
contraceptives production. It is expected that this development will be more in the years 
to come so that more efficient compounds and techniques are to be developed. The 
increase in the world population necessitates the recognition of governments to the 
importance of family planning and population growth control because of the scarcity of 
world's resources. It is anticipated that governments will oppose policies that will be 
forced by law in a way similar o that followed in China so as to control population 
growth in a more strict way (Dunnihoo, 1992).  
 
Contraception is considered to have different consequences that affect the family itself, 
the community and the world in general. In the past, population growth was limited 
because of high death rates. But now, developments in sanitation and health facilities 
resulted in death control especially in infants and children and this resulted in increased 
rate in population growth. Contraception is usually an individual choice that couples 
choose for different reasons. Mainly, contraception is followed to help in family planning 
application either by birth spacing or by limiting family size and thus decreasing 
population growth. Some cases of husband or wife health problems enforce the use of 
contraceptive methods especially in conditions where the wife has a chronic systemic 
disease or when the disease in question can be transmitted to the fetus. In general, 
contraception is now followed in places around the world for different reasons that have 
an overall result presented in population growth decrease (Tindall, 1987). 
 
The use of different methods of contraception has increased in the last 30 years all around 
the world. However, this increase is not directly related to reduction in unintended 
pregnancies nor has it shown better compliance in contraception use (Shields, 2006).  
 
More than 100 million women depend on the oral contraceptive pill as a method for 
contraception worldwide. Half of the married women in Western Europe use the oral 
contraceptive pill and thus rendering it as the most popular contraceptive method in 
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Western Europe. However, in countries of southern east Asia like china, India and Japan, 
the oral contraceptive pill is used to a lesser extent (Blackburn, et al., 2000).  
 
2.2 Contraception and Religion 
 
In the past religion, politics and law had been considered as limitations for the use of 
contraceptives whereas they do not nowadays have a significant effect (Jones, 1999). 
 
Islamic literature has shown that the use of contraceptive methods was not forbidden by 
Islam since its early days. Islam has approved the use of nonpermanent contraceptive 
methods. Table 2.1 shows several legal opinions in Islamic jurisprudence (Fatwa) and 
conferences against contraception in the twentieth century: 
 
Table 2.1: Several Legal Opinions in Islamic Jurisprudence (Fatwa) and 
Conferences against Contraception in the Twentieth Century  
 
 
Year 
 
Fatwa (religious scholar) or conference  
 
Major commentary 
 
1937 Fatwa (Sheik* Abdul-Majid Saleem, 
Mufti of Egypt) 
The use of family planning through al-
azl (coitus interruptus) and new 
contraceptive methods is sanctioned. 
1964 Fatwa (Sheik Abdulllah Al-Qalqili, Mufti 
of Jordan) 
There is clear indication in Sharia that 
contraception is definitely allowed.  
1965 The academy (high council) of Islamic 
research in Cairo, Egypt 
Couples are free to practice family 
planning according to individual 
conscience and sense of religion>. 
1971 The “Islam and family planning” 
conference in Rabat, Morocco 
The Islamic law gives the Muslim 
family the right to deal with sterility 
and to plan suitably spaced 
pregnancies using safe and lawful 
contraceptive methods. 
1979, 
1980 
Fatwa (Sheik Jadel Haq, Mufti of Egypt The contraception in not antagonistic 
to the truth of God, neither is it a 
contradiction to the will of God. 
1988 Fatwa (Sheik Sayyid Tantawi, Mufti of 
Egypt 
Family planning is sanctioned 
liberally for economic, cultural or 
health reasons. 
Source: (Sueyoshi, et al, 2006) 
 
According to Islam and based on sources of Shari’ah (Quran, Hadeeth and Qiyass), 
family planning is considered not forbidden. Where Quran is the word of God, Hadeeth is 
Prophet Muhammad tradition and words base on the revelation of God, Qiyass is analogy 
and Shari’ah is a complete detailed code of conduct based on rules and regulations 
revealed to the prophet Muhammad in the Quran and Hadeeth. However, different 
positions to family planning are seen by Muslim authorities (Mecca in Saudi Arabia, Al 
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Azhar in Egypt, and Qum in Iran). Opponents to family planning build their opposition 
on the fact that Quran described children as great assets and that larger number of 
Muslims means greater power. On the other hand, supporters of family planning state that 
family planning originated among Muslims fourteen centuries ago long before its 
appearance in the West. They quote that Imam Ali (the fourth Caliph) denied in the 
presence of the second Caliph Omar that “al azl” (coitus interruptus) was “wa’d (killing). 
In the same context, breastfeeding as mentioned in the Quran would last two years after 
delivery and breastfeeding is still one of the normal and traditional methods of family 
planning used till nowadays. (Hasna, 2003). 
 
In one of his collected sayings “Hadeeth”, Prophet Muhammad was asked about 
withdrawal and replied that it was permitted for if God wanted to create something no 
one could prevent it. Based on this it was interpreted by analogy “Qiyass” that 
nonpermanent contraceptive methods are allowed to be used (Underwood, 2006).  
 
So in other words, the idea that Islam is against contraception or family planning should 
be related to misunderstandings and misconceptions of Islam rules in this area where 
social and cultural aspects of Islamic world in general and Arab world in specific were 
behind this idea (Hasna, 2003). .   
 
2.3 Contraception Internationally  
 
Contraceptive methods use differs between developed and developing countries. 
Developed countries have high percentage of contraceptive use. For example, 98% of the 
sexually active females in United Kingdom in years 2004 & 2005 were reported to use a 
method of contraception (Shields, 2006).In developed countries, the oral contraceptive 
pills are the most widely use method where 16% of married women use the contraceptive 
pill followed by the intrauterine device and the condom with a percentage of 14% and 
finally come the traditional methods with a percentage less than 14%. As for the 
developing countries, 6% of married women use the pill, 13% use the intrauterine devices 
and 21% use the female sterilization method. However, since the oral contraceptive pill 
use in India and china has been limited, excluding them from these estimates changes the 
percentages of contraceptive methods use totally; i.e. oral contraceptives become the 
most widely used with a percentage of 10%, followed by female sterilization 9%, then 
traditional methods 8% and finally intrauterine devices 7% (Blackburn, et al., 2000). 
 
Oral contraceptives are the most widely used contraceptives in Europe and the world 
(Rosenberg, et al., 1995). Oral contraceptives are the most commonly used method of 
contraception in the United States; 30% of women of reproductive age in USA use oral 
contraceptives (Huber et al., 2006). More than 10 million women in the United States use 
oral contraceptives in order to prevent pregnancy. Unintended pregnancy resulting while 
using oral contraceptives was mainly related to incorrect or inconsistent use, side-effects 
experience or women dissatisfaction (Hansen and Saseen, 2004).  
 
Following a survey data on ever using a contraceptive method, the oral contraceptive pill 
was the most method to be used in 44 out of 68 developing countries. Excluding China 
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(no recent data of ever pill use), 40% of married women in these 68 developing countries 
had used the pill in their lives. Examples of oral contraceptive use in some developing 
countries: 
 
 80% of married women in Brazil have used the pills in their lives 
 nearly 66% of married women in Morocco have ever used the pills 
 44% of married women in Algeria were using the oral contraceptive pill in 1995 
 23% of married women in Iran reported using the pills 
 24% of married women in Kuwait reported using the pills 
 
However, oral contraceptives use is more common in developed countries than in 
developing countries, e.g.  
 
 94% of eastern German women have used the pill 
 86% of surveyed women in Canada in 1995 had used the pill 
 80% of women in the United States born since 1945 have used the pills 
(according to an estimate in 1990). 
 
Patterns and percentages of use for the different types of contraceptive methods change 
constantly. Figure 2.1 shows changes in distribution of contraceptive methods use in 
selected developing countries (Blackburn, et al. 2000). 
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Source: (Blackburn, et al., 2000) 
 
Figure 2.1: Change in Contraceptive Method Mix in Selected Developing Countries 
(1978–1998) 
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As for Arab countries, according to Demographic Health Survey (DHS) in 2003 fertility 
rate was 4.4 per Jordanian woman and contraceptive use was 37.7%. Intrauterine devices 
and oral contraceptives are the most popular methods of contraception among Jordanian 
women. According to Demographic Health Survey (DHS) in 2003; 22.3% of Jordanian 
women used intrauterine devices and 6.3% used oral contraceptives. This percentage for 
oral contraceptives use is due to women's beliefs and misconceptions of oral 
contraceptives (e.g. having side-effects like: cancer, weight gain or infertility). 
Concerning reasons for discontinuation of oral contraceptives among Jordanian women 
side-effects had the higher percentage with (33.4%), followed by health concerns (6%), 
inconvenience (3.8%) and finally fatalism (0.2%) (Kridli and Newton, 2005). 
 
Talking about Palestine necessitates mentioning the status of Arab citizens in Israel.  
Families of Arab citizens in Israel are in general characterized by having five children or 
more. Fertility rate of Muslim women in Israel is 4.6 whereas that of Jewish women is 
2.6 (Abu Ahmed, et al., 2003).  
 
Many studies have been conducted in Israel concerning contraceptive use addressing in 
particular the condition of women in the Arab population. However, Arab women 
attitudes towards family planning and contraception use have not been studied yet. A 
study was conducted in the Arab villages in which Arab women using contraceptives 
were the studied population. In this study, family planning and the use of contraceptives 
among Arab women in Israel was examined. Of the obtained results, 6.9% of the 
participating women (303) were using oral contraceptive pills, 60.8% were using IUDs 
and 11.2% had had tubal ligation (Abu Ahmed, et al., 2003). 
 
2.4 Contraception in Palestine 
 
Concerning Palestine whose total fertility rate was calculated to be 4.6 (5.8 in Gaza Strip 
and 4.1 in the West Bank) 2005 (MOH, 2005), the most popular contraceptive methods 
used were: the intra uterine devices (IUD) followed by oral contraceptives (PCBS, 1999).  
 
According to the Demographic Health Survey conducted by the PCBS in 2004, the 
contraceptive prevalence rate in Palestine was 50.6 %( 55.1% in the West Bank and 
43.0% in Gaza Strip) as shown in (Figure 2.2) (MOH, 2005). 
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Source:  (The Status of Health in Palestine, Annual Report, MOH, 2005) 
 
Figure 2.2: Percentage of Currently Married Women Aged 15-49 Years who are 
Using a Contraceptive Method by Region, 2005 
 
Use of family planning methods was reported to be 55.3% by rural women, 50% by 
urban women and 44.7% by refugee camp women (MOH, 2005). 
 
A significant increase (16.8%) in the use of contraceptive methods has been noticed in 
Palestine where the number of all beneficiaries’ visits (new and repeated) from family 
planning services in the Ministry of Health was 110,478 visits in 2005 compared with 
94,578 visits in 2004 (MOH, 2005).  
 
In the West Bank, the increase was by 6.5%: from 52,249 visits in 2004 to 55,633 visits 
in 2005. In Gaza Strip, the increase was by 29.5% from 42,329 visits in 2004 to 54,845 
visits in 2005. New beneficiaries getting family planning services of the Ministry of 
Health centers were 16,474 constituting 14.9% of the total beneficiaries and preferred to 
use the contraceptive pills among other contraceptive methods (MOH, 2005). 
 
From regional distribution point of view, the most popular contraceptive method in the 
West Bank was intrauterine devices (40.2%), whereas oral contraceptive pills were the 
mostly used in Gaza strip (44.9%) as shown in (Table 2.2) (MOH, 2005). 
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Table 2.2: Distribution of Contraceptive Methods Used by New Clients in MOH-
Palestine, 2005 
 
 
Source: (The Status of Health in Palestine, Annual Report, MOH, 2005)
 
 
Different health sectors provide the Palestinian community with family planning 
methods. Sources of family planning methods differ between the West Bank and Gaza 
Strip. The main source for family planning methods in the West Bank is the private sector 
(including hospitals, health centers specialized physicians) with a percentage of 47.6%. In 
Gaza Strip, the main source for family planning methods is the UNRWA hospitals and 
health centers with a percentage of 58.1%. (PCBS, 2004) 
 
According to Palestinian Ministry of Health, the percentage of oral contraceptives used of 
the total contraceptive in governmental family planning clinics is 38.7% (44.9% in Gaza 
Strip and 34.1% in the West Bank) (MOH, 2005). 
 
Ministry of health is not the only party providing family planning services in Palestine. 
United Nations Relief and Works Agency (UNRWA) clinics and Non Governmental 
Organizations clinics (NGOs) also provide family planning services. The most popular 
contraceptive method in the UNRWA family planning centers were the pills with a 
percentage of 44.8% followed by condoms with a percentage of 26.1% of total 
contraceptive methods. As for the NGOs, intrauterine devices wee the most popular 
method with a parentage of 40.0% of total contraceptive methods (MOH, 2005). 
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As for age distribution for women using family planning, in the West Bank 2.5% of users 
were less than 20 years, 45.5% were women between 20-30 years old and 52% were 
women more than 3o years old as shown in (Figure 2.3) (MOH, 2005). 
 
                                                                  Source:  (The Status of Health in Palestine, Annual Report, MOH, 2005) 
 
Figure 2.3: Percentage of Women Using Family Planning Methods by Age groups, 
West Bank, 2005 
 
Results of the Demographic Health survey in 2004 showed the effect of age, level of 
education and place of residence on the use of family planning methods. These results are 
illustrated in the following figures:   
 
 
                               Source: (PCBS, Demographic and Health Survey – 2004: Final Report, February, 2006)  
Figure 2.4: Percentage of Women Aged 15-49 Years Ever-Used Family Planning 
Methods by Region and Age (PCBS, 2004) 
 
 18 
The percentage of women aged 15-49 years who ever-used family planning methods is 
78.5% in the West Bank and 65.9% in Gaza Strip as shown in (Figure 2.4). The figure 
also shows that use of family planning methods is increased with older ages with a peak 
of 84.8% at the ages 40-44 yrs (PCBS, 2004). 
 
 
Source: (PCBS, Demographic and Health Survey – 2004: Final Report, February, 2006)  
 
Figure 2.5: Percentage of Women Aged 15-49 Who Currently Use Family Planning 
Methods by Region and Type of Locality (PCBS, 2004) 
 
The contraceptive prevalence rate in the West Bank is higher than that in Gaza Strip with 
percentages of 55.1% and 43.0% respectively as shown in (Figure 2.5).  It also shows 
that family planning methods are most widely used in rural areas than in urban areas or 
refugee camps with percentages of 55.3%, 50.0%, and 44.7% respectively (PCBS, 2004). 
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Source: (PCBS, Demographic and Health Survey – 2004: Final Report, February, 2006)  
 
Figure 2.6: Percentage of Women Aged 15-49 Who Currently Use Family Planning 
Methods by Age and Education (PCBS, 2004)  
 
Figure (2.6) shows that older women tend to use family planning methods more than 
younger ones. In the same context, women with higher education use family planning 
methods more than less educated women (PCBS, 2004). 
 
Family planning methods are used to achieve one of two main outcomes: child spacing 
and/or stop having children. Most of women who ever-used a contraceptive method use it 
for spacing between children with a percentage of 76% (PCBS, 1998) Number of 
children the family has is decided by husband and wife with a percentage of (77.9%), the 
husband alone with a percentage of (13.8%) or the wife alone with a percentage of 
(6.9%). Nearly 50% of women at child bearing age want to stop having more children, 
44.4% want to have more children, 2.4% are not able to have more children and 1.5% are 
not sure of what they want (PCBS, 2000).  
 
Main sources of information about contraceptive knowledge were a friend or a relative 
for both West Bank and Gaza Strip followed by media as seen in (Figure 2.7). This 
implies the needs to examine the quality and level of the information Palestinian women 
have. As for the main medical source of information, doctors with a percentage of 
(35.4%) were reported to be as a source of information in the West Bank, whereas nurses 
with a percentage of (48%) were reported as a source of information for women in Gaza 
Strip  (PCBS, 2000).  
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Source: (PCBS, Palestinian Maternal and Child Health: A Qualitative National Study, July, 2000) 
 
 
Figure 2.7: Percentages of Ever-Married Women Aged 15-49 Years by Source of 
Information about a Contraceptive Method and Region (PCBS, 2000) 
 
 Many reasons are behind not using any contraceptive method by Palestinian women 
(Table 2.3). The main reason is the fear of having side effects. Religious opposition for 
contraception is mainly related to misconception of Islam and should be related to 
Palestinian customs and social culture rather than Islam (PCBS, 2000).  
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Table 2.3: Percentage of Currently Married Women who are not currently Using 
Contraceptive Methods by Reason and Region (1996, 2000) 
 
Reasons for not Using 
Palestinian 
Territories 
Gaza Strip West Bank 
2000 1996 2000 1996 2000 1996 
Oppose Family 
Planning 
0.8 12.6 0.2 14.3 1.2 11.2 
Husband Oppose 5.7 17.7 5.9 21.8 2.6 14.5 
Relative Oppose 0.2 1.3 0.4 1.0 0.1 1.5 
Side Effects 13.1 10.8 10.1 10.3 15.1 11.2 
Lack of Knowledge 0.3 2.1 0.3 2.3 0.3 2.0 
Cost Too Much 0.2 0.6 0.0 0.7 0.4 0.6 
Inconvenient 4.0 3.7 3.5 3.0 4.2 4.3 
Menopause 10.3 43.6 11.9 39.9 9.7 46.5 
Religious Oppose 1.6 7.3 1.2 6.7 1.9 7.8 
Source: (PCBS, Health and Demographic Indicators of Census, Health and Demographic Surveys Data: Pocket Book, May, 2002.) 
 
2.5 Oral Contraceptives Overview 
 
Highly effective contraception methods are hormonal contraceptions like oral 
contraceptive pills, injections and implants. These methods have high efficacy and their 
failure is due to discontinuation and inconsistence use (Shields, 2006), (Cheung and Free, 
2005).  
 
Oral contraceptives are of the hormonal contraceptives that prevent pregnancy through 
their action on hormones in the woman body. The mechanism of action of oral 
contraceptives is through suppressing ovulation and controlling the levels of estrogen and 
progestin. When oral contraceptives are used consistently on a regular daily routine, they 
give 99.5-99.9% rate of effectiveness in preventing pregnancy and a failure rate of 0.5-
3.0%. Oral contraceptives are of two types based on their composition: combined tablets 
of progestin and estrogen or progestin only tablets called "minipills" (Branden, 
November/December 1998). 
 
Since first introduced in 1960, twenty different formulations of oral contraceptive pills 
have been developed. Early formulations had more side-effects than the formulations 
found nowadays because they had higher concentrations of estrogen (Moore, et al., 
September 1996; Curtis, et al., 2006). 
 
Progestin only tablets or minipills prevent pregnancy by changing the nature of the 
cervical mucous and the uterine linings so as to prevent implantation. Progestin only 
tablets reduce the incidence of anemia by decreasing menstrual bleeding and are free of 
the estrogen side-effects like hypercoagulability. Progestin only tablets do not decrease 
milk supply and thus are suitable to be used by lactating women. However, progestin 
only tablets have side-effects like irregular bleeding, weight gain, breast tenderness, and 
increased risk of osteoporosis. Oral contraceptives have to be taken every day on the 
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same time so as to be effective with little failure rates of 0.5% (Branden, 
November/December 1998). 
 
2.6 Oral Contraceptives Discussion 
 
2.6.1 History of Oral contraceptives 
 
In the beginning of the twentieth century, European scientists: Beard, Loeb and  Prenant 
developed a concept saying that during pregnancy ovulation is suppressed due to the 
secretions of the corpus luteum. In 1927, Haberlandt, an Austrian physiologist, was able 
to produce temporal sterility in rodents by feeding them with ovarian and placental 
extracts (Brunton, 2006). In 1930s, scientists determined the structures of hormones and 
found that high doses of androgens, estrogens or progesterones inhibit ovulation 
(Wikipedia, 2006). In 1937, Makepeace and colleagues found that progesterone had 
blocked ovulation in rabbits and in 1939, Astwood and Fevold talked about the same 
effect in rats (Brunton, 2006). In 1939, Marker (an organic chemistry professor), 
developed a method for the synthesis of progesterone from plant steroid sapogenins 
(Wikipedia, 2006). The years of 1950s witnessed development in contraceptive research 
by many scientists. In 1950s, John A. Rock developed contraceptive hormones from a 
wild inedible Mexican yam and was given the name "father of the pill" (Wikipedia, 
2006). Garcia, Pincus and Rock found in 1950 that progesterone and 19-nor progestins 
inhibit ovulation in females (Brunton, 2006). In 1956 Garcia and Rice-Way performed 
the first clinical studies in Puerto Rico (Dunnihoo, 1992). In 1960, "Envoid" (composed 
of norethynodrel and mestranol) was the first contraceptive pill approved by the Food and 
Drug Administration and was marketed by the Searle Pharmaceutical Company (Brunton, 
2006; Wikipedia, 2006). In 1962, Ortho-Novum (composed of norethindrone and 
mestranol) was the second pill approved by the FDA (Brunton, 2006). In 1965, Pincus 
and Chueh-Chang published the first research studies on contraceptive pills (Brunton, 
2006). By 1966, there were many oral and injectable contraceptives available in different 
formulations (Brunton, 2006). Although approved by the FDA, oral contraceptives were 
only approved for use in France in 1967 when the "Neuwirth Law" allowed contraception 
including the contraceptive pill (Wikipedia, 2006). In 1970s, reports concerning 
undesired side effects of oral contraceptives appeared. These side effects were seen to be 
dose related and thus a second generation of oral contraceptives with lower hormonal 
concentrations was developed (Brunton, 2006). In 1980s, non contraceptive health 
benefits of oral contraceptives were recognized (Brunton, 2006). 1n 1990s, a third 
generation of oral contraceptives was developed which was distinguished for containing 
progestins with reduced androgenic effects like norgestimate or desogestrel (Brunton, 
2006). Although oral contraceptives have been available for use in USA and Europe, 
Japan Medical Association allowed their use in Japan only in 1999 (Wikipedia, 2006). 
 
2.6.2 Social and Cultural Impact of Oral Contraceptives 
 
Since their first introduction to use in 1960, oral contraceptives have had a wide social 
impact. Oral contraceptives have become very popular because of their effectiveness in 
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comparison to previously used methods of contraception and also due to the fact that they 
are used with no relation to intercourse. (Wikipedia, 2006). 
 
In the1970s that witnessed the recognition of oral contraceptives side effects, breast 
cancer reports due to oral contraceptives appeared. This made oral contraceptives loose 
some of their reputation (Wikipedia, 2006). 
 
Because of being a female contraceptive method, oral contraceptives gave rise to some 
gender related issues. Oral contraceptives were seen by the feminist movement as a male 
invention used by women and can possibly threaten their health while men themselves 
are free from this outcome (Wikipedia, 2006). 
 
2.6.3 Environmental Impact of Oral Contraceptives 
 
Synthetic estrogens undergo hepatic metabolism that result in active metabolites excreted 
in the bile, breast milk and urine (Katzung, 2004). 
 
Synthetic estrogens like ethinylestradiol are excreted in the urine unchanged. Sewage 
treatment does not involve the treatment of these chemicals and thus are discharged in the 
water system resulting in chemical pollution that can affect aquatic organisms like fish, 
frogs or plankton (Wikipedia, 2006).   
 
Synthetic progestins are excreted in the urine in the form of inactive metabolites after 
undergoing hepatic metabolism (Katzung, 2004). 
 
2.6.4 Types of Oral Contraceptives 
 
Oral contraceptives are categorized into two main categories based on their active 
constituents: combination oral contraceptives and progestin-only oral contraceptives 
(Berek, 2002; Brunton, 2006).  
 
1. Combination Oral Contraceptives: these are composed of estrogen and 
progesterone derivatives in different concentrations and are in turn of three 
types: 
 
a. Monophasic: this type of oral contraceptives is composed of the same 
concentrations (doses) of estrogen and progesterone in tablets and is taken 
every day (Berek, 2002). Most oral contraceptives are monophasic. 
Monophasic oral contraceptives are found in two forms of packages. Some 
packages contain 21 tablets taken for 21 days and all are of the same 
colour. However, most packages contain 28 tablets for 28 days of which 
the first 21 tablets are active while the last 7 tablets (with different colour) 
are inactive for they contain inert matter and are included to facilitate use 
(Marks and Crandall, 2004; MedlinePlus, 2004). 
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b. Biphasic: these contain the same concentrations of estrogen but varying 
concentrations of progesterone so that the progesterone/estrogen ratio is 
different in the two phases (Brunton, 2006). Packages of biphasic oral 
contraceptives are found as 21 or 28 packages. Concerning the 21-
packages; tablets are found in two different colors to differentiate the two 
phases:  the first phase has tablets whose progesterone/estrogen ratio is 
lower in order to allow the thickening of the endometrium as it normally 
does; the second phase has tablets whose progesterone/estrogen ratio is 
higher to allow normal shedding of the lining of the uterus to occur. As for 
the 28-packages; additional 7 inert tablets of a third color are included to 
complete the 28 tablets (Marks and Crandall, 2004; MedlinePlus, 2004). 
 
c. Triphasic: these contain varying concentrations of estrogen and 
progesterone in order to mimic the normal ratios of estrogen and 
progesterone in the body during the menstrual cycle (Brunton, 2006). 
Packages of triphasic oral contraceptives are found as 21 or 28 packages. 
Concerning the 21-packages; tablets are found in three different colors to 
differentiate the three phases. As for the 28-packages; additional 7 inert 
tablets of a fourth color are included to complete the 28 tablets (Marks and 
Crandall, 2004; MedlinePlus, 2004). 
 
2. Progestin-Only Oral Contraceptives: these are generally referred to as 
"the mini-pill". They do not contain estrogen and are composed of 
progesterone alone (Berek, 2002, Brunton, 2006). Progestin only tablets are 
considered to be less effective then the combined oral contraceptives but are 
the best to use by lactating women since they are not excreted in milk nor do 
they reduce milk production (Hatcher, et al., 2001; Katzung, 2004). They 
are also useful in women with liver problems, hypertension, psychosis or 
previous thromboembolism (Katzung, 2004). 
 
2.6.5 Mechanism of Action of Oral Contraceptives 
 
Combination oral contraceptives exert their effects through the effects of estrogen and 
progesterone together. Their mechanism of action is related to the negative feedback of 
estrogen on the pituitary gland that results in inhibiting the pituitary function i.e. the 
follicle stimulating hormone and luteinizing hormone release are inhibited and thus 
ovulation is inhibited (Taylor, et al., 2003; Katzung, 2004; Brunton, 2006). This 
ovulation inhibition is accompanied by physiological changes in the uterus and cervix 
which are related to both hormones. Cervical changes are related to thickening of the 
cervical mucous which in turn limits sperm movement and prevents its penetration and 
thus decrease the possibility of conception. Uterine changes are seen as thinning of the 
endometrium so that implantation is inhibited (Taylor, et al., 2003; Katzung, 2004; 
Brunton, 2006). Estrogen also accelerates ovum transport and thus decreases the chance 
for fertilization (Borgelt-Hansen, 2001).     
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Progestin-only contraceptives mechanism of action does not involve ovulation inhibition. 
It is mainly related to the cervical and uterine physiological changes responsible for 
conception and implantation inhibition (Taylor, et al., 2003; Katzung, 2004; Brunton, 
2006). By thickening the cervical mucosa, progestin slows sperm transport and inhibits 
the activation of enzymes that permit the sperm to penetrate the ovum (Borgelt-Hansen, 
2001).   
 
2.6.6 Effects of Oral Contraceptives on Different Body Organs 
 
Oral contraceptives have effects on different body organs including reproductive and non 
reproductive organs. 
  
2.6.6.1 Effects on Reproductive Organs 
   
a. Effects on the Ovary: ovary function is changed and suppressed by the 
use of oral contraceptives where follicular development is diminished and 
the ovaries become smaller than before. Discontinuation of oral 
contraceptives makes the ovary retain its ovulatory function and thus the 
return of normal menstruation. However, normal menstruation and 
ovulation reoccurrence may need time after the discontinuation of oral 
contraceptives (Katzung, 2004).    
 
b. Effects on the Uterus: cervix may undergo hypertrophy and polyp 
formation when oral contraceptives are used for long periods. Secretions 
of the cervical mucous become less and thicker (Katzung, 2004).     
 
c. Effects on the Breast: enlargement of the breast occurs while using oral 
contraceptives. Lactation is suppressed in combined oral contraceptives as 
a result of estrogenic effect (Katzung, 2004).    
  
 2.6.6.2 Effects on Non Reproductive Organs 
 
a. Effects on the Cardiovascular System: oral contraceptives have little 
effect on the cardiovascular system noticed as slight increase in blood 
pressure, heart rate and cardiac output. These changes are usually 
reversible and disappear upon discontinuation of oral contraceptives 
(Katzung, 2004).    
 
b. Effects on the Blood: thromboembolism has been noticed to occur in 
women using oral contraceptives. This issue has been subjected to 
extensive research and theories since the first years of oral contraceptives 
use. Coagulation seen in women using oral contraceptives occurs in the 
same way as that occurring in pregnant women, but a clear image is still 
not available. Other blood effects are increased serum iron and folic acid 
deficiency anemia (Katzung, 2004). 
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c. Effects on the Nervous System: these effects are difficult to study or 
evaluate. There have been studies on the effects of progesterone and 
estrogens in animals more than in humans. However, mood changes 
occurring in the premenstrual syndrome have responded to the 
administration of estrogen (Katzung, 2004). 
    
d. Effects on the Endocrine System: in addition to the inhibition of the 
pituitary function, estrogens result in adrenal function changes in a way 
that increases the excretion of cortisol in urine due to increasing the blood 
concentration of corticosteroid-binding globulin. In addition, aldosterone 
secretion is increased due to changes in the rennin-angiotensin-aldosterone 
system. As for the thyroid, total thyroxin levels in the blood are increased 
due to thyroxin-binding globulin increase (Berek, 2002; Katzung, 2004).    
 
e. Effects on the Liver: oral contraceptives have serious effects on the liver 
functions. Estrogen and progesterone cause changes in the metabolism of 
drugs undergoing hepatic metabolism and excretion. They also affect 
lipids and carbohydrates metabolism. Estrogen increases the levels of 
triglycerides and high-density lipoproteins and decreases the levels of low-
density lipoproteins. However, progesterone effects on lipid metabolism 
are the opposite of estrogen effects so that the net outcome in combination 
oral contraceptives is the decrease of triglycerides and high-density 
lipoproteins levels. As for carbohydrates metabolism, oral contraceptives 
reduce the rate of absorption of carbohydrates from the gastrointestinal 
tract. Progesterone increases insulin level. However, the oral 
contraceptives effects on carbohydrates metabolism are reversible and are 
similar to changes in carbohydrates metabolism occurring in pregnancy 
(Berek, 2002; Katzung, 2004).    
 
f. Effects on the Skin: oral contraceptives increase skin pigmentation and 
can also result in acne development (Katzung, 2004).    
   
2.6.7 Effectiveness of Oral Contraceptives 
 
Combination oral contraceptives are more effective than progestin-only oral 
contraceptives. Combination oral contraceptives have pregnancy rate about 2-3 per 1,000 
women per year; while progestin-only oral contraceptives have higher pregnancy rate 
about 3-4 per 1,000 women per year (Berek, 2002).  
 
Combination oral contraceptives are very effective when used correctly and consistently 
with pregnancy rate equal to 0.1 pregnancies per 100 women in first year of use i.e. 1 
pregnancy per 1,000 women. However, when combination oral contraceptives are 
commonly used (less level of correctly and consistently used), they are considered 
effective with a pregnancy rate of 6-8 pregnancies per 100 women in first year of use i.e. 
1 pregnancy in every 17 to 1 pregnancy in every 12 women (Hatcher, et al., 2001).  
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As for progestin-only oral contraceptives, they are very effective when used correctly and 
consistently with pregnancy rate equal to 0.5 pregnancies per 100 women in first year of 
use i.e. 1 pregnancy per 200 women which makes them less effective than the 
combination oral contraceptives (Hatcher, et al., 2001).  
 
2.6.8 Oral Contraceptives Efficacy 
 
Most studies concerning oral contraceptives compliance and efficacy have been 
conducted on small numbers of subjects and mainly on adolescents (Rosenberg, et al., 
1995-a; Rosenberg, et al., 1995-b). 
 
The contraceptive efficacy of oral contraceptives if used properly is more than 99% in 
preventing pregnancy. However, the real rate of oral contraceptives efficacy rate is (92-
97) % due mainly to misuse & inconsistent use of oral contraceptives (Rosenberg, et al., 
1995-b). 
 
If taken daily and properly, combined oral contraceptives are about 100% effective. 
However, a failure rate of 8% in the first year of use reflects that pills are being missed 
(Curtis, et al., 2006). 
 
According to surveys from around the world, there are 60% irregular users among the 
combined oral contraceptive users (Potter and Oakley, July/August 1996).  
 
Studies conducted in the United States and Europe to investigate reasons for the 
discontinuation of oral contraceptives showed that the majority of women stop using the 
contraceptive method because of its side-effects (Huber et al., 2006). 
 
Nearly all studies addressing the issue of improving the effectiveness of hormonal 
contraceptives in general and oral contraceptives in particular have shown that knowing 
and understanding the reasons lying behind women discontinuation or inconsistence use 
of hormonal contraceptives helps in developing strategies that help to improve the 
expected and desired effectiveness (Cheung and Free, 2005).    
 
Oral contraceptives have a high efficiency that is similar to the intrauterine devices, 
implants or injection in addition to the non-contraceptive benefits they provide. Non-
contraceptive benefits of oral contraceptives include less menstrual bleeding and cramps, 
improvement of acne and hirsutism, decreased occurrence of ectopic pregnancies, and a 
decreased incidence of endometrial and ovarian cancers However, in order for oral 
contraceptives to be highly effective, they require compliance and proper use (Rosenberg, 
et al., 1995-a; Branden, November/December 1998). 
 
The most important step in the issue of contraceptive method effectiveness and achieving 
desired goals is choosing the suitable method of contraception. The method chosen 
should be suitable to the user’s personal characteristics and lifestyle in order to use it 
properly and consistently; in other words, it should be effective and safe in a way that its 
benefits are far more obvious than its risks (Pinter, 2002).  
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Contraceptives' users are not the only party that needs to be worked on in order to 
improve compliance and encourage regular use, i.e. health-care providers should be able 
to promote contraceptives and encourage their use. In other words, in order to increase 
patients’ knowledge and encourage their consistent use of oral contraceptives, many 
skills and attitudes in counseling patients should be followed (Davis and Wysocki, 1999). 
  
Patient education is a very important step in this issue and can be achieved by providing 
patients with the needed information while concentrating on the social, intellectual and 
biological variations between patients. Written information in addition to the inserted 
leaflet can be helpful especially at the first visit after which oral information is rarely 
fully retained and applied (Davis and Wysocki, 1999). 
 
In general, the patient and pharmacist or health team member communication may be 
difficult because of shyness or discomfort to discuss issues of sexuality or contraception. 
Women taking oral contraceptives especially in the first time need to be educated how to 
take the pills properly. They also need to learn how to use the calendar pack and to 
understand the presence of active and inactive tablets in the pack if any. In addition, 
backup methods are to be discussed with the emphasis on their importance in the cases of 
missing pills (Borgelt-Hansen, 2001).   
 
The questions that health professionals need to ask in order to improve women’s 
knowledge on contraception can be classified in three groups: 
 
1- Factors associated to pill failure. Including: sever diarrhea, vomiting, missing pill 
by 12 hours, starting packet late, and use of antibiotics.  
 
2- Subsequent action after pill failure. Continue taking the pill, using extra 
precautions especially during pill failure and for more seven days. 
 
3- Emergency contraception. Emergency pill, 22 hours time limit (Little, et al., 
1998). 
 
In a study conducted in England, results obtained showed that leaflets are most useful 
way for increasing the number of women knowing the pill rules since they need little 
time for health-care providers to support. In addition, the study showed that asking 
questions improve the knowledge of women. In other words, this study emphasis on the 
importance of improvement in knowledge of contraception for women using 
contraceptions because very few know the basic rules for avoiding pregnancy (Little, et 
al., 1998). 
 
2.6.9 Complications and Side Effects of Oral Contraceptives 
 
Oral contraceptives have undesired side effects like other drug groups. Side effects 
reporting appeared shortly after the introduction of oral contraceptives. However, oral 
contraceptives available nowadays have lower hormonal concentrations than the first 
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used oral contraceptives. This is because it was noticed that the side effects were dose 
related and in the same time the newer generations of oral contraceptives have the same 
desired contraceptive effects as their ascendants (Brunton, 2006). 
 
Oral contraceptives side effects range from mild to moderate to severe but are generally 
reversible and disappear upon the discontinuation of use. Toxicities related to oral 
contraceptives are rare (Katzung, 2004). 
 
Major and more serious side effects of oral contraceptives are related to the 
cardiovascular system (e.g. hypertension, myocardial infarction or stroke), blood or 
circulatory system (e.g. embolism or venous thrombosis), cancers (e.g. breast cancer or 
cervical cancer) or endocrine system (Brunton, 2006). 
 
So in other words, oral contraceptives side effects can be grouped according to their 
severity or according to the affected site in the body. Side effects listed below are 
according to their severity in different body sites. 
 
2.6.9.1 Mild Side Effects: these side effects are temporary and related usually to 
estrogen concentration in the contraceptive pill and are treated by switching to 
another preparation (Katzung, 2004).  
 
a. Headache: this is usually mild and temporary, but women having 
migraine may suffer migraine exacerbation (Katzung, 2004; 
Brunton, 2006). 
 
b. Breakthrough bleeding: (bleeding in the middle of the cycle); this is 
related to estrogen concentration in the contraceptive pill (Katzung, 
2004). 
 
c. Absence of withdrawal bleeding: (no bleeding at all as in the normal 
menstruation); this causes confusion so that the woman may doubt 
pregnancy and usually occurs in combination oral contraceptives 
(Katzung, 2004; Brunton, 2006). 
 
d. Nausea, muscle aches and edema: related to estrogen concentration 
in the contraceptive pill (Katzung, 2004; Brunton, 2006). 
 
e. Changes in serum proteins seen as changes in the endocrine function 
(Katzung, 2004). 
  
 
2.6.9.2 Moderate Side Effects: experiencing these side effects involves 
discontinuance of the oral contraceptive (Katzung, 2004). 
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a. Weight gain: common in combination oral contraceptives containing 
androgen-like progestins; solution involves switching to pills with less 
progestin effect and also following diet (Katzung, 2004). 
 
b. Menstrual irregularities: these are common in women using oral 
contraceptives with amenorrhea being the most common.  
Breakthrough bleeding is also common especially in women using 
progestin-only oral contraceptives, treated usually by switching to 
biphasic or triphasic preparations because their estrogen content 
decreases breakthrough bleeding (Katzung, 2004). 
 
c. Acne and hirsutism: androgen-like progestins worsen acne and 
hirsutism while pills with high concentrations of estrogen result in 
acne improvement (Katzung, 2004). 
 
d. Increased skin pigmentation: this increases with time and is seen in 
women with dark skins in particular, but is usually reversible and fades 
away upon discontinuation of the pills (Katzung, 2004).  
 
e. Urethral dilation: occurs usually in pregnancy and involves bacterial 
infections (Katzung, 2004). 
 
f. Vaginal infections (Katzung, 2004). 
 
2.6.9.3 Severe Side Effects 
 
a. Cardiovascular problems: these were of the earliest reported oral 
contraceptives side effects. Cardiovascular side effects are numerous 
and can occur at all ages with no relation to smoking status; but the 
risk is increased in heavy smoker women above 35 years (Berek, 2002; 
Katzung, 2004). Cardiovascular side effects include: 
 
i. Thromboembolism: the incidence of thromboemolic problems 
in women using oral contraceptives is three times greater than 
women not using oral contraceptives. Thromboembolism is 
related to estrogen concentration in the contraceptive pill. 
Thromboembolism may be pulmonary or venous depending on 
some genetic factors and predisposing condition of the women.  
The risk for thromboembolism is increased during the first 
month of contraceptive use and hence remains constant and can 
return to normal only by discontinuation of the contraceptive 
within a month after that (Katzung, 2004). 
 
ii. Myocardial infarction: smokers, obese women, diabetic, 
hypertensive or hyperlipoproteinemia women have higher risk 
for developing myocardial infarction. Myocardial infarction 
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occurrence is associated with increased levels of low-density 
lipoproteins, decreased levels of high-density lipoproteins and 
increased platelet aggregation which are changed due to the 
metabolic effects of oral contraceptives (Katzung, 2004). 
 
iii. Stroke: current users of oral contraceptives are in risk of having 
stroke while past users are not (Katzung, 2004). In a study 
conducted by the World Health Organization from 1989 to 
1993 in 17 countries from Europe and the developing world, 
increased risk for stroke was seen in women from the 
developing world and in European women using high-dose oral 
contraceptives (Berek, 2002). The same study showed 
increased risk for stroke in smokers using oral contraceptives 
compared to smokers not using oral contraceptives (Berek, 
2002). 
 
iv. Hypertension: this is a does-related side effect depending on 
the estrogen-induced effects (Berek, 2002).  
 
b. Gastrointestinal problems: these are liver related disorders. Jaundice, 
gallbladder problems or hepatic adenomas have been reported in oral 
contraceptives users (Katzung, 2004).  
 
c. Nervous system disorders: depression is the main nervous system side 
effect reported in oral contraceptives users (Katzung, 2004). 
 
d. Cancer: relation between oral contraceptives and cancer in female 
reproductive organs has been extensively studied and is still 
controversial. Breast cancer risk in oral contraceptives users and in the 
whole population do not show great variation; however some studies 
have shown an increased risk for younger women (Katzung, 2004). In 
a study conducted in Britain, a small increased risk of breast cancer 
was seen in women using oral contraceptives containing more than 
50mcg estrogen before 36 years of age (Berek, 2002). However, the 
study showed that progestin-only contraceptives formed a protective 
factor against breast cancer (Berek, 2002). So the conclusion of most 
studies addressing the relation between oral contraceptives and breast 
cancer can be summarized in that duration of use of oral 
contraceptives, dose, age at first use have small increased risk 
(Brunton, 2006).  As for cervical cancer, some studies showed that this 
type of cancer has increased risk in oral contraceptive users having 
human papillomavirus cervical infection and still the issue is 
controversial. On the other hand, it is proved now by many studies that 
oral contraceptives decrease the risk of endometrial and ovarian 
cancers (Katzung, 2004). Combination oral contraceptives decrease 
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the incidence of endometrial cancer by 50% for 15 years after the pills 
have been stopped (Brunton, 2006). 
  
2.6.10 Contraindications of Oral Contraceptives 
 
Oral contraceptives of newest generations are considered to be safe in most healthy 
women for they contain low hormonal concentrations and thus lower risk of side effects. 
However some cases in which exacerbations of some health problems have been 
reported, so these health problems have been considered as risk factors in which oral 
contraceptives use is contraindicated (Brunton, 2006). 
 
Oral contraceptives are contraindicated in women with the following health conditions:  
 
- Asthma. 
 
- Before undergoing surgery (to eliminate the possibility of post surgery 
thromboembolism). 
 
- Brittle diabetes: (when a person's blood glucose (sugar) level often swings 
quickly from high to low and from low to high) (Wikipedia, 2008). 
 
- Cancers including: malignant endometrial neoplasm, suspected breast 
carcinoma, malignant melanoma, leukemia, pituitary adenoma. 
 
- Cardiovascular problems including: history of thromboembolic disease, 
thrombophlebitis, atherosclerosis, stroke, myocardial infarction, history of 
cerebrovascular disease, coronary artery disease, coronary thrombosis, 
angina pectoris, hypertension.  
 
- Depression.  
 
- Familial hyperlipidimia  
 
- Heavy cigarette smoking. 
 
- Hyperprolactinemia 
 
- Known or suspected pregnancy 
 
- Liver problems including: acute liver disease, history of cholestatic 
jaundice, previous gall bladder disease. 
 
- Migraine headaches. 
 
- Prolonged immobilization. 
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- Psychosis. 
 
- Sickle cell anemia. 
 
- Systemic lupus erythematosis.  
 
- Undiagnosed vaginal bleeding.  
 
- Varicose veins. 
 
Oral contraceptives of high hormonal concentrations are contraindicated in all the 
mentioned cases above; however, oral contraceptives of low hormonal 
concentrations can be given in some cases when benefits are more than undesired 
outcomes but under continuous supervision (Dunnihoo, 1992; Katzung, 2004; 
Brunton, 2006).           
 
2.6.11 Drug Interactions of Oral Contraceptives 
 
Oral contraceptives like any drug family have drug interactions. These interactions 
may result in increased/decreased effects of the oral contraceptive itself or the other 
drug used with it depending on the mechanism of interaction (Berek, 2002; 
Wikipedia, 2006). 
 
- Alcohol: reduces the efficacy of oral contraceptives. 
 
- Allopurinol (Zylol®): can potentiate the adverse effects of oral 
contraceptives. 
 
- Analgesics: levacetylmethadol may reduce oral contraceptive effect while 
paracetamol (Acamol®) may increase plasma-oral contraceptives 
concentrations.  
 
- Angiotensin Converting Enzyme (ACE) Inhibitors like enalapril 
(Convertin®) and Angiotensin-II Antagonists like losartan (Ocsaar®): 
combination oral contraceptives can antagonize the hypotensive effects of 
these antihypertensive drugs. 
 
- Antibacterials: Rifampin (Rimactan®) and broad spectrum antibacterials 
like ampicillin (Penibrin®) and tetracycline (Tevacycline®) can reduce the 
efficacy of both combination and progestin-only oral contraceptives by 
accelerating their metabolism. Whereas chloramphenicol can potentiate the 
adverse effects of oral contraceptives. 
 
- Anticoagulants: oral contraceptives can antagonize the anticoagulant effect 
of acenocoumarol (Sintrom®), phenindione and warfarin (Coumadin®). 
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- Anticonvulsants: carbamazepine (Tegretol®), phenobarbitone (Luminal®), 
phenytoin (Epanutin®), primidone (Prysoline®), ethosuximide (Zarontin®) 
and topiramate (Topamax®) can reduce the efficacy of both combination 
and progestin-only oral contraceptives by accelerating their metabolism. 
 
- Antidepressants: oral contraceptives can antagonize the antidepressant 
effect; side effects of tricyclic antidepressants like imipramine (Tofranil®) 
can be increased due to higher plasma concentrations when administered 
with oral contraceptives. 
 
- Antidiabetics: oral contraceptives antagonize their hypoglycemic effects. 
 
- Antifungals: griseofulvin (Grifulin Forte®), itraconazole (Sporanox®) and 
ketoconazole (Nizoral®) can reduce the efficacy of oral contraceptives by 
accelerating their metabolism. 
 
- Antihypertensives: combination oral contraceptives can antagonize 
hypotensive effects. 
 
- Ascorbic Acid (Vitamin C): increase plasma-oral contraceptives 
concentrations. 
 
- Beta-Blockers like propranolol (Deralin®): combination oral contraceptives 
can antagonize their hypotensive effects. 
 
- Benzodiazepines like diazepam (Valium®): oral contraceptives reduce their 
plasma clearance and thus increase their effects.  
 
- Cimetidine (Tagamet®): potentiate the adverse effects of oral 
contraceptives. 
 
- Coticosteroids and Glucocorticosteroids: oral contraceptives increase their 
plasma concentrations.  
 
- Cyclosporine (immunosuppressant): increased plasma–cyclosporine 
concentration when administered with oral contraceptives. 
 
- Diuretics: combination oral contraceptives antagonize the diuretic effects. 
 
- Modafinil (Provigil®): reduce the efficacy of oral contraceptives by 
accelerating their metabolism. 
 
- Phenothiazines: potentiate the adverse effects of oral contraceptives. 
 
- Proton pump inhibitors like lansoprazloe (Zoton®): can possibly accelerate 
the metabolism of oral contraceptives. 
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- Retinoids: oral tretinoin (Roaccutane®) can reduce the efficacy of both 
combination and progestin-only oral contraceptives by accelerating their 
metabolism. 
 
- Tacrolimus (Prograf®) (immunosuppressant): possible reduction of oral 
contraceptives efficacy. 
 
- Theophylline (Theotard®): increased plasma-theophylline concentration 
due to delayed excretion by combination oral contraceptives. (Berek, 2002, 
Wikipedia, 2006). 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
2.6.12 Non-Contraceptive health benefits of Oral Contraceptives 
 
Oral contraceptives use has resulted in health benefits other than contraception 
usually referred to as "Non-contraceptive Health Benefits". These health benefits 
include: 
 
- Reduced risk of ovarian cysts 
- Reduced risk of ovarian cancer 
- Reduced risk of endometrial cancer 
- Reduced risk of colorectal cancer 
- Reduced risk of ectopic pregnancy 
- Reduced risk of endometriosis 
- Improvement of premenstrual symptoms 
- Decreased frequency of dysmenorrhea 
- Decreased number of bleeding days  
- Decreased incidence of pelvic inflammatory disease 
- Reduced risk of iron deficiency anemia 
- Less hirsutism 
- Improved acne 
- Preservation of bone mass (Dunnihoo, 1992; Borgelt-Hansen, 2001; Berek, 
2002; Berga, 2002; Katzung, 2004; Brunton, 2006). 
 
2.6.13 Oral Contraceptives Choice Strategy 
 
There are many oral contraceptives preparations available for use with different 
hormonal concentrations. Choice for an oral contraceptive is different between 
individuals according to personal differences. However, the chosen oral 
contraceptive should provide users with the effective contraceptive action and least 
side effects (Berek, 2002; Brunton, 2006).  
 
Choosing a suitable contraceptive depends on many factors including: 
 
- The desire for reversible or irreversible contraception 
- Age 
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- Cost 
- Medical condition 
- Cultural and religious beliefs (Berga, 2002). 
 
Lactating women and certain women with health problems in which combination 
oral contraceptives are contraindicated and so progestin-only tablets are a better 
choice (Brunton, 2006). 
 
Concomitant use of other drugs influences the choice of the oral contraceptive to be 
used because of drug interactions (Brunton, 2006).     
 
2.6.14 Oral Contraceptives in Lactating Women 
 
Choose of a hormonal contraceptive method in lactating women is restricted due to 
the possible hormonal effects on milk quality and quantity and the secretion of 
hormones in the milk and thus affecting the infant (Truitt, et al., 2003).  
 
According to a trial conducted by the WHO, significant decline in breast milk 
quantity was seen in women taking combined oral contraceptives compared to 
women taking progestin-only oral contraceptives. However, no difference in infant 
growth was observed in both groups (Truitt, et al., 2003).  
 
2.6.15 Oral Contraceptives Use  
 
Proper and correct use of oral contraceptives along with good compliance make oral 
contraceptives highly effective.  
 
2.6.15.1 Combination Oral Contraceptives 
 
The initiation of combination oral contraceptives usage depends on the woman's 
position in respect to her menstrual cycle or time after delivery (Hatcher, et al., 
2001). 
 
Normally menstruating woman can initiate her pills on any day of the first seven 
days after her menstrual bleeding begins though the first day to begin on makes it 
easier for her to remember (Hatcher, et al., 2001). 
 
For lactating women, combination oral contraceptives use should be delayed six 
months after delivery. If the woman is not lactating and wants to use combination 
oral contraceptives, she can use them three to six weeks after delivery at any time 
she wants with no respect to menstruation (Hatcher, et al., 2001).   
 
Combination oral contraceptives are taken on daily basis: one pill at the same 
time each day (Hatcher, et al., 2001). 
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Packages with 28-pills should be taken continuously i.e. a woman has to start a 
new packet just after the finished one with no free days. As for packages with 21-
pills, a woman should wait seven days between the last tablet from the used 
packet and the first tablet from the next packet (Hatcher, et al., 2001). 
 
Missing pills results in decreased oral contraceptive efficacy and increased failure 
rates. Dealing with missing pills differs between monophasic and multiphasic 
types. Missing a tablet from a monophasic oral contraceptive inquires taking the 
tablet once remembered and taking the next tablet on its regular time.  When 
using a multiphasic type and a tablet has been missed, dealing with this situation 
depends on the tablet missed and its order in the packet. When missing one tablet 
of the active tablets of the multiphasic combination oral contraceptive, it should 
be taken once remembered and the rest taken as usual. However, if the tablet 
missed is inactive (inert), it should be thrown away and the rest taken as usual.  If 
two or more tablets lying in the first fourteen tablets of the packet were missed, 
one tablet should be taken at once and the rest continued as usual with the use of 
an additional contraceptive method for seven days. If two or more tablets form the 
mid-tablets are missed (after the first fourteen tablets), one tablet should be taken 
once remembered and the rest of the active tablets should be continued while the 
inactive tablets should be throw away and a new packet should be started 
(Hatcher, et al., 2001). 
    
2.6.15.2 Progestin-only Oral Contraceptives 
 
Progestin-only contraceptives are less effective than combination oral 
contraceptives and so their use is restricted to some cases.  
 
Progestin-only oral contraceptives are usually used by lactating women. If a 
woman is fully breastfeeding, she can start progestin-only oral contraceptives 
after six months of delivery or after she has her first menstruation. If the woman is 
partially breastfeeding, she can start progestin-only oral contraceptives six weeks 
after delivery. On the other hand, non lactating women can start progestin-only 
oral contraceptives in the first four weeks after delivery (Hatcher, et al., 2001). 
 
Progestin-only oral contraceptives are taken on daily basis: one pill at the same 
time each day. When one packet is finished, the next one is started on the next day 
with no free days in-between (Hatcher, et al., 2001). 
 
If one or more pills were missed, the woman should take a pill once she 
remembers and continue taking one pill a day as usual with the use of an 
additional contraceptive method for two days if not breastfeeding (Hatcher, et al., 
2001). 
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2.7 Attitudes and Behaviors towards Oral Contraceptives  
 
Although oral contraceptives have great efficacy and safety, they are still surrounded by 
some myths and misconceptions. This implies the need for massive communication 
between health-care providers and patients in order to correct the false information and 
elevate fears so as to encourage oral contraceptives use (Davis and Wysocki, 1999). 
 
Women’s perceptions of the safety of contraceptive methods affect their use in a way that 
makes those women have little motivation to use contraceptive methods if they perceive 
them unsafe (Kridli and Newton, 2005). 
 
Many factors affect beliefs and attitudes concerning contraceptives. One of these factors 
is the media which plays a very important role in developing different attitudes towards 
contraceptives in general and towards oral contraceptives in particular. This effect is 
obvious in the decreased use of intrauterine devices and implants. In addition, different 
demographic factors including age, race and ethnicity affect contraceptive use. According 
to data from the National Survey of Family Growth (NSFG) conducted in 1982, 1988, 
1995 in USA, the percentage of women between 15-44 years using contraceptives 
increases with age. As for race and ethnicity, their effect on contraceptive use has 
diminished since 1982 (Jones, 1999). 
 
2.8 Factors Affecting Contraceptives' Use 
 
There are many choices among which a method for contraception can be chosen. 
Choosing the most suitable method of contraception helps to maximize the benefits of the 
method chosen and to minimize non-compliance problems. One contraceptive method 
can be suitable for a woman and not suitable for another. Oral contraceptives have been 
available since 1960s and ever since research has been directed towards lowering the 
concentration of estrogen and using different dosages and types of progestins (Schwartz 
and Gabelnick, November/December 2002). 
 
Factors affecting contraceptive behaviors have been classified into demographic factors 
and non-demographic factors. Demographic factors include: number of children, gender 
of children, habitat, religion, level of education, maternal age, employment status and 
source of contraceptive services. Demographic factors showed no obvious impact on 
Jordanian Muslim women use of oral contraceptives. Non-demographic factors include: 
knowledge about contraceptive methods, pressure to have children, husband’s position or 
wanting more children. Jordanian Muslim women who have used oral contraceptives 
previously have positive attitudes and beliefs towards oral contraceptives and are more 
compliant than women who have not used oral contraceptives before (Kridli and Newton, 
2005).  
 
Using or not using contraceptive methods is affected by different demographic factors. 
Factors affecting contraceptive usage in Palestine are summarized in Table 2.4, (PCBS, 
August, 2003) 
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Table 2.4: Percentages of Currently   Married Women at Child Bearing Age Using a 
Contraceptive Method according to different Criteria 
 
Criteria Using a Contraceptive 
Method 
Not Using a Contraceptive 
Method 
Level of Education 
Illiterate 45.3% 54.7% 
Elementary 52.3% 47.7% 
Preparatory 51.9% 48.1% 
Secondary and more 53.6% 46.4% 
Type of Residence 
Urban 51.1% 48.9% 
Rural 52.9% 47.1% 
Camp 50.1 49.9% 
Age (years) 
Less than 20 16.1% 83.9% 
20-24 41.1% 58.9% 
25-49 57.3% 42.7% 
Number of Live Children 
0-3 75.7% 31.5% 
4-7 16.9% 49.0% 
≥ 8 7.3% 19.5% 
Region 
West Bank 54.3% 45.7% 
Gaza Strip 46.1% 53.9% 
Palestine 51.4% 48.6% 
   
Source: (PCBS, Fertility Determinants in the Palestinian Territory: Dissemination and Analysis of Census Findings, In-depth 
Analysis Study Series, August, 2003)
  
                                                          
 
As seen in (Table 2.4), women of secondary and higher levels of education use 
contraceptive methods than less educated women with a percentage of (53.6%). Women 
from rural areas use contraceptive methods more than urban women or camp women with 
a percentage of (52.9%). Concerning age groups, older women (57.3%) use contraceptive 
women more than younger women (PCBS, 2003).  
  
Jordan is an Arab Muslim country located in the Middle East who has quite similar 
demographics to Palestine. In the Demographic Health Survey (DHS) of 1992, Jordan's 
population was 4 millions; it has a birth rate of 45.3 per 1,000 population and a fertility 
rate of 6.2 per woman. This fertility rate is considered high and is related to the modest 
use of contraceptives and also to the short intervals between births. Like other countries 
in the Middle East, studies concerning family planning in Jordan have investigated the 
relationship between demographic factors on women's contraceptive behaviors. One of 
these studies was conducted by Abdel-Aziz and colleagues in 1986 which looked for the 
effects of women's level of education, socioeconomic status and number of children on 
contraceptive behavior. Moreover, the Demographic and Health Survey in 1992 studied 
the effect of location of residence of Jordanian women’s on their contraceptive behavior. 
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However, the effects of non-demographic factors like psychosocial factors were not 
identified and their effects on women's contraceptive behaviors were not determined. It is 
important to investigate the women’s attitude about using contraceptives, the effect of 
significant others on their contraceptive use and their perceived ability to use them 
(Kridli and Libbus, 2002). 
 
The Arab Islamic culture affects fertility in a way resulting in high fertility whose 
benefits are seen from the economic and social values of the children. Children generally 
and males particularly contribute in the family income by performing a variety of tasks or 
jobs like farming or construction. This contribution provides the family with physical 
security, political strength, social prestige and economic security for the parents in their 
old age (Kridli and Libbus, 2001). 
 
According to Farsoun et al. (1996), three types of pressure are responsible for having 
children in Jordan: 
 
1- Traditional pressure: this pressure is based on the inherited traditions that imply 
the importance of having children since they help their parents in work and take 
care of them when they get old.  
 
2- Familial pressure: it is the pressure the family members impose for having more 
children particularly boys so as to preserve the family name.  
 
3- Religious pressure: this depends on the belief that Muslims should have many 
children that God will take care of no matter how bad the economic status of their 
parents was (Kridli and Libbus, 2001). 
 
The Palestinian society has different factors affecting the family size and the total 
fertility. One factor is familial pressure. Like other societies, a newly married couple lies 
under the pressure of quickly having children by family members and especially in-laws. 
Having a child strengthen the relation between the wife and husband and in many cases 
infertility was behind polygamy or divorce among Palestinians. Another factor is the 
political factor. Statistics have shown that the Palestinian fertility rate in countries other 
than Palestine has fallen while it remained relatively high within Palestine due to the 
political conditions in Palestine. According to the Palestinian Ministry of Health (MOH), 
a sharp increase in birth rate was seen between the years 1987 and 1994 due to the 
instability of the political situation. However, this was followed by a decrease in birth 
rate between the years 1995 and1997 (PCBS, 2000).  
 
The number of living children a woman has affects her to desire to have more children or 
stop having children and thus affects the contraceptive behavior. In 1986, The United 
Nations population assessment found that the mean numbers for children desired by 
women in Jordan, Mauritania, Sudan, Syria and Yemen ranged from 5.5 to 6.4 children 
per woman. Having a second child is due to the family pressure imposed due to the fear 
that the only child might die and thus leave the parents childless. This sequence affects 
the contraceptive behavior negatively because parents seek having a second child to 
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protect themselves from being childless. After having a second child, the pressure to have 
additional children is reduced resulting in changed contraceptive behavior and thus a 
decision to use contraceptive method may be taken (Kridli and Libbus, 2001). 
 
Gender of children affects the contraceptive behavior in Arab Muslim societies. Having 
sons is preferable in Jordan as well as in other Arab countries for the importance of sons 
over daughters as perceived from cultural points of view. Sons are supposed to help the 
family economically, help and secure their parents in their old ages and for sure they 
carry the family name and preserve the family from vanishing. In other words, married 
couples fall under the pressure of their families to have sons which in turn affects family 
planning and contraceptive use negatively (Kridli and Libbus, 2001).   
 
In Palestine, there is also preference to have male children than female children where 
10% of women having four male children are willing to have more male children; while 
only 2% of women having female children are willing to have more female children. This 
is because maintain the continuity of the family, improve economic conditions of the 
family by earning income and are considered as a source of security and strength for their 
families (PCBS, 1998).   
 
Location of residence is also related to contraceptive use by Jordanian women. Lifestyle 
in rural areas requires having more children than urban areas to help families in field 
work. In addition, rural areas suffer from inadequate educational programmes concerning 
contraceptives which results in lower rate of contraceptive use (Kridli and Libbus, 2001). 
As for contraceptive use in Palestine, differences between rural, urban and camp areas are 
little. However, the percentage of women using contraceptives in the West Bank is higher 
than that in Gaza Strip (PCBS, 1998).  
 
In Jordan, religion is considered a very effective factor in the issue of contraception and 
affects the contraceptive behaviors of both men and women. In a study conducted by 
Warren et al. in 1990, 50% of Jordanian husbands said that God decides the family size. 
According to a study conducted by Farsoun et al. in 1996, men and women's beliefs 
concerning contraception and family planning were studied. Participants had different 
opinions concerning family planning. Some believed that Islam is against family planning 
and forbids the use of contraceptives. Others believed that Islam accepts the idea of 
family planning in its spacing concept not in preventing birth. Others believed that family 
planning is acceptable if natural methods (like rhythm or breast feeding) are followed and 
that contraceptive methods are only applicable if the natural methods fail. Others 
believed that family planning is not prohibited by Islam especially if there is a good 
reason like poor health of the mother (Kridli and Libbus, 2001). 
 
According to the Demographic Health Survey (DHS) in 1994, the level of education 
effect on contraceptive behavior of Jordanian women is vague; in other words, the rate of 
contraceptive use did not increase as the women's level of education increased. 
Regardless to education level, the most popular methods of contraception in Jordan were 
found to be intrauterine devices and oral contraceptives. In contrast to level of education, 
age appeared to be strongly related to contraceptive use among Jordanian women. 
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According to Demographic Health Survey (DHS) in 1994, percentage of Jordanian 
women using different contraceptive methods increased with increasing age groups 
studied. As for employment status, differences in contraceptives use between working 
women and housewives were seen with no specific trend to distinguish the effect of 
employment status in general on contraceptives use (Kridli and Libbus, 2001).  
 
Intrauterine devices and oral contraceptives are the most popular methods of 
contraception in Jordan. Between 1976 and 1983, there was a clear change in the pattern 
of contraceptives methods use in Jordan. The use of intrauterine devices increased from 
2% to 8%, while oral contraceptives use decreased from 12% to 8%. Despite being the 
most popular method of contraception used in Jordan, intrauterine devices are surrounded 
by fears from their complications. As for the second popular method, oral contraceptives 
are believed to have adverse effects on health like cancer, hair loss or weight gain in 
addition to fetal abnormalities and infertility. These beliefs affect their use and their use 
effectiveness negatively (Kridli and Libbus, 2001). In Palestine, intrauterine device is the 
most widely s\used contraceptive method with a percentage of (27.8%) followed by oral 
contraceptive pills with a percentage of (7.2%). Among users of intrauterine device in 
Palestine, (53.6%) complain from menstrual problems and (48.3%) complain from 
vaginal discharge (PCBS, 2004).  
Besides the demographic factors, contraceptive use is also affected by non demographic 
factors including:  
 
- husband position 
- knowledge vs. lack of knowledge about contraceptive methods 
- reported side-effects 
- religious reasons 
- health reasons (Kridli and Libbus, 2001). 
 
2.9 Fears from Oral Contraceptives' Side-Effects 
 
Women fears from oral contraceptives arise from the fact that they are associated with 
increased risk in breast and ovary cancers. On the other hand, most women do not know 
that oral contraceptives use provides protection against ovary and uterus cancers. Mainly, 
women beliefs about oral contraceptives come from others experiences (e.g. relatives 
especially mothers) when oral contraceptives formulations used to contain high 
concentrations of estrogen (50-150mcg). However, nowadays pills contain 35 mcg 
estrogen or less and thus have fewer side-effects (Davis and Wysocki, 1999). 
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Table 2.5: What to Tell Women about Risks of Cancer and Cardiovascular Disease: 
 
Risk Current knowledge regarding low-dose (<35 mg) OC use 
Breast cancer Slightly increased risk of diagnosis in current users. No 
difference in risk of diagnosis >= 10 yr after discontinuing 
use; compared with non-OC users,
6
 similar to that 
associated with pregnancy 
Endometrial cancer OC use decreases risk by 50% compared with nonusers
4
 
Ovarian cancer OC use decreases risk by >=40% compared with nonusers
5
 
Myocardial infarction 
(heart attack) 
Only women. age 35 yr who smoke are at increased risk
9
 
Cerebrovascular 
accident (stroke) 
Rare among women of childbearing age: low-dose OC do 
not increase risk
8 
Venous 
thromboembolism 
(blood clots) 
Three- to fourfold increased risk associated with OC
7
 
(Based on data from WHO, 4 Cancer and Steroid Hormone Study, 5 Collaborative Group, 6 World Health Organization, 7 Petitti et al, 
8 and World Health Organization.9 OC, oral contraceptives. (Davis and Wysocki, 1999)) 
 
A survey of 336 young women at Brown University in 1997 showed that more than 75% 
did not know that oral contraceptives use can protect against ovary and uterus cancers 
(Tessler and Peipert, 1997). 
 
The primary reason for which women discontinue taking oral contraceptives is “feeling 
ill” rather than a specific side effect of oral contraceptives like nausea or break through 
bleeding (Davis and Wysocki, 1999). 
 
Many contraceptive methods produce changes in the menstrual cycle that vary between 
different women according to the method used and the duration of use. Intrauterine 
device's side-effects may be seen as increased bleeding and cramping. Irregular menstrual 
patterns like increased periods of bleeding or amenorrhea may occur while using implants 
or injections. Different studies have examined the relationship between menstrual 
changes and discontinuation of contraceptive methods (Tolley, et al., March 2005). 
 
Concerning oral contraceptives disadvantages, the two major ones are the increased 
incidence of thrombophlebitis and pulmonary embolism as a result of hypercoagulability 
and cardiovascular disease including hypertension. These effects are due to the high 
levels of estrogen hormone in the earlier introduced pills. Other side-effects include: 
nausea, vomiting, headaches, weight gain, menstrual changes, enlarged breasts and 
depression (Branden, November/December 1998).  
 
In a study conducted in Egypt by Declerque et al in 1986, Egyptian women’s beliefs 
about modern contraceptive methods were studied. The study results showed that about 
80% of Egyptian women heard that oral contraceptives cause side-effects like morning 
sickness and 40% of them believed that these symptoms were reversible and that they 
disappeared once the method had been stopped. The study also showed that few Egyptian 
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women were using oral contraceptives daily and correctly whereas fewer than half were 
able to tell if a pill was missed by a back-up routine. Misuse of oral contraceptives by 
Egyptian women was due to adverse beliefs about them (Kridli and Newton, 2005) 
 
Jordanian women believe that oral contraceptives have serious side-effects like cancer, 
back pain, headaches, dizziness, hair loss, weight gain, fetal abnormalities, and infertility. 
These unfavorable beliefs about oral contraceptives affect their use and use effectiveness 
negatively (Kridli and Libbus, 2002). 
 
2.10 Compliance vs. Non-Compliance 
 
In order for a contraceptive method to exert its desired effects properly and effectively, 
the contraceptive use should comply with two principles: continuation and compliance 
(Pinter, 2002). 
 
“Compliance rates measure the percentage of users who take all doses as prescribed and 
indicate the degree to which patients adhere to a prescribed regimen (Pinter, 2002). 
 
Continuation is defined as “the rate of women still using a contraceptive method after a 
certain period of time with regard to reasons for discontinuation”. Thus, continuation of 
use is related to the acceptability of the contraceptive method. Continuation rate describes 
the proportion of women continuing to use a contraceptive method at the first year. 
Contraceptives with high continuation rates are considered to be of the most appropriate 
contraceptives. Continuation/discontinuation rates are based on data from clinical trials or 
data from the National Survey of Family Growth (NSFG) in the USA (Pinter, 2002). 
 
Modern methods of contraception have low failure rates and are highly effective if used 
constantly and properly according to the simplest compliance rules. But when there is 
misuse or no compliance, unintended pregnancies result in giving the impression that the 
method used has higher failure rates than documented. Arising from the fact that 
contraceptives prevalence is high, providers should concentrate on providing users with 
the information needed to improve their compliance and to correct their use. Many 
studies have been conducted to evaluate contraceptives compliance and improve the level 
of knowledge concerning the correct use of contraceptives by the inclusion of certain 
interventions. The results obtained showed the success of these studies but they shared 
the limitation that follow up was for a short time interval; this is because long periods of 
follow up are required to prove that the effect is sustained. Knowledge of contraception is 
very important to provide better contraceptive use and improve compliance and thus less 
unintended pregnancies. Poor knowledge or lack in knowledge may be an important 
factor resulting in contraception failure and unintended pregnancies (Shields, 2006). 
 
Users of oral contraceptives are like users of other chronically used drugs in their 
suffering from compliance difficulties which may be greater than expected. For example, 
20% of the annual unintended pregnancies in the United States are related to non-
compliance or discontinuation of oral contraceptives. According to recent research, 
compliance problems are found among users of all ages and may be due to the occurrence 
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of side-effects, lack of knowledge or low evaluation of personal health. In contrast, good 
compliance is related to the absence of side-effects, satisfaction with the health-care team 
and to a high level of knowledge about oral contraceptives issues. Health-care team is 
considered the most important party in strengthening the issue of compliance to oral 
contraceptives. They are supposed to provide women with simple and clear information 
concerning instructions for correct use of oral contraceptives, explanation of possible 
side-effects and what to do when missing a dose (Rosenberg and Waugh, 1999). 
 
Compliance is an expression used to describe the level of patients' adhesion to a 
prescribed treatment. When speaking about poor compliance to oral contraceptives, this 
may be manifested in different forms including missing pills, taking pills out of order, 
starting a package early or late, discontinuing a method without using a backup method 
or due to the cost of the medication (Rosenberg and Waugh, 1999). 
 
Health team may be able to improve oral contraceptives' compliance and thus efficacy by 
exploring the factors lying behind missing pills (Smith and Oakley, 2005).  
 
In a study conducted in Slovenia in 1990, the continuation rates were calculated in a 
sample of 469 women aged 15-44 years included in the Fertility Survey in Slovenia. The 
highest continuation rates were found for intrauterine devices (86%), followed by pills 
(63%). 22% of discontinuation rates were related to medical reasons or dissatisfaction 
with the method followed by 10% due to unintended pregnancies (Pinter, 2002). 
 
In a population-based survey of women in New Zealand, out of 252 of injections users, 
the most important reason for discontinuation within 21 months of use was irregular 
bleeding followed by heavy bleeding while amenorrhea was a reason for discontinuation 
for users after 2-5 years of use (Tolley, et al., March 2005). 
 
Factors like menstrual irregularities or experiencing other side-effects are related to 
discontinuous and inconsistence of hormonal contraceptive methods (Cheung and Free, 
2005).  
 
Missing one or more pills in each cycle of oral contraceptive's use may result in higher 
incidence of breakthrough bleeding which is one of the major reasons behind oral 
contraceptives' discontinuation (Borgelt-Hansen, 2001).  
  
Compliance problems in general maybe due to the fact that treatments are complicated, 
expensive, inconvenient and are to be followed for a long period and may be forever. 
Many researches studied the issue of compliance and have grouped patients into three 
groups: 
 
- 1/3 patients always comply. 
- 1/3 never complies. 
- And 1/3 sometimes comply 
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But motivation and depressant factors that guide patients into those groups are still not 
fully determined. Poor compliance to oral contraceptives is manifested in missing pills, 
taking pills out of order or starting a package early or late. Consequences of oral 
contraceptives misuse may be nothing, minor like spotting or profound like an intended 
pregnancy (Rosenberg, et al., 1995-a; Pinter, 2002). 
 
Factors to which non-compliance is related to have been widely studied and three models 
have been used to identify them:  
 
1- Individualistic Model: many factors and behaviors are measured in nonspecific 
model in order to determine patients with poor compliance. 
 
2- Health Belief Model: in this model the benefits of compliance to oral 
contraceptives versus the costs of non-compliance are studied. This comparison 
between costs and benefits depends on: 
 
a) the patients’ perception of their susceptibility to the unwanted outcome 
result accompanying poor compliance which is pregnancy in this case 
and its consequences 
b) the patients’ beliefs of the benefits that compliance has. 
 
3- Patient-Provider Model: this model studies the interaction between patient and 
provider in order to determine compliance. The quality of information given by 
the physician and his attitude towards the patient along with the patient’s 
questions all determine compliance (Rosenberg, et al., 1995-a). 
 
Improving compliance is not the responsibility of patients alone; it is also the 
responsibility of health-care providers and drugs manufacturers. Health-care providers’ 
role in improving oral contraceptives compliance may be manifested first of all in helping 
women to choose the suitable contraceptive method depending on their background and 
special needs. They should also discuss the possible side –effects of oral contraceptives 
as well as their non-contraceptive benefits. Health-care providers should help women 
express themselves clearly and to ask any question they consider important in order to 
keep them provided with the needed information; especially how to act and what to do 
when missing a pill. They should also emphasize on the importance of reading and 
understanding the leaflets well and on follow-up visits to evaluate compliance and solve 
arising problems early. As for oral contraceptives manufacturers, they have to perform 
researches in order to determine factors related to compliance. Packages used should be 
designed in a way that encourages compliance and the leaflets should be written in simple 
language that is understandable by women from different social and educational 
backgrounds. Concerning oral contraceptives users, they should set themselves a specific 
time to take the pill. They should also read the leaflets carefully and know what to do in 
emergency cases and to be aware enough to use back-up methods when necessary 
(Rosenberg, et al., 1995-a). 
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In a study conducted in five European countries: Denmark, France, Italy, Portugal and 
United Kingdom, poor compliance and oral contraceptives discontinuation were studied 
and related to some factors. Women participating in the study were of different age 
groups and from different social status (Rosenberg, et al, 1995-b). 
 
According to this study, 81% of women used oral contraceptives consistently and 
effectively, 19% missed one or more pills per cycle and 10% missed two or more pills 
per cycle. Users in this study were found to be grouped into three groups according to 
factors that were found to affect proper use of oral contraceptives: user characteristics, 
contraceptive services side-effects and dosing regimen of oral contraceptives. The 
strongest factor was the user characteristics of which failure to take the pill at the same 
time each day was the most strongly related (Rosenberg, et al., 1995-b). 
 
As for the contraceptive service care system characteristics, 47% of women reported that 
they did not receive enough information and help concerning oral contraceptives usage 
from their health-care providers when oral contraceptives were first prescribed and thus 
these women were nearly 1.5 times more likely to use oral contraceptives inconsistently 
than women who received more information on oral contraceptives (Rosenberg, et al., 
1995-b). 
 
As for side-effects, inconsistent use was related to some side-effects in different ratios:  
 
- Relative risk of 2.1 for women experiencing hair growth 
- Relative risk of 1.2 for women having breast tenderness 
- Relative risk of 1.4 for women having nausea (Rosenberg, et al., 1995-b). 
 
Age, pill brand used, where to keep the pills, knowledge of non-contraceptive benefits 
and type of doctor prescribing the pill were factors that were not significantly related to 
the consistent use of oral contraceptives (Rosenberg, et al., 1995-b). 
 
According to this study, health-care providers represent the most important factor helping 
women to be more compliant and consistent in using oral contraceptives. They should 
provide women with the correct use of oral contraceptives in their initial counseling and 
make sure that they understand the instructions well so as to guarantee their compliance 
and proper use (Rosenberg, et al., 1995-b). 
 
When looking at compliance from a general point of view, it is noticed that non-
compliance exists no matter how severe its consequences are. Even when these 
consequences can be fatal patients do not take their medications exactly as prescribed 
25% of the time. As for the contraceptive pills, the fear of pregnancy does not result in 
taking the pill every day and regularly (Pinter, 2002). 
 
Consequences of non-compliance can be: 
 
1- Unintended pregnancy 
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2- Experiencing side-effects 
 
3- Diminished non-contraceptive health benefits (Pinter, 2002). 
 
Compliance has different elements to form its dimensions:  
 
1- Contraceptive efficacy and effectiveness: effectiveness of a birth control method 
is measured methods developed by researchers and method developers depending 
on how frequently pregnancy would occur if used exactly as instructed; “perfect 
use”; while, “typical use” reflects contraceptive use by the average woman 
according to factors affecting the way a prescribed regimen is followed, such as 
occasionally forgetting to use the method as directed (Branden, 
November/December 1998). Patients usually comply more to more effective 
methods and less with less effective ones (Pinter, 2002). 
 
2- Contraceptive safety: compliance is directly related to the safety of the 
contraceptive method (Pinter, 2002). Patient's perceptions of a contraceptive's 
method safety affect compliance to this method. Women continue using a 
contraceptive method and comply with it as long as they see it is safe and free of 
side-effects (Branden, November/December 1998).  
 
3- Side-effects: adverse effects may result in contraceptive method non-compliance 
(Pinter, 2002). Sometimes women experiencing side-effects of contraceptives and 
consider them as signs of failure for the contraceptive method used and thus 
discontinue using the method and increase the risk of unplanned pregnancy. 
According to many studies, compliance is improved when fewer side-effects are 
experienced (Branden, November/December 1998). 
 
4- Patient comprehension of use of a contraceptive method: according to studies 
over the years, women are more consistent to a contraceptive method when they 
understand the method well. Continuous follow up and counseling by health-care 
providers increase compliance and improve knowledge (Branden, 
November/December 1998). Recounselling sessions and follow-up visits support 
the education of women by the health professionals so as to stick more to the 
contraceptive method used (Pinter, 2002).  
 
5- Personal characteristics and considerations: compliance with a contraceptive 
method is affected by patient characteristics such as: lifestyle, level of health 
literacy, partner involvement, capability to understand information and 
instructions and socioeconomic status (Pinter, 2002). Many studies have 
mentioned that different personal patient considerations and characteristics affect 
compliance to contraceptives. Some of these conditions are: lifestyle, 
socioeconomic status, medical problems, level of domestic violence, partner 
involvement, level of health literacy and intellectual capability to understand 
information received and ability to apply it everyday (Branden, 
November/December 1998). 
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6- Non-contraceptive benefits: most contraceptives have non-contraceptive health 
benefits like those of oral contraceptives or dual protection associated with 
condom use most of which are not known by users (Pinter, 2002). Oral 
contraceptives have a wide range of non-contraceptive benefits including: 
protection from ovarian and endometrial cancers, reduction of the risk of 
cardiovascular disease and decrease of menstrual irregularities (Branden, 
November/December 1998). 
 
7- Health-care provider preferences: based on personal experiences, informal patient 
surveys, or formal research health-care providers frequently have a number of 
contraceptive methods and brands that they prefer for their patients (Branden, 
November/December 1998; Pinter, 2002). 
 
Women using oral contraceptives are usually young and healthy women who may not be 
fully aware of the consequences of non-compliance to oral contraceptives and thus may 
get involved in unintended pregnancies or menstrual problems. In order to understand 
compliance well, it is needed to look for a model that explains women's behaviors 
towards it. The most appropriate model that reflects the beliefs and behaviors of women 
using oral contraceptives is "The Health Belief Model". This model is based on the 
patient's perceptions of being susceptible to the consequence of non-compliance, their 
severity and costs on one hand and the benefits of compliance on the other hand 
(Rosenberg and Waugh, 1999). 
 
Compliance and commitment to preventive treatments are usually evaluated by the 
Health Belief Model as a theoretical framework. Oral contraceptives are used mainly for 
pregnancy prevention and thus Health Belief Model is the used to evaluate and predict 
compliance with contraceptive use. Health Belief Model components reflected in the 
compliance issue are presented as:  
 
1- Patient perceptions of susceptibility to getting pregnant which is the consequence 
of non-compliance in this case. 
 
2- Severity of non-compliance consequences. 
 
3- Comparison between costs and benefits associated with the use of contraceptive 
and its consequences. 
 
4- Difficulties in using contraceptives (e.g. side-effects, understanding the 
contraceptive’s mechanism of action) (Pinter, 2002). 
 
In the United States in 1995, 15.5% of oral contraceptives users reported missing one pill 
and 13.3% reported missing two or more pills in the last three months (Abma, et al., May 
1997).  
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The issue of compliance has been subjected for lots of intensive research. In one study 
conducted among adolescents using oral contraceptives, an average of three pills were 
missed in each cycle and 50% discontinued the pills in the first three months. In another 
study, missing one pill per cycle was reported by third of oral contraceptive users 
(Rosenberg and Waugh, 1999). 
  
Compliance to contraceptive methods is a complicated issue that is affected by many 
factors thus affecting the efficacy rate of the contraceptive method. Efficacy rate for a 
contraceptive method is presented by the percentage of avoided pregnancies when using a 
contraceptive for one year, while failure rate is the percentage of occurring pregnancies in 
one year as well. Success and failure rates are based either on perfect use or typical use. 
Perfect use of a contraceptive is related to the contraceptive use exactly as recommended 
by the producer while typical use is when a contraceptive method is frequently used 
inconsistently (Branden, November/December 1998). 
       
Missing oral contraceptives and poor compliance are related to many factors including: 
 
- Absence of daily routine reminder to take the pill on time 
- Problems in reading and understanding the leaflet in the oral contraceptive's 
package 
- Lack of information provided and explanation from the health care provider 
- Experiencing side effects (Rosenberg, et al., 1995-b). 
 
In a study conducted in the United States, concerning compliance and satisfaction with 
oral contraceptives, 47% of pill users reported missing one or more pills per cycle and 
22% missed two or more pills. It was noted in the study results that compliance 
difficulties were associated with user characteristics and experienced side-effects. 
Women who did not have a specified routine for taking the pill were 3.6 times more 
likely to miss two or more pills per cycle when compare to women having such a routine. 
Women who understood little or none of the information in the inserted leaflet and 
women who understood some of the information were 2.8 and 2.3 respectively more 
likely to miss pills than those who read and understood all that written information. 
Women reporting heavy or extended periods or those reporting spotting were 1.6-1.7 
times to miss two or more pills per cycle than those not reporting those side-effects. 22% 
of women using pills called their providers complaining of related side-effects; 54-55% 
of them complained from breast tenderness or mood changes and 44-46% complained 
from nausea and spotting. However, 9% of women using pills returned to their providers 
because of side-effects; 60% complaining about weight gain, 53-54% complaining about 
mood changes, breast tenderness or nausea. Concerning care and counseling received 
from health-care providers, 34% reported care given to be very good, and 30% reported it 
to be good whereas 11% reported dissatisfaction from their providers. Dissatisfaction was 
reported by women having side-effects, women compliant and women paying the highest 
prices for the pills (Rosenberg, et al., March/April 1998).  
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2.11 Oral Contraceptives Related Mortality 
 
In a 25 year cohort study conducted in Britain that covered 46,000 women, health records 
and death certificates were monitored. Obtained results had shown that the risk of death 
from all causes was similar in ever users and never users of oral contraceptives and the 
risk of death for most particular causes did not differ significantly in the two groups. This 
means that oral contraceptives have their main effect on mortality while being used and 
in the 10 years after use is stopped. Ten or more years after use stops mortality in past 
users is similar to that in never users (Beral, et al., 1999).  
 
2.12 Summary 
 
Use of contraceptive methods has been present since ages. However, excessive use has 
been seen in the last decades. In this duration of time, a big progress in development of 
contraceptive methods has occurred. Different types of contraceptives are now found and 
available for use.  
 
Use of contraceptive methods varies between countries depending on many factors. In 
general, developed countries use contraceptive methods more than the developing 
countries. Not only this, they also differ in the most preferable method used and the 
distribution of methods used.  
 
Hormonal methods of contraception are considered the most effective methods out of 
which the oral contraceptives are the most to be used. Different formulations of oral 
contraceptives have been found and a massive development in this field has occurred so 
as to produce highly effective oral contraceptive pills with limited side effects. This was 
achieved by the use of new hormonal formulations in small concentrations. Oral 
contraceptives have high efficacy reaching up to 99% if used properly.  
 
Choosing a contraceptive method in general depends on many factors that differ from 
region to another. In addition, choice of a contraceptive method depends in the first 
degree on the characteristics of the woman herself so that the suitable method of 
contraception for the woman makes her a specific case.  
 
Use of a contraceptive method depends on many factors among which the demographic 
factor is a very important one. Place of residence of woman (rural or urban), number of 
children a woman has, woman's age and work status; all are factors affecting 
contraceptive methods use and choice. 
 
Oral contraceptives are the type of contraceptives that need compliance and consistent 
use to give their desired effect in prevention of pregnancy.  Good knowledge of the 
contraceptive mode of action, benefits, side effects and strategy when missing pills all 
help in better compliance and thus better effects and more efficacy.  
 
Women using the oral contraceptives also need to be supported by a health team that 
helps them always to stay compliant. Every aspect about oral contraceptives needs to be 
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discussed with users so that clear and simple information are provided to ensure and 
guarantee compliance. 
 
Oral contraceptives side effects are truly present alongside their health benefits. Mortality 
related to oral contraceptives use does not exist as used to be when oral contraceptives 
were newly introduced to use.  Many studies have proved that the risk of death from all 
causes was similar in ever users and never users of oral contraceptives. 
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3.1 Introduction 
 
Contraception is achieved by many ways nowadays. Oral contraception is one way of the 
ways used. It involves the use of oral pills composed of certain hormones that are 
responsible for the consecutive steps that finally lead to contraception. In order to 
understand contraception well, one has to know how the normal system works in order to 
be able to counter act it. The female body undergoes many changes that precede and 
prepare for pregnancy. Systemically used contraceptives target these changes. The 
effectiveness of contraceptive methods not only depends on the method itself; it also 
depends on the user as well. It is important to know that the used contraceptive methods 
impose good and consistent use to result in the desired outcomes in contraception.  
 
3.2 Terms Definitions 
 
Different terms are used in the study. Definitions of certain terms were based on 
definitions mentioned in the Demographic and Health survey conducted in 2004 by the 
Palestinian Central Bureau of Statistics. These definitions are as follows. 
 
 
Age at Marriage 
 
The age of the individual in years at the time a person is 
actually married. 
 
Breastfeeding 
 
Refers to the method of feeding infants and children and is 
defined as feeding a child breast milk directly from the breast 
or expressed 
 
Contraceptive Pill 
 
One of the methods used by women for delaying or avoiding 
the coming pregnancy by taking a tablet every day 
 
Family Planning Method 
 
A method used for delaying or stopping pregnancy. Modern 
methods include pills, IUD, injection, vaginal methods, 
female jelly, female sterilization, male sterilization and 
condoms. 
 
Health Care Provider 
 
An individual whose responsibility involves one or more of 
the following: the provision, administration, teaching and 
development of health services, activities or supplies. The 
provider may have direct or indirect interest in health 
industry. 
 
Illiterate 
 
A person who cannot read or write a short abstract about his 
or her life and understand it. 
 
IUD 
 
A flexible, plastic intrauterine device. It often has copper wire 
or sleeves on it. It is inserted into the women’s uterus through 
her vagina. 
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Place of Residence 
 
Place of residence is divided into urban, camps and rural. A 
population outside municipal boundaries and camps are 
considered a village population. 
 
Reproductive Health 
 
Defined by WHO as a state of physical, mental and social 
wellbeing in all matters relating to the reproductive system at 
all stages of life. The term implies that people are able to have 
the capability to reproduce and the freedom to decide if, when 
and how often to do so. Implicit in this are the rights of men 
and women to be informed and to have access to safe, 
effective, affordable and acceptable methods of the family 
planning method of their choice and the right to appropriate 
health-care services that enable women to safely go through 
pregnancy and childbirth. 
 
 
3.3 Definition of Contraception and Contraceptive 
 
Contraception is the opposite of conception; in other words the prevention of conception. 
It is the intentional prevention of fertilization of an ovum by a spermatozoon. The major 
goal of contraception is birth control in which family size is being limited and thus family 
planning is achieved (Tindall, 1987).  
 
Contraceptive is the mean or method used to result in contraception. Contraceptives used 
may be classified into:  
 
1. Physiologic methods 
2. Chemical barriers 
3. Mechanical barriers 
4. Intra uterine devices 
5. Hormonal control 
6. Subdermal implants. 
 
Choice between these methods depends mainly on woman's health condition and personal 
will (Dunnihoo, 1992).  
 
3.4 Contraceptive Methods Classification 
 
Contraception is the prevention of unwanted pregnancy using various means (Blackburn, 
et al., 2001). 
 
Contraceptives are classified into groups in many ways.  
 
 Classification according to the mechanism of action: 
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- Ovulation prevention: these are the hormonal contraceptives composed of the 
combination of progesterone and estrogen hormones. These are taken on regular 
basis and are found in different formulations. Pills are taken orally on a daily 
basis, injections and subcutaneous implants taken every three months (Hatcher, 
et al., 2001).  
 
- Fertilization prevention: these prevent the fertilization of the ovum by the sperm. 
These are usually mechanical methods like condoms, diaphragms or surgical 
intervention (Hatcher, et al., 2001).  
 
- Implantation prevention: these prevent the implantation of the fertilized ovum in 
the uterus like intrauterine devices (Hatcher, et al., 2001).   
 
 Classification according to composition: 
 
- Physiologic methods: these methods depend on the physiology of the human 
body. The main method in this group is the rhythm method in which intercourse 
is avoided in the fertility period of the menstrual cycle. Fertility period is when 
ovulation occurs and the ovum is available for fertilization (Hatcher, et al., 
2001).  
 
- Mechanical methods: these are mechanical barrier methods like condoms, 
diaphragms, cervical caps and intrauterine devices (Hatcher, et al., 2001). 
 
- Chemical methods: these include the use of agents containing spermicidal 
agents. Spermicides are found in different formulations including suppositories, 
gels, foams or creams (Hatcher, et al., 2001). 
 
- Hormonal control methods: these involve the use of hormones as a birth control 
method. Hormones are found as oral pills, injections and subdermal implants 
(Hatcher, et al., 2001). 
 
 Classification according to reversibility: 
 
- Reversible method: this means that the method chosen can be stopped at any 
time without long-term effects on fertility and that the woman can become 
pregnant after stopping the method use. Intrauterine devices oral contraceptives 
condoms and injectable contraceptives are examples for reversible contraception 
(Ozalp, et al., 2000).  
- Irreversible method: this means that the method used can not be reversed, most 
likely because it involved surgery. Surgical sterilization can be performed on 
women and is called in this case "tubal ligation", or it can be performed on men 
and is called "vasectomy" (Ozalp, et al., 2000).  
 
 Classification according to nature: 
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- Natural method: the rhythm or safety period method for prevention of pregnancy 
and the natural contraception caused by lactation period during which pregnancy 
usually doesn't occur (Wikipedia, 2006).   
 
- Unnatural methods: all methods other than the safety period method and the 
lactation period are considered to be unnatural or artificial (Wikipedia, 2006). 
 
3.5 Study Conceptual Model  
 
A model was constructed for the study based on the aim and the objectives of the study. 
Different variables and outcomes were connected according to the objectives. The main 
goal of the study was to examine the extent and depth of information given to current 
women users of oral contraceptives alongside their level of adherence and compliance 
behavior in administration and usage. Relations between variables themselves from one 
side and between variables and outcomes were constructed based on the objectives of the 
study. Main objectives of the study were to evaluate the quality of information provided 
to women about oral contraceptives and their degree of compliance to oral contraceptives 
use. Variables measuring information studied women have and their compliance to oral 
contraceptives were tested to see their dependence on other variables like women's age, 
locality, educational level, income and source of information. Knowledge and 
compliance are related so that compliance is better with better knowledge. As for 
knowledge, it is affected by factors like: lack of information, source of information, level 
of education, current age, age at marriage and locality. As for compliance, it is affected 
by economical status, number of children and the experience of side effects. Relations 
between these variables were put together in a model in order to be tested and measured.  
 
Variables in the study were categorized into categories in order to meet the study 
objectives. These categories are as follows: 
 
1. Demographic and socioeconomic background: this category covers demographic 
variables including place of residence (district and locality), family income, 
woman’s and husband's level of education and employment status. 
 
2. General health status: this category covers health status variables including 
weight, height, having chronic diseases, taking chronic medications, smoking, 
lactation. 
 
 
3. Maternal history: this category covers maternal history variables including 
woman's age at marriage, woman's age at first pregnancy, woman's age at first 
delivery, number and sex of children, number of abortions. 
 
4. Use of oral contraceptives: this category covers variables related to oral 
contraceptives use including reason for using the oral contraceptive, oral 
contraceptive prescriber, use of the calendar pack and use of a backup method. 
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5. Knowledge about oral contraceptives: this category covers variables related to 
women's knowledge about oral contraceptives being used including the name of 
the oral contraceptive used, nature of oral contraceptive, knowledge of oral 
contraceptive side effects, knowledge of oral risk factors, knowledge of oral 
contraceptives interactions with other medications or substances and knowledge 
of oral contraceptives health benefits 
 
6. Compliance to oral contraceptive use: this category covers variables measuring 
compliance to oral contraceptives including taking the oral contraceptive 
regularly, missing taking the oral contraceptive (frequency and number per 
month), use of backup methods and use of reminder.    
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Figure 3.1: Study Conceptual Model 
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3.9 Summary 
 
Different methods of contraception available can be grouped into categories depending 
on different points of view like mechanism of action in the body, mode of application, 
industry or active components. Although contraceptive methods have been known and 
used long time ago, the massive development in this field is only decades aged now. On 
the other hand, quick development is going on and is also expected in the years to come.  
 
Contraceptives are used in the first place to prevent pregnancy in an action to stop having 
children or to space between them. However, cases having different reasons for 
contraceptive use are also available. Among these cases is the presence of a chronic 
disease that makes it danger for the woman to become pregnant or the fear to transport a 
congenital disease to the children.  
 
Despite the fact that oral contraceptives are preferred by many women for the ease of use 
and the other health benefits they have, oral contraceptives are still surrounded by 
different myths and misunderstandings.  
 
Oral contraceptives action depends on the hormonal cycle of the woman. Oral 
contraceptives are found as combination of estrogen and progestin hormones or as 
progestin hormone only pills. Each of these hormones has a different mechanism of 
action resulting eventually in prevention of conception.  
 
Oral contraceptives are like other drug groups that have desired beneficial effects besides 
their original action and also have undesired effect and complications. The most desired 
beneficial effect of oral contraceptives may be the decreased bleeding experienced by 
women and thus less occurrence of anemia. In contrast to their possibility of developing 
breast or cervical cancers, oral contraceptives play the role of protective factor against 
ovarian and endometrial cancers.  
 
Use of oral contraceptives is forbidden in many cases in which their use may exacerbate 
current health conditions like cardiovascular problems and varicose veins.  
 
Interactions of oral contraceptives with other medications result in decreasing their effect 
by the acceleration of their metabolism by other medications or increased level of side 
effects by increasing their concentrations in the body through decreased metabolism. 
Also, oral contraceptives themselves can affect the concentrations of other medications in 
the same way.  
 
Choosing a contraceptive method in general and oral contraceptive in specific depends on 
factors that need to be taken into consideration so as to be able to maximize their effect 
and decrease their undesired outcomes. Different formulations of oral contraceptives are 
now available. Some of which are combination oral contraceptives with estrogen and 
progestin hormone derivatives and others contain only progestin hormones. Many brands 
are now available thus providing a wide range of choices to choose from. Lactation is one 
of the important factors affecting the choice of the oral contraceptive. In this case a 
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progestin only pill is usually chosen to preserve the production of breast milk. 
Combination oral contraceptives are found in more varieties than the progestin only pills.  
 
Missing pills is a problem facing oral contraceptive users. Women using oral 
contraceptives should be taught not to miss pills and also taught to act properly when 
missing pills. Reaching the high effectiveness of oral contraceptives requires corporation 
from women using contraceptive pills and from the health team providing this service in 
order to fulfill the anticipated results from their use.  
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4.1 Introduction 
 
Objectives of this study were best to be reached by a descriptive cross-sectional study. 
The Official approval for data collection was obtained from The Palestinian Family 
Planning and Protection Association centers in the West Bank based on an official letter 
from the researcher and the supervisor through the team of The School of Public health at 
Al-Quds University. Preparing for the questionnaire that was used as the research tool 
followed the scientific methodology. Inclusion and exclusion criteria for participants in 
the research were developed so that women currently using oral contraceptives were 
included in the study. Ethical consideration was followed in sample determination and 
during data collection. Data were collected in a four months period between December 
2007 and March 2008 where 149 women filled the questionnaire. Data entry and data 
analysis for the filled questionnaires were performed using version 15 of The Statistical 
Package for Social Sciences program (SPSS 15). 
 
4.2 Study Design 
 
This is a descriptive cross-sectional study. The study was done in the clinics of the 
PFPPA in Bethlehem, Halhoul, Hebron and Ramallah and Tulkarem. The questionnaires 
were filed by the women who were visiting the clinics for the provision of oral 
contraceptives.  
 
4.3 Sample Determination 
 
The research objectives and problem statement implied that the women participating in 
the research should be currently using oral contraceptives. So, after the approval of The 
Family Planning and Protection Association, women currently using oral contraceptives 
were determined as the sample population.  
 
4.4 Inclusion and Exclusion Criteria  
 
Women currently using oral contraceptives were defined as those who have been using 
the oral contraceptive for at least one month before the research commenced and visited 
the clinic for the provision with the oral contraceptive for the next month. 
Women who were prescribed the oral contraceptive for the first time and wanted to 
commence using them after that visit were not included in the study, unless they visited 
the center once again during the four months research duration and asked for further 
supply of the oral contraceptive.  
 
On the other hand, women using oral contraceptive who visited The Family Planning and 
Protection Association centers to get advice for changing from oral contraceptives to 
another contraceptive method were not included in the research.  
 
So, every woman visiting any of The Family Planning and Protection Association centers 
in Bethlehem, Halhoul, Hebron, Ramallah and Tulkarem from December 2007 to the end 
of March 2008 who was currently using any oral contraceptive as defined above was 
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asked to fill in the questionnaire. During this period, 149 women agreed to fill the 
questionnaire and thus data were collected.  
 
4.5 Research Field 
 
Research field was determined after getting the approval from The Family Planning and 
Protection Association to collect the data and fill the questionnaires from women visiting 
their clinics in Bethlehem, Halhoul, Hebron, Ramallah and Tulkarem. A written letter for 
this purpose was sent from the researcher through supervisor and the university and 
approval was the answer. 
  
4.6 Ethical Considerations 
 
A description for the study and its objectives was found with each questionnaire and thus 
studied women were able to know the reason for the study. The questionnaires were filled 
by the women with complete privacy without asking for their names. No one had been 
given access to the completed questionnaires other than the researcher to ensure privacy 
and accuracy. 
 
4.7 Research Tool 
 
While developing the questionnaire, many questionnaires for researches concerning oral 
contraceptive use and compliance were explored. One of these questionnaires was a 
questionnaire used in a study with the title "Jordanian Married Muslim Women's 
Intentions to Use Oral Contraceptives" by Suha Kridli and Sarah Newton in Jordan 
(Kridli and Newton, 2005). The researcher used the questionnaire as a basis for 
developing her own questionnaire to meet the research aim and objectives. Then 
questionnaire was given to a validation committee, i.e.an obstetrician gynecologist, two 
midwives and a nurse, for evaluation. Suggestions given by the committee were studied 
by the researcher and the supervisor and were taken into consideration and worked on.  
Some suggestions asked to change way of asking some questions in order to avoid 
leading questions, add some choices to the answers of some questions or delete some 
questions. 
  
The questionnaire was translated to the Arabic language to ensure understanding the 
questions and avoid misunderstanding. 
 
The questionnaire was composed of 90 questions in order to cover the research 
objectives. This issue was seen by some of the women who filled the questionnaire as a 
limitation since filling the questionnaire took sometimes fifteen to twenty minutes.  
 
The questions in the questionnaire were categorized into six parts according to the study 
aim and objectives. 
 
The parts and its questions are the following:   
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1. Demographic and socioeconomic background: these questions asked for 
information concerning: 
 
 place of residence  
 age 
 religion 
 family income 
  woman's and husband's level of education 
  woman's and husband's employment status. 
 
2. General health status: these questions asked women about: 
 
 weight  
  height 
 having chronic diseases 
 taking chronic medications 
 previous surgery  
 family history of certain diseases 
 smoking status 
 lactation. 
 
 
3. Maternal history: this category looked for information including:  
 
 woman's age at marriage 
 woman's age at first pregnancy 
 woman's age at first delivery 
 number and sex of children   
 number of abortions. 
 
4. Use of oral contraceptives: in this category, women were asked to give 
information concerning:  
 
 their use of oral contraceptives at previous occasions in numbers and 
durations if any 
 their intentions to continue using oral contraceptives or to quit in the coming 
months 
 reason for using the oral contraceptive 
 oral contraceptive prescriber and provision site 
 
5. Knowledge about oral contraceptives: in this category women's knowledge about 
oral contraceptives being used was explored through asking them about: 
 
 the name of the oral contraceptive used 
 source and level of information supplied 
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 knowledge of oral contraceptive risk factors 
 knowledge about oral contraceptives side effects 
 knowledge about oral contraceptives health benefits 
 knowledge of oral contraceptives interactions with other medications or 
substances 
 nature of oral contraceptives 
 whether they lack information concerning oral contraceptives and in which 
area 
 means for filling information gaps 
 
6. Adherence to oral contraceptives use: these questions covered women's 
compliance to oral contraceptives use by asking questions concerning: 
 
 taking the oral contraceptive regularly 
 missing taking the oral contraceptive (frequency and number per month) 
 actions and backup methods if oral contraceptive was missed 
 reminder means for taking the oral contraceptive 
 action upon experiencing side effects from the oral contraceptive 
 the occurrence of pregnancy while using the oral contraceptive.    
 
4.8 Pilot Study 
 
After developing the questionnaire and inspecting the by the validation committee, a pilot 
study was performed. In this study, ten women currently using oral contraceptives but 
from area other than the research field were asked to fill the questionnaire. These women 
were from Jerusalem which was not included in the research field. These women were 
currently using oral contraceptives i.e. were using them before filling the questionnaire 
and intended to continue using them after filling the questionnaire. These questionnaires 
were not included in the sample analyzed.  After the pilot the needed modifications were 
done. 
 
4.9 Data Collection 
 
Data collection commenced on the first of December 2007 till the thirty first of March 
2008 in a period of four months.  
 
The researcher visited the PFPPA centers in Bethlehem, Halhoul, Hebron, on Saturdays 
and in Ramallah on Sundays where the researcher colleted the data by herself.  
 
By the help of the team work in the stated centers, the researcher was freely able to talk 
to women currently using oral contraceptives. The women who approved to participate in 
the research were given the questionnaire to fill it by themselves.  
 
Data collection in Tulkarem was made through the nurse at the center due to the 
difficulty in reaching the clinic by the researcher. The nurse at the PFPPA center at 
Tulkarem distributed the questionnaire for women currently using oral contraceptives 
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according to the above stated criteria. The women took the questionnaire, filled it and 
returned it in the next visit. At the end of the research period, all the questionnaires (filled 
and unfilled) were returned to the researcher for analysis.  
 
4.10 Research Obstacles 
 
Difficulty in transportation and reaching the city of Tulkarem made the researcher send 
the questionnaires to the PFPPA center there where the women took the questionnaire, 
filled it and returned it to the center. Same criteria in inclusion and exclusion of women 
were followed. The researcher then collected the questionnaires form the center for 
analysis.  
 
4.11 Data Analysis 
 
Data collected was analyzed using the Statistical Package for the Social Sciences (SPSS 
16). Methods of analysis used were chosen to meet the objectives of the study and to look 
for areas of significance.  
 
Based on the study objectives, descriptive and univariate analysis for the data was 
accomplished.  
 
In the descriptive part of data analysis, frequencies for different variables were done. 
Results were presented either in tables or bar figures. Variables analyzed in this part 
were: 
 
 Demographic variables to determine differences in demographic factors on 
compliance to oral contraceptives.  
 
 Variables determining women’s general health status and maternal history. 
 
 Variables determining the use patterns of oral contraceptives. 
 
 Variables investigating reason for oral contraceptives use or cessation. 
 
 Variables detecting oral contraceptives providers and information provision 
sources.  
 
 Variables studying the level of knowledge of oral contraceptives women had. 
 
 Variables exploring information provided to women using oral contraceptives and 
information gaps. 
 
 Variables measuring compliance to oral contraceptives usage.  
 
The univariate analysis part studied the relation between different variables and the main 
outcome. Compliance to oral contraceptives use was the main outcome of the study and 
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thus cross tabulations and Pearson Chi-Square Test were calculated for factors affecting 
compliance directly and indirectly. Relations between compliance determinants were 
accomplished. Based on the study conceptual model, compliance determinants were 
analyzed: 
 
 Relation between compliance and demographic and variables were studied.  
 
 Relation between compliance and socioeconomic variables were studied.  
 
 Relation between compliance and knowledge variables were studied. 
 
 Relation between compliance and women’s health status variables were studied. 
 
 Relation between compliance and women’s maternal history variables were 
studied. 
 
 Relation between compliance and patterns of oral contraceptives use were 
studied. 
  
4.12 Summary 
 
The study was accomplished by cross sectional design. The designed questionnaire was 
developed depending on previous questionnaires studying oral contraceptives' use and 
compliance and was subjected to changes according to the objectives studied. Then the 
questionnaire was submitted for evaluation by health professionals. The questionnaire 
was originally designed in English and was later translated to Arabic. 
 
 A pilot study was performed on women with the same criteria of women participating in 
the study but from a different setting. Women who passed the pilot study were from 
Jerusalem city while women participating in the study itself were from the Wes Bank 
districts. Data was collected in a three months period from women using oral 
contraceptives visiting the PFPPA clinics in Bethlehem, Halhoul, Hebron, Ramallah and 
Tulkarem.  
 
Studied women were asked to fill a questionnaire. The questionnaire asked for 
information concerning demographic and socioeconomic background, general health 
status, maternal history, use of oral contraceptives, knowledge about oral contraceptives 
and adherence to oral contraceptives use.  
 
Collected data were treated and analyzed using The Statistical Package for the Social 
Sciences (SPSS 16).   
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5.1 Introduction 
 
The aim of the study was to investigate compliance to oral contraceptives usage and its 
determinants among current users of oral contraceptives in the clinics of PFPPA in the 
West Bank. One hundred forty nine questionnaires were completed by women visiting 
the PFPPA clinics in Bethlehem, Halhoul, Hebron, Ramallah and Tulkarem from 1-12-
2007 to 31-03-2008. 
 
Data analysis in this chapter is categorized into two parts:  
 
 Descriptive analysis for the study population. 
  
 Univariate analysis to study the associations between the outcome and the various 
determinants. 
 
5.2 Data Analysis 
 
5.2.1 Descriptive Analysis 
 
5.2.1.1 Demographic Distribution 
 
In this study, 39.60% of the studied women were from Halhoul, 32.21% from Hebron, 
11.41% from Tulkarem, 10.07% from Bethlehem and 6.71% from Ramallah (Figure 5.1). 
The studied women came from cities, villages and camps. As shown in (Figure 5.2), 
69.8% of the women were from cities, 29.53% were from villages and 0.67% were from 
camps. Concerning locality in each district, studied women were mainly distributed 
among cities and villages with only one woman from Bethlehem district coming from 
camp; (Figure 5.3) shows these results. From Ramallah district, 10.00% were from the 
city itself and 90.00% were from Ramallah villages. As for Hebron district, 77.08% came 
from the city itself, 22.92% from Hebron villages. 93.22% of the women from Halhoul 
came from the city itself whereas 6.78% came from villages. Concerning Bethlehem, 
40.00% were from the city itself, 63.33% from villages and 6.67% from camp. Studied 
women from Tulkarem district were from the city itself:  29.41% and the villages: 
70.59%. 
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Figure 5.1: Distribution of Women Studied according to Districts 
 
 
 
Figure 5.2: Distribution of Women Studied according to Locality  
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Figure 5.3: Distribution of Women Studied according to Districts and Locality 
 
5.2.1.2 Distribution according to Age 
 
Age was asked for in the questionnaire based on groups for both the studied women and 
their husbands. As displayed in (Figure 5.4), 2% of studied women were younger than 18 
years old, 6.7% were between 19 and 23 years old, 24.2% were between 24 and 28 years 
old, 26.2% between 29 and 33 years of age while 40.9% were 34 years old or more. As 
for their husbands: no one of them was younger than 18 years, and most of them were 34 
years old or more with a percentage of 67.1%.   
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Figure 5.4: Distribution of Women Studied and their Husbands according to Age 
Groups 
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5.2.1.3 Distribution according to Employment Status 
 
Employment status distribution as illustrated in (Figure 5.5) shows that most of the 
women in the study were unemployed with a percentage of 88.6% which is the contrary 
to the husband's employment status whose unemployed percentage is 8.7%. As for other 
sectors of employment, 4% of the studied women were government employees, 6.7% 
private sector employees and 0.7% only were self employed. The majority of husbands 
(36.2%) were self employed, 33.6% were private sector employees and 21.5% were 
government employees.  
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Figure 5.5: Distribution of Women Studied and their Husbands according to 
Employment Status 
 
5.2.1.4 Distribution according to Family Income 
 
Women studied were distributed into different groups measuring family income with the 
higher percent of 49% for monthly income between 1,000 and 2,000 NIS income so that 
70.5% of the women studied came from families whose monthly income was 2,000 NIS 
or less (Figure5.6).   
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Figure 5.6: Distribution of Sample according to Family Income 
 
5.2.1.5 Distribution according to Women's and Husband's Level of Education 
 
In this study, only two women (1.3%) and one husband (0.7%) reported being illiterate 
(Figure 5.7). however, nearly half of both categories women and husbands finished the 
secondary level of education with percentages of 47% and 46.3% respectively. 
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Figure 5.7: Distribution of Women's and Husband's Level of Education 
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5.2.1.6 Chronic Diseases in Studied Women 
 
The majority of the women in the study were not suffering from chronic disease. 90.6% 
of them had no chronic diseases, while only 9.4% had chronic diseases as seen in (Figure 
5.8).  
 
 
 
Figure 5.8: Percentages of Chronic Diseases in Studied Women 
 
Chronic diseases found in the studied women were arthritis (4 cases, 2.68%), asthma (1 
case, 0.67%), diabetes (1 case, 0.67%), hypertension (1 case, 0.67%), migraine (2 cases, 
1.34%), allergy (2 cases, 1.34%), night blindness (1 case, 0.67%), thalasemia (1 case, 
0.67%) and ulcer (1 case, 0.67%). This is shown in (Table 5.1). 
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Table 5.1: Percentages for Chronic Diseases in Studied Women 
 
Chronic Disease  Counts Percent 
Not Having Chronic Diseases 135 90.60% 
Arthritis Patients 4 2.68% 
Asthma Patients 1 0.67% 
Diabetes Patients 1 0.67% 
Hypertension Patients 1 0.67% 
Migraine Patients 2 1.34% 
Allergy Patients 2 1.34% 
Night Blindness Patients 1 0.67% 
Thalasemia Patients 1 0.67% 
Ulcer Patients 1 0.67% 
Total 149 100.00 
 
5.2.1.7 Chronic Medications Use by Studied Women 
 
Ten women from those reporting to have chronic diseases reported being on a chronic 
medical treatment meaning that only 6.7% (Figure 5.9) of the studied women were taking 
at least one other medication with the oral contraceptive.  
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Figure 5.9: Percents for Women Using Chronic Medications 
 
5.2.1.8 Studied Women Having Previous Surgeries 
 
Studied women were asked about having previous surgery. Nearly the quarter (25.5%) of 
the studied women had had previous surgeries from whom 47.4% had cesarean section.  
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5.2.1.9 Studied Women Having Family History for Some Chronic Diseases 
  
Studied women were asked in the questionnaire whether they had a family history for 
chronic diseases or conditions that are considered as risk factors for using oral 
contraceptives. As seen in (Table 5.2), 52 (34.9%) women reported having family history 
for hypertension, followed by 27.5% having diabetes in family history. 2.7% of the 
studied women reported having family history of breast cancer, 0.7% had family history 
for endometrial cancer and none of them had family history for cervical cancer.  
 
Table 5.2: Some Chronic Diseases in the Family History of the Studied Women 
 
Chronic Disease Count Percent 
Breast cancer 4 2.7% 
Cervical cancer 0 .0% 
Endometrial cancer 1 .7% 
Hypertension 52 34.9% 
Thrombosis 16 10.7% 
Varicose veins 20 13.4% 
Diabetes 41 27.5% 
Obesity 28 18.8% 
 
5.2.1.10 Smokers among Studied Women 
 
Only 4 of the studied women (2.7%) reported being smokers as shown in (Table 5.3).  
 
Table 5.3: Smokers among Studied Women 
 
Smoker Count Percent 
yes 4 2.7% 
no 145 97.3% 
 
5.2.1.11 Lactation among Studied Women 
 
Concerning the lactation status of the studied women, 20.8% were lactating and 79.19% 
were not lactating as shown in (Figure 5.10).  
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Figure 5.10: Percents for Lactation among Studied Women 
 
5.2.1.12 Weight of Studied Women 
 
The mean weight (SD) of studied women was 67.01 (± 10.210) kilograms; minimum 
weight was 47 kg while maximum weight was 92 kg as shown in (Table 5.4).   
 
Table 5.4: Weight of Studied Women 
 
Women's Weight 
(kg)    
 
N Valid 149 
Missing 0 
Mean 67.01 
Std. Deviation 10.210 
Range 45 
Minimum 47 
Maximum 92 
 
5.2.1.13 Height of Studied Women 
 
The mean height (SD) of studied women was 160.60 (± 10.044) centimeters; minimum 
height was 72 cm while maximum height was 185 cm as shown in (Table 5.5).  
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Table 5.5: Height of Studied Women 
 
Women's Height 
(cm)   
 
N Valid 149 
Missing 0 
Mean 160.60 
Std. Deviation 10.044 
Range 113 
Minimum 72 
Maximum 185 
 
5.2.1.14 Women's Age at Marriage  
 
Concerning women's age at marriage, 41.6% of studied women married between 15-18 
years of age, while only 2.7% were less than 15 years of age when married as shown in 
(Figure 5.11). 
 
 
 
Figure 5.11: Distributions for Women's Age at Marriage (in completed years) 
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5.2.1.15 Women's Age at 1
st
 Delivery  
 
Studied women were asked for their age at the first delivery. More than the half (51.7%) 
of studied women had their first delivery between 19-22 years of age, 24.8% between 15-
18 and 23.5% were at least 23 years at their first delivery as shown in (Figure 5.12). 
 
 
 
Figure 5.12: Distributions for Women's Age at 1
st
 Delivery (in completed years) 
 
5.2.1.16 Number of Live Children Born to the Woman 
 
The mean number (SD) of live children born to a woman was 4.19 (± 2.117) children; 
minimum number born was 1 child while maximum number born was 13 children as 
shown in (Table 5.6).  
 
Table 5.6: Number of Live Children Born to the Woman 
 
N Valid 149 
Missing 0 
Mean 4.19 
Std. Deviation 2.117 
Minimum 1 
Maximum 13 
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5.2.1.17 Number of Abortions per Woman 
 
The mean number (SD) of abortions per woman was .71 (± 1.022) abortion; minimum 
number of abortions was 0 while maximum number of abortions was 5 as shown in 
(Table 5.7). Percentages of abortions are shown in (Figure 5.13). 
 
Table 5.7: Number of Abortions per Woman 
 
N Valid 149 
Missing 0 
Mean .71 
Std. Deviation 1.022 
Minimum 0 
Maximum 5 
 
 
 
Figure 5.13: Distributions for Number of Abortions per Woman 
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5.2.1.18 Male and Female Children Studied Women Have 
 
The mean number (SD) of male children born to women was 2.24 (± 1.478) male child; 
minimum number of male children studied women have was 0 while maximum number 
of male children studied women have  was 6 as shown in (Table 5.8). 
 
The mean number (SD) of female children born to women was 1.95 (± 1.374) female 
child; minimum number of female children studied women have was 0 while maximum 
number of female children studied women have  was 8 as shown in (Table 5.8).  
 
Frequencies shown in (Table 5.9) show that 31.5% of studied women had 2 male children 
and 3.4 % had 6 male children whereas 9.4% had no male children. 
 
As for female children, (Table 5.9) shows that 30.2% of studied women had 2 female 
children and 0.7 % had 6, 7, 8 female children whereas 11.4% had no female children. 
 
Table 5.8: Male and Female Children Studied Women Have 
 
 Male Female Total 
N Valid 149 149 149 
Missing 0 0 0 
Mean 2.24 1.95 4.06 
Std. Deviation 1.478 1.374 2.246 
Minimum 0 0 0 
Maximum 6 8 13 
 
Table 5.9: Distribution for Number of Male and Female Children Studied Women 
Have 
 
 
# of Children 
Female Male 
Frequency Percent Frequency Percent 
0 17 11.4% 14 9.4% 
1 44 29.5% 35 23.5% 
2 45 30.2% 47 31.5% 
3 28 18.8% 27 18.1% 
4 9 6.0% 11 7.4% 
5 3 2.0% 10 6.7% 
6 1 .7% 5 3.4% 
7 1 .7% 0 0.00% 
8 1 .7% 0 0.00% 
Total 149 100.0% 149 100.0% 
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5.2.1.19 Use of Other Contraceptive Method other than Oral Contraceptives 
 
When asked for previous use of contraceptives methods other than oral contraceptives, 
65.8% reported using other contraceptive methods and 34.2% never used a contraceptive 
method other than the oral contraceptives: (Table 5.10).  
 
Table 5.10: Use of Other Contraceptive Method other than Oral Contraceptives 
 
 Frequency Percent 
yes 98 65.8% 
no 51 34.2% 
Total 149 100.0% 
 
5.2.1.20 Women's Age When First Using Oral Contraceptive 
 
As shown in (Figure 5.14), 43.6% of women were between 18-23 years or 24-29 years 
old when first using oral contraceptives; i.e. 87.2% of women used oral contraceptives for 
the first time between 18-29 years old. 
 
 
 
Figure 5.14: Distributions for Women's Age When First Using Oral Contraceptive 
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5.2.1.21 Number of Children Women Had when 1
st
 Using Oral Contraceptive 
 
Most of women studied started using oral contraceptives after having children (98%). 
Only 2% used oral contraceptives for the first time and did not have children then (Table 
5.11). The Table also shows 53.7% of women started using oral contraceptives after 
having 1 or 2 children.   
 
Table 5.11: Number of Children Women Had when 1st Using Oral Contraceptive 
 
# of Children Frequency Percent 
0 3 2.0% 
1 40 26.8% 
2 40 26.8% 
3 26 17.4% 
4 19 12.8% 
5 11 7.4% 
6 4 2.7% 
7 5 3.4% 
8 1 .7% 
Total 149 100.0% 
 
5.2.1.22 Intension to Stop Oral Contraceptive 
 
When asked whether they intend to stop oral contraceptives' use or not, 54.4% answered 
that they intend to stop using oral contraceptives and 45.6% said that they do not intend 
to stop the oral contraceptive as shown in (Table 5.12).  
 
Table 5.12: Intension to Stop Oral Contraceptive 
 
Intention to Stop OC Frequency Percent 
yes 81 54.4% 
no 68 45.6% 
Total 149 100.0% 
 
5.2.1.23 Reasons for Future Cessation of Oral Contraceptive Use 
 
Many reasons were behind future cessation of oral contraceptives by the studied women. 
30.9% of women who intended to stop oral contraceptives said that their reason was that 
they wanted to have more children, 4.7% were concerned about oral contraceptives' 
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safety, 2.7% suffered from gastric upset and 1.3% either had irregular bleeding or had 
poor compliance (Table 5.13). 
 
Table 5.13: Reasons for Future Cessation of Oral Contraceptive Use 
 
Reasons for OC stop Frequency Percent 
To have more children 46 30.9% 
Cause irregular bleeding 2 1.3% 
Cause gastric upset 4 2.7% 
Concerned about their safety 7 4.7% 
Poor compliance 2 1.3% 
Others 11 7.4% 
NA 66 44.3% 
System missing 11 7.4% 
Total 149 100.0% 
 
5.2.1.24 Reasons for Oral Contraceptive Use 
 
Studied women were asked for reasons of oral contraceptives use, 59.7% reported using 
oral contraceptives for spacing between children, 32.9% said that they were taking oral 
contraceptives in order to stop having children while 4.7% were using oral contraceptives 
due to health problems as seen in (Table 5.14). 
 
Table 5.14: Reasons of Oral Contraceptive Use 
 
Reason for OC Use Frequency Percent 
Stop having children 49 32.9% 
Spacing between children 89 59.7% 
Health Problems 7 4.7% 
Others 2 1.3% 
System missing 2 1.3% 
Total 149 100.0% 
 
5.2.1.25 Advice for Oral Contraceptive Choice among other Contraceptives  
 
Studied women were asked by whom they were advised to choose the oral contraceptive 
among other contraceptives if any. As shown in (Table 5.15), 70.5% said that it was 
advice from their health care providers, 27.5% said that it was a self-made decision while 
2.0% took advice from a relative or a friend.  
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Table 5.15: Advice for Oral Contraceptive Choice among other Contraceptives 
 
OC Use was Advice from: Frequency Percent 
Health care provider 105 70.5% 
Relative/ friend 3 2.0% 
Self made decision 41 27.5% 
Total 149 100.0% 
 
5.2.1.26 Oral Contraceptive Prescriber 
 
Women were asked who their oral contraceptive prescriber was. Main prescriber as 
reported by 66.4% of the studied women was the obstetrician or gynecologist, followed 
by village health workers with a percentage of 29% as shown in (Table 5.16). 
 
Table 5.16 Oral Contraceptive Prescriber 
 
OC Prescriber Frequency Percent 
Obstetrician/Gynecologist 99 66.4% 
General practitioner. 3 2.0% 
Midwife. 7 4.7% 
Village Health Worker. 29 19.5% 
Self 8 5.4% 
Friend 3 2.0% 
Total 149 100.0% 
 
5.2.1.27 Knowledge of Oral Contraceptive's Name 
 
The majority of studied women knew the name of the oral contraceptive they were using. 
As seen in (Table 5.17), 74.5% of thee studied women replied by "Yes" when asked 
whether they knew the name of the oral contraceptives they were using and were able to 
name it. However, 25.5% did not know the name of the oral contraceptive they were 
using.  
 
Table 5.17: Knowledge of Oral Contraceptive's Name 
 
Know OC Name Frequency Percent 
yes 111 74.5% 
no 38 25.5% 
Total 149 100.0% 
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5.2.1.28 Receiving Information about Oral Contraceptives 
 
Women in the study were asked whether they received information about oral 
contraceptives when first prescribed. As seen in (Table 5.18), 96.0% reported that they 
received information and 4% said that they did not receive information when the oral 
contraceptive was first prescribed. 
 
Table 5.18: Receiving Information about Oral Contraceptives 
 
Get Information Frequency Percent 
yes 143 96.0% 
no 6 4.0% 
Total 149 100.0% 
. 
5.2.1.29 Source of Provided Information about Oral Contraceptives 
 
When asked about the source of information provided, 89% stated that the nurse was the 
source of information, 51% of the women had their obstetrician as the information source 
as seen in (Table 5.19). 
 
Table 5.19: Source of Provided Information about Oral Contraceptives 
 
Source of Information Frequency Percent 
Obstetrician 51 34.2% 
Family doctor 1 .7% 
Pharmacist 1 .7% 
Nurse 89 59.7% 
Midwife 1 .7% 
Others 6 4.0% 
Total 149 100.0% 
 
5.2.1.30 Description of Information Provided 
 
As shown in (Table 5.20), 85.9% said that the received information about oral 
contraceptives was clear and understandable. 3.4% said it was unclear, 2.7% found it 
confusing and 5.4% found it brief and shallow. 
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Table 5.20: Description of Information Provided 
 
Information Received Frequency Percent 
Clear & 
understandable 
128 85.9% 
Unclear 5 3.4% 
Confusing 4 2.7% 
Brief and shallow 8 5.4% 
Others 3 2.0% 
System missing 1 .7% 
Total 149 100.0% 
 
5.2.1.31 Getting a Leaflet with the Oral Contraceptive Dispensed 
 
Studied women were asked whether they got a leaflet when receiving the oral 
contraceptive. It is worth to note here that most oral contraceptives are found in a 
package with three packs and one leaflet. About 43% of the studied women never got a 
leaflet with the oral contraceptive, 32.9% sometimes got the leaflet while 24.2% got the 
leaflet all the times (Table 5.21). 
 
Table 5.21: Getting a Leaflet with the Oral Contraceptive Dispensed 
 
Get OC Leaflet Frequency Percent 
Yes, always 36 24.2% 
Sometimes 49 32.9% 
No, never 64 43.0% 
Total 149 100.0% 
 
5.2.1.32 Understanding Information in the Leaflet with the Oral Contraceptive 
Dispensed 
 
Women getting a leaflet with the oral contraceptive pills were asked whether they 
understood the information in the leaflet about oral contraceptives. About 73.2% of those 
women understood the leaflet information and 1.3% did not understand the leaflet 
information as shown in (Table 5.22). 
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Table 5.22: Understanding Information in the Leaflet with the Oral Contraceptive 
Dispensed 
 
Understand Leaflet Frequency Percent 
Yes 109 73.2% 
No 2 1.3% 
NA 38 25.5% 
Total 149 100.0% 
 
5.2.1.33 Lack of Information 
 
Studied women were asked whether they think they lack significant information 
concerning oral contraceptives. As shown in (Table 5.23) 34.2% said they lacked 
significant information while 65.8% said that they did not lack significant information. 
 
Table 5.23: Lack of Information 
 
Lack Information Frequency Percent 
Yes 51 34.2% 
No 98 65.8% 
Total 149 100.0% 
 
5.2.1.34 Information Gaps 
 
Women lacking information were asked to specify fields where they lack information. As 
shown in (Table 5.24): 9.8% of those women said they lack information about oral 
contraceptives' proper use, 13.3% lacked information about oral contraceptives’ benefits, 
24.5% lacked information about oral contraceptives’ side effects, 21% lacked information 
about oral contraceptives’ risk factors, 17.5% lacked information about oral 
contraceptives’ drug interaction. 
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Table 5.24: Information Gaps 
 
Areas of Information Gaps N Percent 
Oral contraceptive's proper use 14 9.8% 
Oral contraceptive's benefits 19 13.3% 
Oral contraceptive's side effects 35 24.5% 
Oral contraceptive's risk factors 30 21.0% 
Oral contraceptive's drug interactions 25 17.5% 
Oral contraceptive's cost 7 4.9% 
Oral contraceptive's effects on sexuality 11 7.7% 
Others 2 1.4% 
Total 143 100.0% 
 
5.2.1.35 Reasons for Lack of Information 
 
Same women who said they lacked information were also asked to specify reasons they 
consider lie behind their lack of information. The two main reasons specified here were 
that their overall health knowledge was poor or they did not know the reasons with 
percentages of 28.6% and 27.0% respectively as seen in (Table 5.25). Other reasons and 
percentages are: forgetting provided information: 15.9%, health center they refer to was 
always busy and no enough time for asking for information: 14.3%, being ashamed to ask 
question and that the information provider spoke quickly and women could not follow: 
4.8% each, provided information was complicated and unclear: 3.2% and 1.6% feared to 
ask for information. 
 
Table 5.25: Reasons for Lack of Information 
 
Reasons for Lack in Information N Percent 
Information provided is complicated and unclear. 2 3.2% 
Information provider speaks quickly  3 4.8% 
Overall health knowledge is poor. 18 28.6% 
Forget the information given. 10 15.9% 
Fear to ask for clarification. 1 1.6% 
Being ashamed to ask for clarification. 3 4.8% 
It is always too busy at my health facility and 
there is no time for questions. 
9 14.3% 
Do not know. 17 27.0% 
Total 63 100.0% 
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5.2.1.36 Ways to Fill information Gaps 
 
Women who previously reported that they lack information concerning oral 
contraceptives were also asked to determine best ways for filling their information gaps. 
About 30.1% of them thought that providing them with printed drug information in 
Arabic could help and 15.8% wanted health professionals to read and explain for them 
the information in the oral contraceptives’ leaflet. This takes us back to the question 
where women were asked whether they receive the oral contraceptives’ leaflet or not and 
how 43% said that they never received a leaflet. Whereas 28.3% of women with 
information gaps said that provision of information by media could be helpful. (Table 
5.26) 
 
Table 5.26: Ways to Fill information Gaps 
 
Ways to Fill Information Gaps N Percent 
Presenting printed drug information in Arabic.  82 30.1% 
Have a health professional to read explain all of the 
informational material written on the leaflet.  
43 15.8% 
Receive information on contraceptive methods 
including OC through media (e.g. TV, radio…) 
77 28.3% 
Make available counseling services on effective use of 
OC after being prescribed. 
32 11.8% 
Have access to a hotline to refer to in OC related 
contingencies 
37 13.6% 
Others 1 .4% 
Total 272 100.0% 
 
5.2.1.37 Ability to Express Oneself and Ask for Information 
 
Studied women were asked whether the first time of oral contraceptives’ prescription 
they were given the opportunity to express themselves and ask for information and 
clarification. 81.9% replied positively and 18.1% replied negatively as seen in (Table 
5.27).  
 
Table 5.27 Ability to Express Oneself and Ask for Information 
 
 Frequency Percent 
yes 122 81.9% 
no 27 18.1% 
Total 149 100.0% 
 92 
 
5.2.1.38 Knowing How Oral Contraceptives Work 
 
Women were asked whether they knew how oral contraceptives worked or not. Asking 
this question did not require that women should know the exact pharmacological action 
of oral contraceptives. It was meant by this question to know if women knew that oral 
contraceptives worked on their hormones in preventing pregnancy. As shown in (Table 
5.28), 67.1% said that they knew how oral contraceptives worked while 32.9% did not 
know how oral contraceptives worked. 
 
Table 5.28: Knowing How Oral Contraceptives Work 
 
Know How OC Work Frequency Percent 
Yes 100 67.1% 
No 49 32.9% 
Total 149 100.0% 
 
5.2.1.39 Knowledge of Oral Contraceptives' Active Ingredient 
 
Studied women were asked to specify among choices the active ingredient of oral 
contraceptives. A percentage of 73.8% said it was a hormonal substance, 1.3% said it was 
a natural substance, 0.7% said it was a chemical substance and 24.2% did not know what 
was the active ingredient. This is illustrated in (Table 5.29). 
 
Table 5.29: Knowledge of Oral Contraceptives' Active Ingredient 
 
OC Active Ingredient Frequency Percent 
Hormonal substance 110 73.8% 
Natural substance 2 1.3% 
Chemical substance 1 .7% 
Do not know 36 24.2% 
Total 149 100.0% 
 
5.2.1.40 Calendar Pack Familiarity 
 
Studied women were asked whether they knew the meaning of "Calendar Pack". 
Calendar pack is the oral contraceptives pills pack which has the days of the week written 
on its back with arrows so that the woman can follow the days and arrows and can simply 
know whether she has taken the pill of the day. As seen in (Table 5.30), 62.4% of the 
studied women replied that they knew the calendar pack and 37.6% did not know what 
was meant by it. This aspect was addressed in another question by asking women if they 
knew how to use the calendar pack and 61.7% said that they knew how to use and 38.3% 
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did not knew how to use it as seen in (Table 5.31).  Women were also asked whether they 
were following the calendar pack or not and 59.1% said that they were following it while 
39.6% were not following the calendar pack: (Table 5.32). 
 
Table 5.30: Calendar Pack Familiarity  
 
Know the "Calendar 
Pack" Frequency Percent 
Yes 93 62.4% 
No 56 37.6% 
Total 149 100.0% 
 
Table 5.31: Knowledge to Follow the Calendar Pack  
 
Knowledge to Follow 
the Calendar Pack Frequency Percent 
Yes 92 61.7% 
No 57 38.3% 
Total 149 100.0% 
 
Table 5.32: Calendar Pack Following  
 
Follow the 
Calendar Pack Frequency Percent 
Yes 88 59.1% 
No 59 39.6% 
Total 147 98.7% 
System missing 2 1.3% 
Total 149 100.0% 
 
5.2.1.41 Oral Contraceptives' Side Effects 
 
Studied women were asked whether oral contraceptives had side effects, 58.4% said that 
oral contraceptives had side effects and 41.6% said that oral contraceptives did not have 
side effects as shown in (Table 5.33). 
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Table 5.33: Oral Contraceptives' Side Effects 
 
OC Have S/E Frequency Percent 
Yes 87 58.4% 
No 62 41.6% 
Total 149 100.0% 
 
5.2.1.42 Serious Side Effects of Oral Contraceptives 
 
A question concerning serious side effects of oral contraceptives was asked for. Women 
were asked to choose among different health conditions if they knew them to be as 
serious side effects for oral contraceptives. Although the stated health conditions in the 
filled questionnaire in this question were all serious, percentages for knowledge of each 
side effect were low as seen in (Table 5.34). Hypertension and nausea/vomiting were 
seen serious by 21.1%, varicose veins by 13.7%, thrombosis by 13.1%, depression by 
12%, breast cancer by 9.7%, cervical cancer by 4.6%, stroke by 2.9% and finally 
myocardial infarction by 1.7%. 
 
Table 5.34: Serious Side Effects of Oral Contraceptives 
 
Knowledge about Serious S/E N Percent 
Breast cancer 17 9.7% 
Cervical cancer 8 4.6% 
Depression 21 12.0% 
Hypertension 37 21.1% 
Myocardial infarction 3 1.7% 
Severe nausea and vomiting 37 21.1% 
Stroke 5 2.9% 
Thrombosis 23 13.1% 
Varicose veins 24 13.7% 
Total 175 100.0% 
 
5.2.1.43 Oral Contraceptives' Drug Interactions 
 
Studied women were asked about oral contraceptives drug interactions. As seen in (Table 
5.35), 15.4% said that oral contraceptives had drug interactions while 84.6% thought that 
oral contraceptives did not have drug interactions.  
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Table 5.35: Oral Contraceptives' Drug Interactions 
 
OC Have Drug 
Interactions Frequency Percent 
yes 23 15.4% 
no 126 84.6% 
Total 149 100.0% 
 
5.2.1.44 Oral Contraceptives' Drug Interactions Studied Women Were Aware of 
 
The question asking whether oral contraceptives had drug interactions was followed by 
another question for women answering positively to choose among options of 
medications that could have interactions with oral contraceptives. Frequencies and 
percents are presented in (Table 5.36). The higher percent was for antibacterials; 10.7% 
said that oral contraceptives had interactions with antibacterials. 
 
Table 5.36: Oral Contraceptives' Drug Interactions Studied Women Were Aware of 
 
 
 
 
 
yes no NA 
OC’s Interactions Count Percent Count Percent Count Percent 
Alcohol 5 3.4% 18 12.1% 126 84.6% 
Analgesics 3 2.0% 20 13.4% 126 84.6% 
Antibacterials 16 10.7% 7 4.7% 126 84.6% 
Anticoagulants 3 2.0% 20 13.4% 126 84.6% 
Anticonvulsants 5 3.4% 18 12.1% 126 84.6% 
Antidiabetics 4 2.7% 19 12.8% 126 84.6% 
Antidepressants 4 2.7% 19 12.8% 126 84.6% 
Antihypertensives 6 4.0% 17 11.4% 126 84.6% 
Benzodiazepines 2 1.3% 21 14.1% 126 84.6% 
Corticosteroids & 
glucocorticosteroids 
1 .7% 22 14.8% 126 84.6% 
Diuretics 0 .0% 23 15.4% 126 84.6% 
Immunosupressants 2 1.35 21 14.1% 126 84.6% 
Vitamin C 0 .0% 23 15.4% 126 84.6% 
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5.2.1.45 Health Benefits of Oral Contraceptives 
 
Studied women were asked whether oral contraceptives had health benefits besides their 
contraceptive action; 45.6% replied positively 54.4% replied negatively: (Table 5.37). 
 
Table 5.37: Health Benefits of Oral Contraceptives 
 
OC Have Benefits 
besides Contraception Count Percent 
yes 68 45.6% 
no 81 54.4% 
Total 149 100.0% 
 
5.2.1.46 Oral Contraceptives' Health Benefits Studied Women Reported 
 
The question asking whether oral contraceptives had health benefits other than their 
contraceptive action was followed by another question for women answering positively 
to choose among options that could be benefits of oral contraceptives. As shown in 
(Table 5.38), 22.7% said that oral contraceptives reduce the frequency of dysmenorrhea, 
followed by 14.0% for reducing heavy menses. 
 
Table 5.38: Oral Contraceptives' Health Benefits Studied Women Reported 
 
OC Health Benefits Responses 
N Percent 
Decreased frequency of dysmenorrhea.  47 22.7% 
Decreased incidence of pelvic inflammatory disease. 12 5.8% 
May result in acne improvement. 17 8.2% 
Improvement of premenstrual symptoms. 26 12.6% 
May result in less hirsutism. 8 3.9% 
Reduced risk of ectopic pregnancy. 15 7.2% 
Reduced risk of endometrial cancer. 13 6.3% 
Reduced risk of endometriosis. 6 2.9% 
Reduced risk of heavy menses. 29 14.0% 
Reduced risk of iron deficiency anemia. 26 12.6% 
Reduced risk of ovarian cancer. 8 3.9% 
Total 207 100.0% 
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5.2.1.47 Taking Oral Contraceptive Pills Regularly 
 
Studied women were asked about taking pills regularly. As seen in (Table 5.39), 89.3% 
reported taking pills regularly all the time, 10.1% were taking the pills regularly most of 
the times and 0.7% were rarely taking the pills regularly. 
 
Table 5.39: Taking Oral Contraceptive Pills Regularly 
 
Take pill Regularly Frequency Percent 
Always 133 89.3% 
Mostly 15 10.1% 
Rarely 1 .7% 
Total 149 100.0% 
 
5.2.1.48 Missing Oral Contraceptive Pills 
 
Another question to test compliance was asked. Women were asked whether they miss 
pills or not. Answers to this question revealed the same degree of compliance as the 
answers to the question about taking pills regularly. 15.4% of the studied women reported 
missing pills and 83.9 % reported not missing pills: (Table 5.40). 
 
Table 5.40:  Missing Oral Contraceptive Pills 
 
Miss Pill Frequency Percent 
yes 23 15.4% 
no 125 83.9% 
System 
missing 
1 .7% 
Total 149 100.0% 
 
5.2.1.49 Number of Missed Pills per Month 
 
Women replying to the question of missing pills positively were asked to specify the 
number of missed pills per month. About 83.9% of the studied women did not miss any 
pill and this is the same percentage as the previous question, 10.1% missed 1 pill 
monthly, 5.4% missed 2 pills monthly and 0.7% missed 3 or more pills monthly: (Table 
5.41). 
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Table 5.41: Number of Missed Pills per Month 
 
# of Missed Pills/Month Frequency Percent 
0 125 83.9% 
1 15 10.1% 
2 8 5.4% 
3 or more 1 .7% 
Total 149 100.0% 
 
5.2.1.50 Compliance Classification 
 
Studied women were asked to describe their degree of compliance in taking the oral 
contraceptive pills. As seen in (Table 5.42), 87.9% said that they had high compliance 
which is a close percent to those not missing pills (83.9%), 10.7% classified their 
compliance as moderate and 1.3% found their compliance to be poor. 
 
Table 5.42: Compliance Classification 
 
Compliance Frequency Percent 
High 131 87.9% 
Moderate 16 10.7% 
Poor 2 1.3% 
Total 149 100.0% 
 
5.2.1.51 Action Taken when Missing Pill/s 
 
Studied women were asked to specify their action when missing or forgetting to take a 
pill. 79.9% were taking the pill once they remembered and 8.7% took the missed pill at 
the next dose time: (Table 5.43). 
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Table 5.43: Action Taken when Missing Pill/s 
 
Action when Missing Pill/s Frequency Percent 
Take it when remembered 119 79.9% 
Take it at next dose. 13 8.7% 
Consult a health care provider 13 8.7% 
Consult a friend/relative using the same 
contraceptive 
1 .7% 
Discontinue using the pills completely. 1 .7% 
Others 1 .7% 
System missing 1 .7% 
Total 149 100.0% 
 
5.2.1.52 Using a Backup Method when Missing Pill/s 
 
Women were asked whether they used a back up method when missing pill/s. Nearly 
26.2% were using backup method and 73.8% were not using any backup methods: (Table 
5.44). 
 
Table 5.44: Using a Backup Method when Missing Pill/s 
 
Use Backup Method Frequency Percent 
yes 39 26.2% 
no 110 73.8% 
Total 149 100.0% 
 
5.2.1.53 Backup Method Used 
 
Women were asked to specify the back method used when missing pill/s: (Table 5.45). 
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Table 5.45: Backup Method Used 
 
Backup Method Frequency Percent 
Condom 14 9.4% 
Stop intercourse till next period 19 12.8% 
Take emergency contraceptive pills 1 .7% 
Other 5 3.4% 
NA 108 72.5% 
System missing 2 1.3% 
Total 149 100.0% 
 
5.2.1.54 Using Pill Reminder  
 
Studied women were asked if they were using a special measure to remind them take the 
pill on a regular basis. As seen in (Table 5.46), 71.8% had a special reminder to take pills 
on time while 27.5% did not have a pill reminder.  
 
Table 5.46: Using Pill Reminder 
 
Use Pill Reminder Frequency Percent 
yes 107 71.8% 
no 41 27.5% 
System missing 1 .7% 
Total  149 100.0% 
 
5.2.1.55 Specification of Pill Reminder 
 
Women using a special pill reminder were asked to specify it: 46.3% were taking the pill 
at bed time, 12.1% were using the calendar pack as a reminder as shown in (Table 5.47). 
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Table 5.47: Specification of Pill Reminder 
 
Type of Pill Reminder Frequency Percent 
Calendar pack. 18 12.1% 
Scratch the day from the calendar when taking the pill. 3 2.0% 
Set the alarm.  5 3.4% 
Take the pill at bedtime. 69 46.3% 
Take the pill when brushing teeth. 2 1.3% 
Others  7 4.7% 
NA 41 27.5% 
System missing 4 2.7% 
Total  149 100.0% 
 
5.2.1.56 Experiencing Side Effects 
 
Studied women were asked whether they had experienced side effects upon using oral 
contraceptives. As seen in (Table 5.48), 38.3% said that they experienced side effects 
while 61.7% did not experience side effects.  
 
Table 5.48: Experiencing Side Effects 
 
Experience S/E Frequency Percent 
Yes 57 38.3% 
No 92 61.7% 
Total 149 100.0% 
 
5.2.1.57 Side Effects Experienced 
 
Women experiencing side effects were asked to specify the side effects they had 
experienced; (Table 5.49): 21.7% experienced nausea, 17.9% experienced weight gain, 
17% had mode instability, 15.1% suffered from headaches, 13.2% had changes in their 
menstrual cycle, 4.7% had vaginal infections or experienced breast tenderness, 3.8% 
experienced fatigue and 1.9% had anemia.  
 
 
 
 
 
 
 
 
 102 
Table 5.49: Side Effects Experienced 
 
Side Effects N Percent 
Weight gain 19 17.9% 
Breast tenderness 5 4.7% 
Changing in the menstrual cycle     14 13.2% 
Headache 16 15.1% 
Nausea 23 21.7% 
Mode instability 18 17.0% 
Fatigue 4 3.8% 
Anemia 2 1.9% 
Vaginal infections 5 4.7% 
Total 106 100.0% 
 
5.2.1.58 Action when Experiencing Side Effects 
 
Women experiencing side effects were asked to specify their action upon having side 
effects. About 40.7% tend to seek professional assistance, 20.4% continue taking the pills 
either because they were temporary or because benefits of the pills are more then the side 
effects, 16.8% discontinue the pills and 1.8% seek friend's assistance: (Table 5.50). 
 
Table 5.50: Action when Experiencing Side Effects 
 
Action upon Having S/E N Percent 
Discontinue the pills. 28 16.8% 
Seek professional assistance. 68 40.7% 
Seek a friend's assistance. 3 1.8% 
Continue taking the pills because benefits 
are more than side effects. 
34 20.4% 
Continue taking the pills because these side 
effects are temporary. 
34 20.4% 
Total 167 100.0% 
 
5.2.1.59 Women Getting Pregnant while Oral Contraceptives' Use 
 
Studied women were asked for the occurrence of pregnancy while using the oral 
contraceptive pills. As shown in (Table 5.51), 4% got pregnant while using oral 
contraceptives and 96% never got pregnant while using oral contraceptives. 
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Table 5.51: Women Getting Pregnant while Oral Contraceptives' Use 
 
Got Pregnant 
while OCs Use Frequency Percent 
yes 6 4.0% 
no 143 96.0% 
Total 149 100.0% 
 
5.2.1.60 Reasons of Pregnancy while Oral Contraceptives' Use 
 
Women replying positively to getting pregnant while using oral contraceptives were 
asked whether they knew the reason behind that. As seen in (Table 5.52), 4% of them 
replied that they knew the reason for getting pregnant while using oral contraceptives. 
These women were asked to specify the reason of pregnancy among different choices 
listed in the questionnaire. As seen in (Table 5.53), 2.7% said that missing pills was 
behind their pregnancy and 1.3% said that the possible reason for pregnancy was using 
other medications while taking the oral contraceptives. 
 
Table 5.52: Knowing Reason of Pregnancy while Oral Contraceptives' Use 
 
Know Reason 
for Pregnancy Frequency Percent 
yes 6 4.0% 
NA 143 96.0% 
Total 149 100.0% 
 
Table 5.53: Possible Reason for Pregnancy while Oral Contraceptives' Use 
 
Possible Reason  for 
Pregnancy Frequency Percent 
Missing pills 4 2.7% 
Taking other 
medications 
2 1.3% 
NA 143 96.0% 
Total 149 100.0% 
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5.2.2 Univariate Analysis 
 
5.2.2.1 Introduction 
 
As the study objectives were to evaluate level of women’s knowledge of oral 
contraceptives and how it affected compliance; examine the relation between compliance 
and oral contraceptives use pattern; examine the effect of women’s health status and 
maternal history on compliance to oral contraceptives; and identify the effects of 
demographic and socioeconomic factors on compliance to oral contraceptives, 
crosstabulation and univariate analysis were made depending on variables measuring 
these outcomes. The most suitable statistical test to be used in this study was found to be 
Pearson Chi-Square.  Pearson Chi-Square is a test of independence that tests if there is a 
relationship between two discrete (nominal or ordinal) variables each with two or more 
categories. First of all, Pearson Chi-Square was applied on the available data as it was but 
the expected value in some cases was found to be < 5 which is not applicable in this test, 
so, merging of categories was implemented.  
 
For example, age categories were squeezed into two categories: less than 34, equal or 
more than 34. Same thing was made to other categories used in the cross tabulation and 
in the Pearson Chi-Square Test.   
 
Variables measuring information studied women have and their compliance to oral 
contraceptives were tested to see their dependence on other variables like women's age, 
educational level, income, source of information and so on as seen in the next part of this 
section. 
 
Knowledge and compliance are related so that compliance is better with better 
knowledge. As for knowledge, it is affected by factors like: lack of information, source of 
information, level of education, current age, age at marriage and locality. As for 
compliance, it is affected by economical status, number of children and the experience of 
side effects. Relations between these variables were tested using crosstabulation and the 
Pearson Chi-square test and the results obtained are shown in the following section. 
 
5.2.2.3 Pearson Chi-Square Tests 
 
5.2.2.3.1 Association between Women's Current Age and Oral Contraceptives' Use 
and Knowledge 
 
Results of Pearson Chi-square test for women's current age relation to variables affecting 
use of oral contraceptives and knowledge indicate the absence of association between 
women's current age and the other variables. This is because the results of chi-square test 
for independence of women's current age and other variables gave statistical significance 
higher than (α=0.05) for all the variables, (Table 5.54).  
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Table 5.54: Association between Women's Current Age and Oral Contraceptives' 
Use and Knowledge 
 
 Women's Current Age 
(yrs) 
< 34 ≥34 
Chi-
square  
Know the name of the OC Yes Count 69 42 
.188 
Percent 78.4% 68.9% 
No Count 19 19 
Percent 21.6% 31.1% 
Received information concerning the 
prescribed OC was clear & 
understandable 
Yes Count 77 52 
.691 
Percent 87.5% 85.2% 
No Count 11 9 
Percent 12.5% 14.8% 
OCs have risk factors Yes Count 50 29 
.265 
Percent 56.8% 47.5% 
No Count 38 32 
Percent 43.2% 52.5% 
Reading the leaflet Yes Count 61 50 
.082 
Percent 69.3% 82.0% 
No Count 27 11 
Percent 30.7% 18.0% 
Understanding the leaflet Yes Count 59 50 
.196 
Percent 96.7% 100.0% 
No Count 2 0 
Percent 3.3% .0% 
Lacking significant information 
concerning OCs 
Yes Count 27 24 
.273 
Percent 30.7% 39.3% 
No Count 61 37 
Percent 69.3% 60.7% 
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Table 5.54-a: Association between Women's Current Age and Oral Contraceptives' 
Use and Knowledge 
 
 Women's Current Age 
(yrs) 
< 34 ≥34 
Chi-
square 
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
Yes Count 72 50 
.981 
Percent 81.8% 82.0% 
No Count 16 11 
Percent 18.2% 18.0% 
Know how OCs work Yes Count 61 39 
.492 
Percent 69.3% 63.9% 
No Count 27 22 
Percent 30.7% 36.1% 
Know the active ingredient of the pill Yes Count 66 47 
.774 
Percent 75.0% 77.0% 
No Count 22 14 
Percent 25.0% 23.0% 
Know the meaning of "calendar 
pack" 
Yes Count 55 38 
.980 
Percent 62.5% 62.3% 
No Count 33 23 
Percent 37.5% 37.7% 
OCs have side effects Yes Count 52 35 
.835 
Percent 59.1% 57.4% 
No Count 36 26 
Percent 40.9% 42.6% 
OCs have interactions with other 
drugs/substances 
Yes Count 12 11 
.465 
Percent 13.6% 18.0% 
No Count 76 50 
Percent 86.4% 82.0% 
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5.2.2.3.2 Association between Women's Level of Education and Oral 
Contraceptives' Use and Knowledge 
 
Results of Pearson Chi-square test for women's level of education to variables affecting 
use of oral contraceptives and knowledge indicate the presence of association between 
women's level of education and the other variables for the values of chi-square with 1 
degree of freedom have statistical significance lower than (α=0.05), (Table 5.55). For 
example: a statistical significance of 0.000 for relation of women's level of education and 
knowing that oral contraceptives have interactions with other drugs. This means that 
women's level of education and knowing that oral contraceptives have drug interactions 
are dependent variables. In the same contrast, women's level of education shows 
significance association with reading the leaflet and knowing that oral contraceptives 
have side effects (statistical significance for each variable = 0.017), knowing how oral 
contraceptives work (statistical significance = 0.002), knowing the nature of the active 
ingredient of the oral contraceptive (statistical significance = 0.001) and finally knowing 
the meaning of the calendar pack (statistical significance = 0.003).   
 
Table 5.55: Association between Women's Level of Education and Oral 
Contraceptives' Use and Knowledge 
 
 Woman's Level of 
Education 
≤2°educ
-ation 
> 
2°educ-
ation 
Chi-
square  
Know the name of the OC Yes Count 78 33 
.475 
Percent 72.9% 78.6% 
No Count 29 9 
Percent 27.1% 21.4% 
Received information concerning the 
prescribed OC was clear & 
understandable 
Yes Count 90 39 
.159 
Percent 84.1% 92.9% 
No Count 17 3 
Percent 15.9% 7.1% 
OCs have risk factors Yes Count 53 26 
.173 
Percent 49.5% 61.9% 
No Count 54 16 
Percent 50.5% 38.1% 
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Table 5.55-a: Association between Women's Level of Education and Oral 
Contraceptives' Use and Knowledge 
 
 Woman's Level of 
Education 
≤2°educ
-ation 
> 
2°educ-
ation 
Chi-
square 
Reading the leaflet Yes Count 74 37 
.017
*
 
Percent 69.2% 88.1% 
No Count 33 5 
Percent 30.8% 11.9% 
Understanding the leaflet Yes Count 72 37 
.313 
Percent 97.3% 100.0% 
No Count 2 0 
Percent 2.7% .0% 
Lacking significant information 
concerning OCs 
Yes Count 39 12 
.362 
Percent 36.4% 28.6% 
No Count 68 30 
Percent 63.6% 71.4% 
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
 
 
 
Yes 
 
 
Count 
 
85 
 
37 
.217 
 
Percent 79.4% 88.1% 
No Count 22 5 
Percent 20.6% 11.9% 
Know how OCs work Yes Count 64 36 
.002
*
 
Percent 59.8% 85.7% 
No Count 43 6 
Percent 40.2% 14.3% 
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Table 5.55-a: Association between Women's Level of Education and Oral 
Contraceptives' Use and Knowledge 
 
 Woman's Level of 
Education 
≤2°educ
-ation 
> 
2°educ-
ation 
Chi-
square 
Know the active ingredient of the pill Yes Count 73 40 
.001
*
 
Percent 68.2% 95.2% 
No Count 34 2 
Percent 31.8% 4.8% 
Know the meaning of "calendar 
pack" 
Yes Count 59 34 
.003
*
 
Percent 55.1% 81.0% 
No Count 48 8 
Percent 44.9% 19.0% 
OCs have side effects Yes Count 56 31 
.017
*
 
Percent 52.3% 73.8% 
No Count 51 11 
Percent 47.7% 26.2% 
OCs have interactions with other 
drugs/substances 
Yes Count 8 15 
.000
*
 
Percent 7.5% 35.7% 
No Count 99 27 
Percent 92.5% 64.3% 
 
5.2.2.3.3 Association between Women's Age at Marriage and Oral Contraceptives' 
Use and Knowledge 
Concerning association between women's age at marriage and oral contraceptives' use 
and knowledge, knowing that oral contraceptives have risk factors has a statistical 
significance of 0.014, followed by knowing the calendar pack (statistical significance = 
0.022) and finally the knowledge that oral contraceptives have drug interactions 
(statistical significance = 0.038) as seen in (Table 5.56). On the other hand, a statistical 
significance of 0.974 shows no significant association for women's age at marriage with 
received information.  
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Table 5.56: Association between Women's Age at Marriage and Oral 
Contraceptives' Use and Knowledge 
 
  Women's Age at Marriage 
(yrs) 
≤18 
 
19-22 ≥23 
Chi-
square 
Know the name of the OC Yes Count 47 45 19 
.706 
Percent 71.2% 77.6% 76.0% 
No Count 19 13 6 
Percent 28.8% 22.4% 24.0% 
The information you received 
concerning the prescribed OC Clear 
& understandable  
Yes Count 57 50 22 
.974 
Percent 86.4% 86.2% 88.0% 
No Count 9 8 3 
Percent 13.6% 13.8% 12.0% 
OCs have risk factors Yes Count 27 39 13 
.014
*
 
Percent 40.9% 67.2% 52.0% 
No Count 39 19 12 
Percent 59.1% 32.8% 48.0% 
Reading the leaflet Yes Count 51 38 22 
.077 
Percent 77.3% 65.5% 88.0% 
No Count 15 20 3 
Percent 22.7% 34.5% 12.0% 
Understanding the leaflet Yes Count 50 37 22 
.756 
Percent 98.0% 97.4% 100.0% 
No Count 1 1 0 
Percent 2.0% 2.6% .0% 
Lacking significant information 
concerning OCs 
Yes Count 23 20 8 
.967 
Percent 34.8% 34.5% 32.0% 
No Count 43 38 17 
Percent 65.2% 65.5% 68.0% 
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Table 5.56-a: Association between Women's Age at Marriage and Oral 
Contraceptives' Use and Knowledge 
 
  Women's Age at Marriage 
(yrs) 
≤18 
 
19-22 ≥23 
Chi-
square 
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
Yes Count 57 44 21 
.303 
Percent 86.4% 75.9% 84.0% 
No Count 9 14 4 
Percent 13.6% 24.1% 16.0% 
Know how OCs work Yes Count 46 35 19 
.317 
Percent 69.7% 60.3% 76.0% 
No Count 20 23 6 
Percent 30.3% 39.7% 24.0% 
Know the active ingredient of the pill Yes Count 48 42 23 
.117 
Percent 72.7% 72.4% 92.0% 
No Count 18 16 2 
Percent 27.3% 27.6% 8.0% 
Know the meaning of "calendar 
pack" 
Yes Count 44 29 20 
.022
*
 
Percent 66.7% 50.0% 80.0% 
No Count 22 29 5 
Percent 33.3% 50.0% 20.0% 
OCs have side effects Yes Count 43 30 14 
.307 
Percent 65.2% 51.7% 56.0% 
No Count 23 28 11 
Percent 34.8% 48.3% 44.0% 
OCs have interactions with other 
drugs/substances 
Yes Count 7 8 8 
.038
*
 
Percent 10.6% 13.8% 32.0% 
No Count 59 50 17 
Percent 89.4% 86.2% 68.0% 
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5.2.2.3.4 Association between Women's Lack of Information and Oral 
Contraceptives' Use and Knowledge 
 
A statistical significance of 0.000 for the association between women finding themselves 
lacking information about oral contraceptives and knowing how oral contraceptives work 
and women knowing the name of the oral contraceptive they use as shown in (Table 5.57) 
indicates significant association between these variables.  
 
Table 5.57: Association between Women's Lack of Information and Oral 
Contraceptives' Use and Knowledge 
 
 Lack Significant 
Information about OCs 
Yes No 
Chi-
square  
Know the name of the OC Yes Count 29 82 .000
*
 
Percent 56.9% 83.7% 
No Count 22 16 
Percent 43.1% 16.3% 
Received information concerning the 
prescribed OC was clear & 
understandable 
Yes Count 39 90 .009
*
 
Percent 76.5% 91.8% 
No Count 12 8 
Percent 23.5% 8.2% 
OCs have risk factors Yes Count 22 57 .081 
Percent 43.1% 58.2% 
No Count 29 41 
Percent 56.9% 41.8% 
Reading the leaflet Yes Count 39 72 .690 
Percent 76.5% 73.5% 
No Count 12 26 
Percent 23.5% 26.5% 
Understanding the leaflet Yes Count 38 71 .657 
Percent 97.4% 98.6% 
No Count 1 1 
Percent 2.6% 1.4% 
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Table 5.57-a: Association between Women's Lack of Information and Oral 
Contraceptives' Use and Knowledge 
 
 Lack Significant 
Information about OCs 
Yes No 
Chi-
square  
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
Yes Count 39 83 .216 
Percent 76.5% 84.7% 
No Count 12 15 
Percent 23.5% 15.3% 
Know how OCs work Yes Count 23 77 .000
*
 
Percent 45.1% 78.6% 
No Count 28 21 
Percent 54.9% 21.4% 
Know the active ingredient of the pill Yes Count 35 78 .138 
Percent 68.6% 79.6% 
No Count 16 20 
Percent 31.4% 20.4% 
Know the meaning of "calendar 
pack" 
Yes Count 31 62 .767 
Percent 60.8% 63.3% 
No Count 20 36 
Percent 39.2% 36.7% 
OCs have side effects Yes Count 26 61 .186 
Percent 51.0% 62.2% 
No Count 25 37 
Percent 49.0% 37.8% 
OCs have interactions with other 
drugs/substances 
Yes Count 5 18 .170 
Percent 9.8% 18.4% 
No Count 46 80 
Percent 90.2% 81.6% 
 
 
 
 
 114 
5.2.2.3.5 Association between Taking Pills Regularly and Oral Contraceptives' Use 
and Knowledge 
 
A statistical significance of 0.027 indicates significant association between women taking 
pills regularly and receiving clear and understandable information when first prescribed 
as seen in (Table 5.58).  
 
Table 5.58: Association between Taking Pills Regularly and Oral Contraceptives' 
Use and Knowledge 
 
 Take The Pill Regularly 
Yes No 
Chi-
square  
Know the name of the OC Yes Count 102 9 
.076 
Percent 76.7% 56.2% 
No Count 31 7 
Percent 23.3% 43.8% 
Received information concerning the 
prescribed OC was clear & 
understandable 
Yes Count 118 11 
.027
*
 
Percent 88.7% 68.8% 
No Count 15 5 
Percent 11.3% 31.2% 
OCs have risk factors Yes Count 73 6 
.188 
Percent 54.9% 37.5% 
No Count 60 10 
Percent 45.1% 62.5% 
Reading the leaflet Yes Count 99 12 
.961 
Percent 74.4% 75.0% 
No Count 34 4 
Percent 25.6% 25.0% 
Understanding the leaflet Yes Count 97 12 
.619 
Percent 98.0% 100.0% 
No Count 2 0 
Percent 2.0% .0% 
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Table 5.58-a: Association between Taking Pills Regularly and Oral Contraceptives' 
Use and Knowledge 
 
 Take The Pill Regularly 
Yes No 
Chi-
square  
Lacking significant information 
concerning OCs 
Yes Count 44 7 
.396 
Percent 33.1% 43.8% 
No Count 89 9 
Percent 66.9% 56.2% 
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
Yes Count 108 14 
.537 
Percent 81.2% 87.5% 
No Count 25 2 
Percent 18.8% 12.5% 
Know how OCs work Yes Count 90 10 
.678 
Percent 67.7% 62.5% 
No Count 43 6 
Percent 32.3% 37.5% 
Know the active ingredient of the pill Yes Count 100 13 
.593 
Percent 75.2% 81.2% 
No Count 33 3 
Percent 24.8% 18.8% 
Know the meaning of "calendar 
pack" 
Yes Count 85 8 
.278 
Percent 63.9% 50.0% 
No Count 48 8 
Percent 36.1% 50.0% 
OCs have side effects Yes Count 76 11 
.374 
Percent 57.1% 68.8% 
No Count 57 5 
Percent 42.9% 31.2% 
OCs have interactions with other 
drugs/substances 
Yes Count 20 3 
.698 
Percent 15.0% 18.8% 
No Count 113 13 
Percent 85.0% 81.2% 
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5.2.2.3.6 Association between Women's Compliance and Oral Contraceptives' Use 
and Knowledge 
 
As for having high  compliance, no significant association is seen as shown in (Table 
5.59) except with knowing the name of the oral contraceptive used for the statistical 
significance here which equals 0.002  is < α.  
 
Table 5.59: Association between Women's Compliance and Oral Contraceptives' 
Use and Knowledge 
 
 Compliance 
Yes No 
Chi-
square  
Know the name of the OC Yes Count 103 8 
.002
*
 
Percent 78.6% 44.4% 
No Count 28 10 
Percent 21.4% 55.6% 
Received information concerning the 
prescribed OC was clear & 
understandable 
Yes Count 115 14 
.243 
Percent 87.8% 77.8% 
No Count 16 4 
Percent 12.2% 22.2% 
OCs have risk factors Yes Count 73 6 
.074 
Percent 55.7% 33.3% 
No Count 58 12 
Percent 44.3% 66.7% 
Reading the leaflet Yes Count 98 13 
.813 
Percent 74.8% 72.2% 
No Count 33 5 
Percent 25.2% 27.8% 
Understanding the leaflet Yes Count 96 13 
.603 
Percent 98.0% 100.0% 
No Count 2 0 
Percent 2.0% .0% 
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Table 5.59-a: Association between Women's Compliance and Oral Contraceptives' 
Use and Knowledge 
 
 Compliance 
Yes No 
Chi-
square  
Lacking significant information 
concerning OCs 
Yes Count 45 6 
.932 
Percent 34.4% 33.3% 
No Count 86 12 
Percent 65.6% 66.7% 
Opportunity to express oneself by 
asking questions to get more 
information & further clarification 
the first time the OC was prescribed 
Yes Count 106 16 
.410 
Percent 80.9% 88.9% 
No Count 25 2 
Percent 19.1% 11.1% 
Know how OCs work Yes Count 88 12 
.966 
Percent 67.2% 66.7% 
No Count 43 6 
Percent 32.8% 33.3% 
Know the active ingredient of the pill Yes Count 99 14 
.838 
Percent 75.6% 77.8% 
No Count 32 4 
Percent 24.4% 22.2% 
Know the meaning of "calendar 
pack" 
Yes Count 83 10 
.522 
Percent 63.4% 55.6% 
No Count 48 8 
Percent 36.6% 44.4% 
OCs have side effects Yes Count 78 9 
.441 
Percent 59.5% 50.0% 
No Count 53 9 
Percent 40.5% 50.0% 
OCs have interactions with other 
drugs/substances 
Yes Count 21 2 
.588 
Percent 16.0% 11.1% 
No Count 110 16 
Percent 84.0% 88.9% 
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5.2.2.3.7 Association between Women's Compliance, Taking pills regularly, and 
Family Income, Number of Children and Experiencing Side Effects 
 
Family income, number of children and experiencing side effects; all have no significant 
associations with compliance and taking pills regularly for all have a statistical 
significance > α as seen in (Table 5.60).   
 
Table 5.60: Association between Women's Compliance, Taking pills regularly, and 
Family Income, Number of Children and Experiencing Side Effects 
 
 
 
Take Pills Regularly High Compliance 
Yes No Chi-
square 
Yes No Chi-
square Count Percent Count Percent Count Percent Count Percent 
Family 
income (NIS) 
<1000 
27 84.4% 5 15.6% 
.522
a
 
27 84.4% 5 15.6% 
.366 
1001-
2000 
67 91.8% 6 8.2% 67 91.8% 6 8.2% 
>2000 
39 88.6% 5 11.4% 37 84.1% 7 15.9% 
Number of 
live children 
born to the 
woman  
(Binned) 
< 5 
77 89.5% 9 10.5% 
.900 
76 88.4% 10 11.6% 
.843 
5+ 
56 88.9% 7 11.1% 55 87.3% 8 12.7% 
Experiencing 
Side Effects 
Yes 
49 86.0% 8 14.0% 
.306 
49 86.0% 8 14.0% 
.564 No 84 
91.3% 8 8.7% 82 89.1% 10 10.9% 
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5.3 Summary  
 
Distributed questionnaires were filled by 149 women form Bethlehem, Halhoul, Hebron 
and Ramallah and Tulkarem districts using oral contraceptives as a method of 
contraception and visiting the PFPPA clinics regularly.  
 
Data analysis was performed using The Statistical Package for the Social Sciences (SPSS 
16).   
 
Data analysis was undertaken at two levels: descriptive analysis and univariate analysis.  
 
In the study, 39.60% of the studied women were from Halhoul, 32.21% from Hebron, 
11.41% from Tulkarem, 10.07% from Bethlehem and 6.71% from Ramallah. Studied 
women were mainly from cities or villages and only one of them was from a camp.  
 
About 41% of studied women were 34 years old or older and about 41.6% were 15-18 
years old when married.  
 
Most of the women in the study (about 65%) have previously used other contraceptive 
methods.  
 
The mean reason for oral contraceptive use by the studied women was spacing (59.7%) 
between children followed by stop having children (32.9%). 
 
The obstetrician was the major prescriber for oral contraceptives as reported by studied 
women (66.4%). However, the nurse was the main source of information (59.7%) 
provided to women who reported that the information reported was clear and 
understandable by (85.9%).  
 
Family income, number of children and experiencing side effects were variables that 
showed no significant association with taking pills regularly and having high compliance.  
 
Other variables for women's knowledge and compliance were explored and more 
information is stated and discussed in the following chapter.  
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6.1 Introduction 
 
The study was conducted in order to investigates compliance to oral contraceptives usage 
and its determinants among current users in the West Bank. Women visiting the PFPPA 
and who were current users of oral contraceptives were targeted and asked to fill the 
study questionnaire.  
 
The questionnaire was filled personally by every woman visiting the PFPPA clinics any 
time within four months period: from December 2007 to March 2008. Women filling the 
questionnaire were only current users of oral contraceptives. One hundred forty nine 
women filled the questionnaire in the mentioned period and all the questionnaires were 
fully completed. 
 
6.2 Demographic and Socioeconomic Background 
 
In this section of the questionnaire, information concerning place of residence, age, 
religion, family income, women's and husbands' level of education and employment 
status were sought. 
 
The majority of participants were from Halhoul district (39.6%) and city locality 
(69.8%). This result shows that oral contraceptives' use is more prevalent in urban areas 
than in rural areas which is a similar result to a study conducted in Jordan where 44% of 
the sample where from urban areas while 34% came from rural areas (Kridli and Libbus, 
2001).  
 
Normally, we expect that younger women tend not to use of oral contraceptives since all 
newly married women want to have children. In this study, 40.9% of the studied women 
were in the age 34 years old or more.  These results are very similar to results seen in 
most Arab countries and Asian countries, i.e. most developing countries. This indicates 
that women after a certain age decrease their will to have children as compared to 
younger ages which is a similar result to that of the Jordanian study where women older 
than 34 years showed more contraceptive use (Kridli and Libbus, 2001).  The similarity 
in the findings between Jordan and Palestine might be due to the fact that both Palestine 
and Jordan are neighboring countries with similar cultural and social background. 
 
Regarding educational level of the mother, 46.3% had completed their secondary 
education, followed by basic school education and university first degree holders 23.5% 
and 22.1% respectively followed by 1.3% illiterate women and only 0.7% having higher 
than university first degree. These results indicate that oral contraceptives' use is spread 
in women from cities more than villages and camps and in more educated women 
(secondary graduates in comparison to illiterate or basic school education). Compared to 
the study in Jordan (Kridli and Libbus, 2001), the majority (36.6%) were of basic school 
education followed by (30.3%) of uneducated women. In other words the results of the 
Jordanian study from the level of education view differs from this study. However in 
another study also conducted in Jordan only 2% of the participating women were not 
educated and the majority (31.1%) were of secondary education (Kridli and Newton, 
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2005).  Also, residents in urban areas are usually more educated and thus know about 
family planning methods and use them more than residents in rural areas. Women with 
higher education levels are aware of family planning methods in general and oral 
contraceptives in specific so that oral contraceptives use is seen among more educated 
women both in Jordan and in Palestine.  
 
In this study, lower income families showed more percents of oral contraceptives' use. 
This may be due to life expenses that make families think of family planning and 
contraception as a way to decrease their expenditure and improve their quality of life. In 
the case of this study, use of oral contraceptives which cost little could be viewed 
economically easier than the burden of expense of having more children in the hard 
economic status. 
 
Finally, women's employment status showed that 88.6% of the women in the sample 
were unemployed. This case contradict the idea that working women tend to follow 
family planning methods more than unemployed ones. It is usually expected that 
employed women are more interested in family planning and contraceptives use. 
However, this study showed that employment may not be a reason for use of 
contraceptives for unemployed women participating in the study were using oral 
contraceptives more than employed ones.   
 
However, these results can not be generalized because this study was not a randomized 
study and was conducted on women referring to the PFPPA clinics only. 
 
6.3 Maternal History 
 
In this section, women were asked for information concerning their maternal history like: 
woman's age at marriage, woman's age at first pregnancy, woman's age at first delivery, 
number and sex of children and number of abortions. 
 
As seen in the results, 22.3% of the studied women had 3 children and 19.6% had 5 
children. Women with more children showed better compliance and less missed pills than 
women with fewer children. This is due to the fact that women with more children are 
more committed to not having children than women with fewer children. As seen in the 
demographic health survey conducted by the Palestinian Central Bureau of Statistics in 
2004,   the mean number of children a women has is 4.5. So, women with more number 
of children are more interested in contraceptive use and this result is well seen in the 
decrease of mean number of children a women has from 4.7 in 2000 to 4.5 in 2004.  
Compared to the most recent United Nations statistics, two child families are becoming 
the norm and also mentioned that fertility in less developed regions has declined to 
slightly fewer than three per family (Brown 2002).  
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6.4 Knowledge about Oral Contraceptives 
 
On initiating treatment with oral contraceptives, much of the visit should consist of 
counseling, including emphasizing the positive effects of oral contraceptives when they 
are used correctly and consistently. Patients should be encouraged to read provided 
written material and call with questions before discontinuing oral contraceptives on their 
own. If patients are scheduled and do not come in for a 15-minute follow-up visit after 
three months, they may have stopped the pill on their own and need a phone call for 
counseling regarding other methods of birth control. 
 
Women in the study were asked in this section to answer questions exploring their 
knowledge about oral contraceptives. Name of oral contraceptive used, source of 
information provided and evaluation of information provided were asked for. Also, 
women were asked about oral contraceptives side effects, risk factors, drug interactions 
and health benefits. In addition, women were asked if they had information gap and to 
specify the reasons for that and the area of gaps if any. 
 
Results showed that 74.5% of the studied women knew the name of their contraceptive 
being used. Older women (>34 years) were the largest category not knowing the name of 
their oral contraceptive. The univariate analysis results showed also that the women's 
level of education affected their knowledge since variables testing for knowledge had 
high levels of statistical significance with their level of education 
 
Based on results of the univarite, level and quality of information given to women using 
oral contraceptives showed that women taking pills regularly reported receiving clear and 
understandable information. The major source of information for studied women was the 
nurse (59.7% followed by the obstetrician (34.2%). These results are compatible with the 
results of a study conducted by the PCBS in 2000 where the main medical source of 
information was nurses with a percentage of (48%) followed by doctors with a 
percentage of (35.4%). This result may be due to the tasks management followed in the 
health care centers where nurses usually provide the guiding information to patients and 
are considered an easier and more reachable source of information However, 85.9% 
reported receiving clear and understandable information.  
 
Although 65.8% of the studied women reported that they do not lack information about 
oral contraceptives, 26.8% of them did not know any risk factor for oral contraceptives, 
24.8% knew nothing about oral contraceptives' side effects, 53.7% had no idea about oral 
contraceptives' drug interactions and 33.6% did not know the non-contraceptive benefits 
of oral contraceptives. These figures highlight the importance of further improvement of 
information quality and quantity delivered to women using oral contraceptives. Several 
studies have shown that improved knowledge may decrease the incidence of unplanned 
pregnancies and, thus, of abortion.  A study in the UK that aims to determine factors 
associated with women's knowledge of taking the contraceptive pill correctly and of 
emergency contraception, and to investigate if their knowledge could be improved in 
general practice by providing women with Family Planning Association information 
leaflets found that “providing women with leaflets about taking the contraceptive pill 
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correctly and about emergency contraception appears to improve significantly their extent 
of such knowledge. If such practice was adopted elsewhere this increased knowledge 
might reduce the number of unplanned pregnancies in the UK. The effect of general 
practitioners personally providing such leaflets, with or without verbal instruction, 
warrants further study”. (Smith and Whitefield, 1995).   
 
6.5 Use and Compliance to Oral Contraceptives 
 
Having identified risk factors for contraceptive failure, researchers next attempted to discover the 
reasons why women discontinue contraceptive methods. In this study the major reason behind 
oral contraceptives' use was spacing between children (59.7%), followed by stop having 
children (32.9%). From the studied women, 54.4% intended to stop taking the oral 
contraceptives from whom 30.9% gave the reason for future oral contraceptives' stop as 
wanting to have more children. However, according to the demographic health survey 
conducted by the Palestinian Central Bureau of Statistics in 2004, 51.8% of married 
women wanted to stop having children and 41.1% wanted to have more children. 
Differences between results of this study and results of the PCBS survey results may be 
due to the small sample studied in this study which only covered women referring to the 
PFPP and were using oral contraceptives compared to the PCBS survey covering the 
whole Palestinian community (PCBS, 2004).   In Egypt, a study in 1988 results showed 
that women reduced the number of pills taken in order to reduce the unwanted side 
effects. The misuse was related to the influences of family and friends, lack of 
information and education, not seeking help from trained personnel for problems, and 
false cause-and-effect connections. Provider interviews confirmed the lack of information 
provided to oral contraceptives users (Loza, 1991).  
 
This part of the study explored women's compliance in taking oral contraceptives; i.e. if 
pills were taken regularly and actions when pills were being missed.  In this study, 15.4% 
reported missing pills of whom 10.1% miss one pill per month, 5.4% miss two pills per 
month and 0.7 miss three or more pills per month. Also, as for action taken by women 
when missing pills, 79.9%of the studied women took the pill once they remember, 8.7% 
took it at the next does or consult health care provider whereas 0.7% consult a friend or 
discontinue the rest of the pack. This result appears to be different from the result in a 
study conducted in the United States because in that study, about 47% were missing one 
or more pills and 22% were missing two or more pills. In other words, women in this 
study showed more compliance than in the United States study (Rosenberg, et al., 1998). 
Differences between this study and the study in the United States may be due to different 
cultural backgrounds between the two countries or to the small size of the sample of this 
study compared to the United States study where 1555 women participated in the study.  
In a study of 6676 European women aged 16–30 years using oral contraceptives, several 
factors were associated with poor compliance. For example, the risk of missing one or 
more pills in a cycle was highest among women who did not use their pills at the same 
time each day, who had read but understood little or nothing of the package insert 
information, or who had not received adequate information or help from their health care 
provider. Although the side effects of breast tenderness, nausea, and irregular bleeding 
were modestly associated with poor pill-taking compliance, abnormal hair growth was 
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the side effect associated with the greatest risk for failure to take oral contraceptive pills 
properly (Rosenberg et al.1995, 1996, 1999).  
 
Concerning taking pills regularly, 89.3% of the studied women reported taking the pills 
regularly all the time. This result is consistent with the result of a study conducted in 5 
European countries (Denmark, France, Italy, Portugal and the United Kingdom), where 
81% of the women used their oral contraceptives consistently and effectively (Rosenberg, 
et al., 1995-b).  The authors of these studies suggest that developing a better 
understanding of the health beliefs and preferences of patients and their decision-making 
processes may ultimately be more effective in designing strategies that improve 
compliance.  
 
In our study, 32.9% of the women experiencing side effects upon oral contraceptives use 
were still using the oral contraceptives consistently, whereas in the European study 
mentioned above nearly 50% discontinued oral contraceptives' use after having side 
effects (Rosenberg, et al., 1995-b). In general, and this is applicable to all medications 
patients use, experiencing side effects lies behind non compliance and medications 
cessation. This may be because to the worries of patients about their health and for not 
desiring to experience side effects or bad outcomes from medications use which is a very 
natural thing revealing human worries about their health and refusal to have additional 
suffering.    
 
In summary, recent oral contraceptive compliance studies continue to confirm previous 
studies that inconsistent pill-taking is prevalent and that side effects can affect both pill-
taking and overall continuation. How material regarding efficacy, side effects, risks, and 
benefits is presented to patients appears to have some effect on compliance. 
 
6.6 Conclusions 
 
Knowledge about oral contraceptives use as reported by studied women did not show 
deep knowledge. In other words, women reporting that they did not think lack 
information about oral contraceptives in fact did not know many major things about oral 
contraceptives like risk factors, side effects, drug interactions and noncontraceptive 
benefits. However, most of the studied women reported receiving clear and 
understandable information. These facts highlight that the provided information may be 
restricted in how the pills should be taken and what to do when pills were missed. This is 
because studied women shoed good knowledge in theses aspects.  
 
Concerning compliance, studied women generally had high compliance with least pills 
missed every month. This may be due to the real will and need of studied women to the 
effectiveness of oral contraceptives in contraception.  
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6.7 Recommendations 
 
Women using oral contraceptives need to receive more information about oral 
contraceptives in a way covering all the important aspects women need to  know but 
always in a simplified way to ensure their understanding and future application.  
 
Discussion of oral contraceptives' side effects, risk factors, and drug interactions need 
more focus so as to keep women using the oral contraceptives always on the safe side and 
aware of options they can use in the cases of emergency. 
 
Oral contraceptives non-contraceptive benefits need to be more discussed with women to 
encourage them for more and better compliance.  
 
Women using oral contraceptives need to be given time to ask for information and 
express themselves especially the first time the pills are prescribed and on the first refill. 
These two occasions are important because in the first time use, the health care provider 
should keep in mind that women may not comply with the medication or undergo side 
effect. So women need to know what to do when missing pills or experiencing side 
effects. As for the first refill, in this visit women usually come back to the health center 
with questions and inquiries after their first use of the contraceptive just like any 
medication. In this case, the health providers themselves need to discuss the women's 
feeling, impressions and health changes upon the use of the contraceptive pills.  
 
Written information in Arabic should be provided for women to refer to and read 
especially if leaflets are not always available.   
 
Importance of calendar package in compliance should be discussed with women to make 
it easier for them to remember taking pills. In addition the use of reminder measure 
should be discussed with women since it has proven its better compliance effects. 
 
Backup methods should also be discussed with women so as to keep them informed of 
the available choices when missing pills occurs.  
 
For putting the women in a more complied status, educational programmes for oral 
contraceptives and other contraceptive methods need to be held to provide women with 
knowledge about available methods and choices for contraception.  Also, providing 
women with a technique to record their exact time of taking the pill (e.g. dairy) to better 
determine the compliance level 
 
Finally, the solution to the problem about birth control in the Palestinian society is not 
simple. Many policies need to change and for that to happen women need to be viewed as 
competent capable beings by those who currently try to infantilize them. Women and 
men need to be educated on contraception and birth control. Blockades need to be 
removed for those women seeking birth control, and barriers impeding forced and 
coerced use of birth control need to be put into place. Doctors need to start having 
conversations with their patients regarding contraception. Without societal views about 
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women and expectations for women changing, nothing will revolutionize contraception 
or women’s reproductive rights.  
 
As for recommendations for future research: 
 
- a follow up study is needed to collect data at the beginning of the 
use of contraceptives.   
 
- the inclusion of educational programmes in the study and then 
exploring their effects on women' s knowledge and compliance 
 
- expanding the sample to oral contraceptive users from different 
cities and different sources of oral contraceptives provision sites. 
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 اسثبياو لاسثطلاع هعرفة الىساء الهسثخدهات لأقراص هىع الحهل
  .في الضفة الغريبة 
 
 
 
 
  غؼاؿج اؿخعلاؽٖج تبؿخعغاى أؿوّة اهيؿص اهّضفٕ غٖؼ اهخسؼٖتٕ.الهىهجية: 
 
 
 
 
اهيؿخعغيبح اهضبهٖبح هلأكؼاص اهيبٌؾج هوضيل فٕ اهيؼانؽ  هجثهع الدراسة وهوقعها:
  ضيبٖج الأؿؼث اهفوؿعٌٖٖج فٕ اهظفج اهغؼتٖج.اهخبتؾج هسيؾٖج خٌغٖى ّ 
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 اهيتضّذج: أعخٕ
 
 نى ّؼضيج الله ّتؼنبخَٖاهؿلاى ؽو
 
اهخٕ خؿخعغى أكؼاص يٌؼ اهضيل فيٕ اهيؼانيؽ اهخبتؾيج  ويؼأثهٌّؽٖج اهيؾوّيبح اهيلغيج  إهٓ خلٖٖىغؼاؿج اهخِغف 
يؿخّْ الاهخؽاى اهضبهٕ تيًٖ  إظبفج إهٓ ػهم، فضص هسيؾٖج خٌغٖى ّضيبٖج الأؿؼث اهفوؿعٌٖٖج فٕ اهظفج اهغؼتٖج.
 فٕ اؿخعغايًِ لأكؼاص اهيبٌؾج هوضيل.  يٌؼ اهضيلبح أكؼاص يؿخعغي
 
يٌيؼ  صتيأكؼا  ؿخؾنيؾ يؾؼفخم ّاهخٕ هِػا الاؿختٖبًتخؾتئخم  اهغؼاؿجهسيِّؼ ُػٍ  ٌؼسّ يّافلخم تبلاٌظيبى
ٌّؽٖيج خِيخى تخلٖيٖى  اهغؼاؿجتبً ُػٍ  ؽويًب الأيذل.اهضيل يً ٌّاضٕ يعخوفج ّيغْ اهخؽايم تأعػُب ؽوٓ اهّسَ 
اهضضٖج ّالاسخيبؽٖج.  لأُيٖخَهويّظّػ ّػهم اهؾويٖج  اهعوفٖج نبفج اهيشبؼنبح تغط اهٌغؼ ؽًاهيؾوّيبح هغْ 
 الأؿيئوج  ؽويٓ نبفيج  الإسبتيج  ييً ضظيؼخن  ً ّآيوًٖضضٖب،  يذلفيسخيؼ فوؿعٌٖٕ  إهُٓبغفًٖ اهّضّل 
 لأغيؼاط  ؿخؿيخؾيل ّؿخؾبيل تؿؼٖج خبييييج ٖبً اهيؾوّيبح اهّاؼغث فٕ الاؿختتيّظّؽٖيج خبيج، ؽويب أً 
 .يؼ اهشنؼ اهسؽٖل هخؾبٌّم فٕ إخيبى ُػٍ اهغؼاؿج اهتضد فلع.
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 الخمفية السكاىية و الاجثهاعية الاقثصادية. )1
 
 اهيضبفغج: .1
 .ؼاى الله .أ 
 اهعوٖل. .ة 
 ضوضّل. .ر 
 تٖح هضى. .غ 
 
 ٌّػ اهخسيؼ اهؿنبٌٕ: .2
 يغٌٖج. .أ 
 كؼٖج. .ة 
 يعٖى. .ر 
 
 ؽيؼ اهيؼأث اهضبهٕ تبهؿٌّاح اهينخيوج:  .3
 ؿٌج ّأكل. 81 . أ
 .32-91 . ة
 .82-42 . ر
 .33-92 . ش
 ّأنذؼ. 43 . ط
 
 ؽيؼ اهؽّر اهضبهٕ تبهؿٌّاح اهينخيوج: .4
 ؿٌج ّأكل 81 .أ 
 .32-91 .ة 
 .82 -42 .ر 
 .33-92 .غ 
 ّأنذؼ. 43 .ٍ 
 
 اهغٖبٌج: .5
 الإؿلاى. .أ 
 اهيؿٖضٖج. .ة 
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 اهضبهج اهّغٖفٖج هوؽّر: .6
 ة. يّغف كعبػ عبص.    أ. يّغف ضنّيج.
 غ. لا ٖؾيل.   ٖؾيل هضؿبتَ اهعبص. ر.
 
 اهضبهج اهّغٖفٖج هوؽّسج: .7
 ة. يّغفج كعبػ عبص.    أ. يّغفج ضنّيج.
 غ. لا خؾيل.   خؾيل هضؿبتِب اهعبص. ر.
 
 غعل الأؿؼث (شٖنل): .8
 .000,2 – 000,1ة.     000,1 < .أ.
 .000,4 – 100,3غ.   .000,3 – 100,2ر. 
 000,4 >.ُي. 
 
 يؿخّْ اهيؼأث اهخؾوٖيٕ: .9
 ة. خؾوٖى يغؼؿج أؿبؿٕ.     أ. أيٖج. 
 غ.غتوّى.    ر. خؾوٖى ذبٌّٔ.
 ّ. أنذؼ يً ػهم.    ٍ. تنبهّؼّٖؾ.
 
 يؿخّْ اهؽّر اهخؾوٖيٕ: .11
 ة. خؾوٖى يغؼؿج أؿبؿٕ.     أ. أيٕ. 
 غ.غتوّى.    ر. خؾوٖى ذبٌّٔ.
 ّ. أنذؼ يً ػهم.    ٍ. تنبهّؼّٖؾ.
 
 لعان.الوضع الصحي ا )2
 
 ّؽً اهيؼأث: ___________ (نغى). .11
 
 عّل اهيؼأث:___________ (ؿى). .21
 
 ُل خؾبًٌٖ يً يؼط/أيؼاط يؽيً/ث؟  .31
 ة. لا.    أ. ٌؾى.
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) "ٌؾى"، يب ُّ اهيؼط/الأيؼاط اهػٔ خؾبًٌٖ يٌَ؟ (ٖينً إعخٖبؼ 31إػا نبً اهسّاة ؽوٓ ؿؤال ( .41
 أنذؼ يً إسبتج)
 ة. اهؼتّ.   أ. اهخِبة اهيفبضل.
 غ. اهنّهؿخؼّل.    هؿؼعبً.ر. ا
 ّ. اهؿنؼٔ.    ٍ. الإنخئبة.
 ش. اؼخفبػ ظغع اهغى.    ؽ. اهضؼػ.
 ٔ. اهػئتج.    ع. أيؼاط اهنتغ.
 ل. ُشبشج ؽغبى.    م. اهشلٖلج.
     ى.خعذؼ اهغى (سوعج).
   ً. غٖؼ ػهم: ___________________________________.
 ُل خأعػًٖ غّاء/أغّٖج تشنل يؽيً؟ .51
 ة. لا.    ٌؾى.أ. 
 
 ) "ٌؾى"، اهؼسبء ػنؼ اهغّاء/الأغّٖج:51إػا نبً اهسّاة ؽوٓ ؿؤال ( .61
    
 __________________________________________.
 
 ُل ؿتق أً أسؼٖح ؽيوٖج سؼاضٖج؟ .71
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، اهؼسبء خضغٖغ ػهم:71إػا نبً اهسّاة ؽوٓ ؿؤال ( .81
 
 ___________________._______________________ 
 
 ُل أٔ يً الأيؼاط اهيػنّؼث أغٌبٍ يّسّغ فٕ خبؼٖظ اهؾبئوج؟ .91
 لا ٌؾى اهيؼط
   ؿؼعبً اهذغٔ.
   ؿؼعبً ؽٌق اهؼضى.
   ؿؼعبً تعبٌج اهؼضى.
   اؼخفبػ ظغع اهغى.
   اهسوعج.
   الأّؼغث اهغّاهٖج.
   اهؿنؼٔ.
   اهتغاٌج.
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 ُل خغعًٌٖ؟  .12
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، يٌػ يخٓ خغعًٌٖ؟_________ ؿٌج.12إػا نبً اهسّاة ؽوٓ ؿؤال ( .12
 
 ُل أٌح يؼظؾج؟ .22
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، يب ُٕ اهيغث ؟_________ شِؼ.22إػا نبً اهسّاة ؽوٓ ؿؤال ( .32
 
 الثاريخ الإىجابي. )3
 
 ؽيؼ اهيؼأث ؽٌغ اهؽّار: (ؿٌج) .42
 .81-51ة.       .41 ≤أ. 
 .32 ≥غ.     .22-91ر. 
 
 ؽيؼ اهيؼأث ؽٌغ اهضيل الأّل: (ؿٌج) .52
 .81-51ة.       .41 ≤أ. 
 (_____). 32 ≥غ.     .22-91ر. 
 ؽيؼ اهيؼأث ؽٌغ الإٌسبة الأّل: (ؿٌج) .62
 .81-51ة.       .41 ≤أ. 
 (_____). 32 ≥غ.     .22-91ر. 
 
 ؽغغ اهيّاهٖغ الأضٖبء هويؼأث: ___________. .72
 ؽغغ الإسِبظبح: _____________. .82
 
 ؽغغ اهيّاهٖغ اهيٖخج: ___________.  .92
 
 ؽغغ الأعفبل الأضٖبء (ضبهٖب): .13
 اهػنّؼ:_________. الإٌبد:___________. اهيسيّػ:__________. 
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 اسثخدان أقراص هىع الحهل. )4
 
 ُل ؿتق أً اؿخعغيح ّؿٖوج يٌؼ ضيل غٖؼ الأكؼاص؟ .13
 ة. لا.    أ. ٌؾى.
 
ب ُٕ اهعؼٖلج/اهعؼق اهخٕ ؿتق هم اؿخعغايِب؟ (يينيً ) "ٌؾى"، ي13إػا نبً اهسّاة ؽوٓ ؿؤال ( .23
 اعخٖبؼ أنذؼ يً سّاة): 
 .الحمقة البلاسثيكيةة.     أ. اهّاكٕ اهػنؼٔ.
 غ. اهوّهة.     ر. اهؼغّث.
 ّ. الاٌؿضبة كتل اهلػف. ٍ. فخؼث الأيبً.
 ؽ. غٖؼ ػهم، اهؼسبء اهخضغٖغ: _____________________________. 
 
 أضغ اهعؼق اهيبٌؾج هوضيل هويؼث الأّهٓ؟ (ؿٌج):  حاؿخعغي بينى نبً ؽيؼم ؽٌغ .33
 .32-81ة.     .81 ≤أ. 
 .53-13غ.     .92-42ر. 
 .53 ≥ٍ. 
 
 ُل ؿتق أً اؿخعغيح الأكؼاص اهيبٌؾج هوضيل كتل اًٗ؟ .43
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، اهؼسبء خضغٖغ ؽغغ اهيؼاح:43إػا نبً اهسّاة ؽوٓ ؿؤال ( .53
 2ة.       1أ. 
 .4 ≥غ.      3ر. 
 
 يب ُٕ يسيل اهيغث اهخؼانيٖج لاؿخعغايم الأكؼاص اهيبٌؾج هوضيل فٕ سيٖؼ اهيؼاح اهؿبتلج: .63
 شِؼ. 21-7ة.     أشِؼ. 6-1أ. 
 شِؼ. 42-91غ.     شِؼ. 81-31ر. 
 ؿٌخًٖ. >ٍ 
 
 يب ُٕ يغث اؿخعغايم هلأكؼاص اهيبٌؾج هوضيل هويؼث اهضبهٖج؟ .73
 ؼ.شِ 21-7ة.     أشِؼ. 6-1أ. 
 شِؼ. 42-91غ.     شِؼ. 81-31ر. 
 ؿٌخًٖ. >ٍ 
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 نى نبً ؽيؼم ؽٌغيب اؿخعغيح الأكؼاص اهيبٌؾج هوضيل هويؼث الأّهٓ؟ .83
 .32-81ة.     .81 ≤أ. 
 .53-13غ.     .92-42ر. 
 (_____). 53 ≥ٍ. 
 
 نى نبً ؽغغ أعفبهم ؽٌغيب اؿخعغيح الأكؼاص اهيبٌؾج هوضيل هويؼث الأّهٓ؟ .93
 اهػنّؼ:_________. الإٌبد:___________. اهيسيّػ:__________. 
 
 ُل خًٌّٖ اهخّكف ؽً اؿخعغاى الأكؼاص اهيبٌؾج هوضيل؟ .14
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، يخٓ خًٌّٖ ػهم؟14إػا نبً اهسّاة ؽوٓ ؿؤال ( .14
 أشِؼ أّ أكل. 6علال  .أ 
 علال ؿٌج. .ة 
 علال ؿٌج ّ ٌضف. .ر 
 علال ؿٌخًٖ أّ أنذؼ. .غ 
 
 إٖلبف اؿخؾيبل الأكؼاص اهيبٌؾج هوضيل؟هى خًٌّٖ  .24
 أؼٖغ إٌسبة اهيؽٖغ يً الأعفبل. .أ 
 الأكؼاص خخؿتة هٕ تٌؽٖف غٖؼ يٌخغى. .ة 
 ألأكؼاص خخؿتة هٕ تئظعؼاتبح تبهسِبؽ اهِظيٕ. .ر 
 خؤذؼ ؽنؿٖب ؽوٓ ٌشبعٕ اهسٌؿٕ.  .غ 
 أشؾؼ تبهلوق يً أؽؼاظِب اهسبٌتٖج. .ٍ 
 كٖل هٕ أٌِب خؿتة اهؿؼعبً. .ّ 
 اهضضٖص ظؾٖف. تخٌبّهِب تبهشنل ٕاهخؽاي .ؽ 
 غٖؼ ػهم، اهؼسبء اهخضغٖغ: _________________________.   .ش 
 
 يً ّضف هم الأكؼاص اهيبٌؾج هوضيل؟ .34
 ة. عتٖة ؽبى.  أ. عتٖة أعضبئٕ أيؼاط ٌؿبئٖج ّخّهٖغ. 
 غ. كبتوج.      ر. ضٖغهٕ.
 ّ. أٌب.     ٍ. اهؾبيوج اهضضٖج. 
 ش. غٖؼ ػهم: _____________.     ؽ. ضغٖلج/كؼٖتج.
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 يً ٌضضم تبؿخعغاى الأكؼاص نيبٌؼ هوضيل غًّ غٖؼُب يً الأؿبهٖة الأعؼْ؟ .44
 ة. كؼٖة/ضغٖق.  أ. اهيؿئّل ؽً اهؼؽبٖج اهضضٖج.
 ر. كؼاؼ شعضٕ.
 
 يب اهؿتة ّؼاء اؿخعغايم هلأكؼاص اهيبٌؾج هوضيل؟  .54
 ة. اهيتبؽغث تًٖ الأعفبل.  أ. اهخّكف ؽً إٌسبة الأعفبل.
 ػهم: ______________.   غ. غٖؼ    ر. يشبنل ضضٖج. 
 
 يً أًٖ خضضوًٖ ؽوٓ الأكؼاص اهيبٌؾج هوضيل؟ .64
 ة. ؽٖبغث الأيّيج ّاهعفّهج.   أ. ؽٖبغث خٌغٖى الأؿؼث.
 غ. يؿخشفٓ غٖؼ ضنّيٕ.   ر. يؿخشفٓ ضنّيٕ.
 ّ. ؽٖبغث اهعتٖة اهعبضج.  ٍ. ؽٖبغث خبتؾج هّنبهج اهغّد.
 ش. غٖؼ ػهم: _____________.     ؽ. اهضٖغهٖج.
  
 يً ٖغفؼ هم يلبتل الأكؼاص اهيبٌؾج هوضيل؟ .74
 ة. أغفؼ ؿؾؼُب نبيلا يً يبهٕ اهعبص.  أ. أضضل ؽوِٖب يسبٌب.
 غ. ؽً عؼٖق اهخأيًٖ اهضضٕ.  ر. أغفؼ سؽء يً ؿؾؼُب. 
 
 الهعرفة بالأقراص الهاىعة لمحهل. )5
 
 ُل خؾؼفًٖ اؿى الأكؼاص اهيبٌؾج هوضيل اهخٕ خؿخعغيٌِٖب؟ .84
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، اهؼسبء ػنؼٍ:84ػا نبً اهسّاة ؽوٓ ؿؤال (إ .94
 ____________________________. 
 
 ؽٌغيب ّضفح هم الأكؼاص اهيبٌؾج هوضيل فٕ اهيؼث الأّهٓ، ُل خى إؽعبءم يؾوّيبح ضّهِب؟ .15
 ة. لا.    أ. ٌؾى.
 
 يضغؼ اهيؾوّيبح اهيؾعبث ُّ: .15
 هؾبئوج.ة. عتٖة ا أ. عتٖة أعضبئٕ أيؼاط اهٌؿبء ّ اهخّهٖغ. 
 غ. اهييؼظج.   ر. اهضٖغهٕ. 
 ّ. غٖؼ ػهم: _____________.       ٍ. اهلبتوج. 
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 نٖف خضفًٖ اهيؾوّيبح اهخٕ خولٖخِب ضٌِٖب؟ .25
 ة. غٖؼ ّاظضج.    أ. ّاظضج ّيفِّيج.
 غ. يؼتنج.      ر. يؾلغث.
 ّ. غٖؼ ػهم: _____________.    ٍ. يعخضؼث ّؿعضٖج.
  
 الأكؼاص اهيبٌؾج هوضيل؟ ُل ٌُبم يعبعؼ لاؿخؾيبل .35
 ة. لا.    أ. ٌؾى.
 
) "ٌؾى"، أٔ يً تًٖ اهضبلاح اهخبهٖج خضيٌف ؽويٓ أٌِيب ييً 35إػا نبً اهسّاة ؽوٓ ؿؤال ( .45
يضغّؼاح اؿخؾيبل الأكؼاص اهيبٌؾج هوضيل؟ (يضغّؼاح: ؽّايل يّسّغث يؿتلًب ؽٌغ اهؿٖغث خضغ 
 يً إينبٌٖج اؿخعغايِب هلاكؼاص).
 لا ٌؾى اهضبهج/اهيؼط #
   ؿٌج. 14نًّ ؽيؼم أنتؼ يً  1
   اهؼتّ. 2
   اهؿؼعبً. 3
   يشبنل كوتٖج. 4
   إؼخفبػ ظغع اهغى. 5
   اهشلٖلج. 6
   يشبنل تبهنتغ. 7
   اؼخفبػ اهشضيٖبح فٕ اهغى. 8
   اؼخفبػ ٌؿتج ُؼيًّ اهضوٖة فٕ اهغى. 9
   اهؽٖبغث اهيفؼعج تبهّؽً. 11
   وج.ؽغى اهخضؼم هفخؼاح عّٖ 11
   ؽلوٕ. ةاظعؼا 21
   أٌٖيٖب اهغى اهيٌسوٖج. 31
   اهخغعًٖ. 41
   اهػئتج. 51
   أّؼغث غّاهٖج. 61
 غٖؼ ػهم، اهؼسبء خضغٖغٍ: 71
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 ؽٌغيب خضضوًٖ ؽوٓ الأكؼاص اهيبٌؾج هوضيل، ُل خنًّ يؼفلج تبهٌشؼث اهعبضج تبهخؾوٖيبح؟ .55
 ة. أضٖبٌب.    أ. ٌؾى، غائيب. 
 لب.ر. لا، يعو
 
 إػا ضضوح ؽوٓ اهٌشؼث، ُل خلؼئٌِٖب؟ .65
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، ُل خفِيًٖ اهيؾوّيبح اهيػنّؼث؟65إػا نبً اهسّاة ؽوٓ ؿؤال ( .75
 ة. لا.    أ. ٌؾى.
 
 يً يً اهخبهٕ ػنؼُى ٖؾختؼ يضغؼم الأؿبؿٕ هويؾوّيبح؟ .85
 ة. اهعتٖة أعضبئٕ أيؼاط اهٌؿبء ّاهخّهٖغ.  أ. لا أضغ يؾًٖ.
 غ. اهضٖغهٕ.  ٖة اهؾبى.ر.اهعت
 ّ. اهييؼظج.    ٍ. اهلبتوج.
 ش. ضغٖلج/كؼٖتج.  ؽ. اهؾبيوج اهضضٖج
 
 ُل خؾخلغًٖ أً يؾوّيبخم اهعبضج تبلأكؼاص اهيبٌؾج هوضيل ٌبكضج؟ .95
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، فبهيؾوّيبح اهٌبكضج هغٖم خخؾوق ة:95إػا نبً اهسّاة ؽوٓ ؿؤال ( .16
    كؼاص اهيبٌؾج هوضيل.أ. الاؿخعغاى اهضضٖص هلأ
 ة. فّائغ الأكؼاص اهيبٌؾج هوضيل.
     ر.اٗذبؼ اهسبٌتٖج هلأكؼاص اهيبٌؾج هوضيل.
 غ. يعبعؼ الأكؼاص اهيبٌؾج هوضيل.
   ٍ.خفبؽلاح الأكؼاص اهيبٌؾج هوضيل يؼ غٖؼُب يً الأغّٖج.
 ّ.ؿؾؼ الأكؼاص اهيبٌؾج هوضيل.
   ج هوضيل.ؽ. أذؼ الأكؼاص ؽوٓ اهٌشبع اهسٌؿٕ اهيبٌؾ
 ش. غٖؼ ػهم: _________________________.  
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 ) "ٌؾى"، هيبػا خؾخلغًٖ خٌلضم ُػٍ اهيؾوّيبح؟95إػا نبً اهسّاة ؽوٓ ؿؤال ( .16
 (ٖينً إعخٖبؼ أنذؼ يً إسبتج)   
 اهيؾوّيبح اهيخّفؼث يؾلغث ّغٖؼ ّاظضج. .أ 
 خَ.اهيؽّغ هويؾوّيبح (اًٖب نبً) ٖخنوى تؿؼؽج ّ لا أؿخعٖؼ يخبتؾ .ة 
 يسيل يؾوّيبخٕ اهضضٖج ظؾٖف. .ر 
 أٌؿٓ اهيؾوّيبح اهيؾعبث. .غ 
 أعشٓ اهؿؤال ؽً اهيؽٖغ يً اهخّظٖص. .ٍ 
 أعسل اهؿؤال ؽً اهيؽٖغ يً اهخّظٖص. .ّ 
 يلّغى اهؼؽبٖج لا ٖشسؾٌٕ ؽوٓ عؼش الأؿئوج. .ؽ 
 لا ٖؿيص اهيسبل تػهم لأً اهيؼنؽ اهضضٕ/اهؾٖبغث خنًّ غائيب ينخغج.  .ش 
 لا أؽؼف. .ع 
 
 ذغؼاح اهيؾؼفٖج هغٖم؟ (يينً اعخٖبؼ أنذؼ يً إسبتج):يبػا تؼأٖم ٖيلأ اه .26
 خؽّٖغٔ تيؾوّيبح يعتّؽج تبهؾؼتٖج. .أ 
 أً ٖلّى الأعضبئٕ اهضضٕ تلؼاءث ّ شؼش اهيؾوّيبح فٕ اهٌشؼث اهيؼفلج. .ة 
اهضضّل ؽوٓ يؾوّيبح تعضّص الأؿبهٖة اهيبٌؾج هوضيل تيب فِٖب الأكيؼاص ييً ّؿيبئل  .ر 
 ).الإؽلاى (يذبل: اهخوفبؽ، الإػاؽج...
 خّفٖؼ عغيبح لإؽعبء ٌضبئص ؽً الإؿخعغاى الأيذل هلأكؼاص اهيبٌؾج هوضيل ؽٌغ ّضفِب. .غ 
 خّفٖؼ عؼٖلج هوضضّل ؽوٓ اهيؾوّيبح فٕ ضبلاح اهعّاؼٔء. .ٍ 
 غٖؼ ػهم: ______________________________________.   .ّ 
 
ٌفؿيم ّ  فٕ أّل يؼث خى ّضف الأكؼاص اهيبٌؾج هوضيل هم، ُل أؽعٖح اهفؼضج هوخؾتٖؼ ؽً  .36
 عؼش الأؿئوج هوضضّل ؽوٓ اهيؽٖغ يً اهيؾوّيبح ّ اهشؼش؟
 ة. لا.    أ. ٌؾى. 
 
 ُل خؾؼفًٖ نٖف خؾيل الأكؼاص اهيبٌؾج هوضيل؟ .46
 ة. لا.    أ. ٌؾى.
 
 أٔ يً اهخبهٕ ٖضف اهيبغث اهفؾبهج فٕ الأكؼاص اهيبٌؾج هوضيل؟ .56
 ة. يبغث عتٖؾٖج.    أ. يبغث ُؼيٌّٖج.
 غ. لا أؽؼف.    ر. يبغث نٖيٖبئٖج.
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 ُل خؾؼفًٖ يب يؾٌٓ" اهؾتّث اهخلّٖيٖج"؟ .66
 ة. لا.    أ. ٌؾى.
 
 ُل خؾويًٖ نٖفٖج اؿخعغايِب؟ .76
 ة. لا.    أ. ٌؾى.
 ُل خختؾٌِٖب؟ .86
 ة. لا.    أ. ٌؾى.
 
 ّٖسغ أٔ آذبؼ سبٌتٖج  هلأكؼاص اهيبٌؾج هوضيل؟ .96
 ة. لا.    أ. ٌؾى.
بهٖج ٖينً أً ٖنيًّ ييً اٗذيبؼ اهسبٌتٖيج ) "ٌؾى"، أٔ يً اهخ96إػا نبً اهسّاة ؽوٓ ؿؤال ( .17
 هلأكؼاص اهيبٌؾج هوضيل؟ 
 ة. ؿؼعبً ؽٌق اهؼضى.    أ. ؿؼعبً اهذغٔ. 
 غ. اؼخفبػ ظغع اهغى.    ر. الإنخئبة.
 ّ. غذٖبً ّ خلٖؤ شغٖغًٖ.    ٍ. ػتضج كوتٖج.
 ش. خعذؼ اهغى (سوعج).    ؽ. ؿنخج غيبغٖج.
  _________.ٔ. غٖؼ ػهم _____    ع. أّؼغث غّاهٖج. 
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 ُل خخفبؽل الأكؼاص اهيبٌؾج هوضيل يؼ ؽلبكٖؼ أّ يّاغ أعؼْ؟  .17
 ة. لا.    أ. ٌؾى.
 
) "ٌؾى"، يؼ أٔ يً اهيّاغ اهخبهٖج يينيً أً خخفبؽيل الأكيؼاص 17إػا نبً اهسّاة ؽوٓ ؿؤال ( .27
 اهيبٌؾج هوضيل؟
 (ٖينً إعخٖبؼ أنذؼ يً إسبتج)   
 
 لا ٌؾى اهغّاء/اهيبغث #
   اهنضّل. 1
   اهيؿنٌبح. 2
   اهيظبغاح اهضّٖٖج. 3
   يبٌؾبح اهخعذؼ. 4
   يظبغاح الإعخلار (أغّٖج اهضؼػ). 5
   أغّٖج اهؿنؼٔ. 6
   يظبغاح الإنخئبة. 7
   يِتعبح اهظغع اهيؼخفؼ (أغّٖج اهظغع). 8
   اهتٌؽّغٖبؽٖتٌٖبح (أغّٖج يِغئج ٌّّيج). 9
ّٖغاح ّ اهسوّنّؼخٖنّؿخٖؼّٖغاح (يشيخلبح اهنّؼخٖنّؿخٖؼ 11
 اهنّخٖؽًّ).
  
   يغؼاح اهتّل. 11
   يذتعبح اهيٌبؽج. 21
   فٖخبيًٖ ر. 31
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 ُل ّٖسغ هلأكؼاص اهيبٌؾج هوضيل فّائغ غٖؼ ؽيوِب الأضوٕ؟ .37
 ة. لا.    أ. ٌؾى.
 
 ً فّائغ الأكؼاص اهيبٌؾج هوضيل؟) "ٌؾى"، أٔ يً اهخبهٖج ٖؾختؼ ي37إػا نبً اهسّاة ؽوٓ ؿؤال ( .47
 (ٖينً إعخٖبؼ أنذؼ يً إسبتج)   
 خلل يشبنل ؽؿؼ اهعيد (آلاى اهغّؼث اهشِؼٖج). .أ 
 خلل اضخيبهٖج الإضبتج تبهخِبة اهضّط اهسّفٕ. .ة 
 يينً أً ٖضؿً (ٖعفف يً شغث) ضة اهشتبة. .ر 
 خضؿًٖ أؽؼاط يب كتل اهغّؼث اهشِؼٖج. .غ 
 ج.يينً أً ٖضؿً (ٖعفف يً شغث) اهشؾؼاٌٖ .ٍ 
 خلل اضخيبهٖج ضغّد اهضيل عبؼر اهؼضى. .ّ 
 خلل اضخيبهٖج الإضبتج تؿؼعبً تعبٌج اهؼضى. .ؽ 
 خلل اضخيبهٖج الإضبتج تبهعيد اهشغٖغ (اهٌؽف). .ش 
 خلل اضخيبهٖج الإضبتج تفلؼ اهغى. .ع 
 خلل اضخيبهٖج الإضبتج تؿؼعبً اهيتبٖط. .ٔ 
 
 الالثزان باسثخدان الأقراص الهاىعة لمحهل. )6
 
 تبٌخغبى؟ُل خخٌبّهًٖ الأكؼاص  .57
 ة. إسيبلا.    أ. غائيب.
 غ. لا أخػنؼ.    ر. ٌبغؼًا.
 
 ُل خٌؿًٖ أعػ الأكؼاص؟ .67
 ة. لا.    أ. ٌؾى.
 
 
 نى كؼضب خٌؿًٖ نل شِؼ؟ .77
 1ة.       1أ. 
 أّ أنذؼ. 3غ.       2ر.
 
 نٖف خلٖيًٖ اهخؽايم تخٌبّل الأكؼاص؟ .87
 ر. ظؾٖف.   ة. يخّؿع.   أ. ؽبهٕ.
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 ٕ اؽخلبغم يينً أً ٖؤذؼ ؽوٓ نفبءث/فبؽوٖج الأكؼاص اهيبٌؾج هوضيل؟أٔ يً اهؾّايل اهخبهٖج ف .97
 إظبؽج أعػ كؼص/أكؼاص. .أ 
 أعػ الأكؼاص تغًّ خؼخٖة. .ة 
 أّ يخأعؼث. ثتغء اهؾتّث يتنؼ .ر 
 الاٌلعبػ ؽً أعػ الأكؼاص تؿتة ؿؾؼُب. .غ 
 يبػا خفؾوًٖ إػا ٌؿٖح أعػ اهلؼص؟ .18
 أعػٍ ؽٌغيب أخػنؼ. .أ 
 أعػٍ ؽوٓ يّؽغ اهسؼؽج اهخبهٖج. .ة 
 ٖؼ أضغ يلغيٕ اهعغيبح اهضضٖجأؿخش .ر 
 أؿخشٖؼ ضغٖلج/كؼٖتج خؿخعغى ٌفؾ اهّؿٖوج اهيبٌؾج هوضيل. .غ 
 أخّكف ؽً خٌبّل الأكؼاص تشنل نبيل. .ٍ 
 أيخٌؼ ؽً اهسيبػ ضخٓ اهغّؼث اهشِؼٖج اهخبهٖج. .ّ 
 غٖؼ ػهم، اهؼسبء اهخضغٖغ:_________________________________. .ؽ 
 
 ّكبٖج إظبفٖج؟ؽٌغ ٌؿٖبً أعػ كؼص، ُل خؿخعغيًٖ ّؿٖوج  .18
 ة. لا.    أ. ٌؾى.
 
 ) "ٌؾى"، اهؼسبء خضغٖغ ُػٍ اهّؿٖوج:18إػا نبً اهسّاة ؽوٓ ؿؤال ( .28
 اهّاكٕ اهػنؼٔ. .أ 
 أيخٌؼ ؽً اهسيبػ ضخٓ اهغّؼث اهشِؼٖج اهخبهٖج. .ة 
 اؿخعغى أكؼاص اهعّاؼٔء اهيبٌؾج هوضيل. .ر 
 غٖؼ ػهم، اهؼسبء اهخضغٖغ:_________________________________. .غ 
  
 غٖم أسؼاء عبص خؿخعغيٌَٖ نّؿٖوج خػنٖؼ لأعػ الأكؼاص تبٌخغبى؟ُل ه .38
 ة. لا.    أ. ٌؾى.
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 :ء) "ٌؾى"، اهؼسبء خضغٖغ ُػا الإسؼا38إػا نبً اهسّاة ؽوٓ ؿؤال ( .48
 (ٖينً إعخٖبؼ أنذؼ يً إسبتج)   
 
 .جأٌغؼ إهٓ اهؾتّث اهخلّٖيٖ .أ 
 أشعة اهّٖى ؽً اهؼؽٌبيج ؽٌغيب آعػ اهلؼص. .ة 
 هيٌتَ ضؿة ّكح خٌبّل اهلؼص.أظتع ا .ر 
 آعػ اهلؼص ؽٌغ اهػُبة هوٌّى. .غ 
 آعػ اهلؼص ؽٌغيب أٌغف أؿٌبٌٕ. .ٍ 
 غٖؼ ػهم، اهؼسبء اهخضغٖغ:_________________________________. .ّ 
 
 ُل ؽبٌٖح يً أؽؼاط سبٌتٖج سّؼاء اؿخعغاى الأكؼاص اهيبٌؾج هوضيل؟ .58
 ة. لا.    أ. ٌؾى.
 
ؾى"، اهؼسبء خضغٖغ الأؽؼاط اهسبٌتٖج اهخيٕ ؽبٌٖيح يٌِيب: ) "ٌ58إػا نبً اهسّاة ؽوٓ ؿؤال ( .68
 (يينً اعخٖبؼ أنذؼ يً إسبتج):
 ة. آلاى فٕ اهضغؼ.    أ. ؽٖبغث فٕ اهّؽً.
 غ. ضغاػ.  ر. خغٖؼاح فٕ اهغّؼث اهشِؼٖج.
 ّ. خغٖؼاح يؽاسٖج.     ٍ. غذٖبً.
 ش. ضة اهشتبة.     ؽ. خؾة.
 (ٖغيق).ٔ. خغٖؼ فٕ هًّ اهسوغ      ع. فلؼ اهغى.
 ل. اهخِبتبح يِتوٖج.    م. اهشؾؼاٌٖج.
 
 يبػا خفؾوًٖ ؽٌغيب خؾبًٌٖ يً الأؽؼاط اهسبٌتٖج؟ .78
 (ٖينً إعخٖبؼ أنذؼ يً إسبتج)   
 
 أخّكف ؽً أعػ الأكؼاص. .أ 
 أتضد ؽً يؿبؽغث يً ػّٔ اهخعضص. .ة 
 أتضد ؽً يؿبؽغث يً ضغٖلج. .ر 
 ٖج.اؿخيؼ فٕ أعػ الأكؼاص لأً فّائغُب أنتؼ يً أؽؼاظِب اهسبٌت .غ 
 اؿخيؼ فٕ أعػ الأكؼاص لأً الأؽؼاط اهسبٌتٖج ُػٍ يؤكخج. .ٍ 
 
 ُل ؿتق ّأً ضيوح تٌٖيب نٌح خؿخعغيًٖ الأكؼاص اهيبٌؾج هوضيل؟ .88
 ة. لا.    أ. ٌؾى.
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 ) "ٌؾى"، ُل خؾؼفًٖ اهؿتة اهيضخيل هضغّد اهضيل؟88إػا نبً اهسّاة ؽوٓ ؿؤال ( .98
 ة. لا.    أ. ٌؾى.
 
 "ٌؾى"، أٔ يً اهخبهٖج كغ ٖنًّ اهؿتة؟) 98إػا نبً اهسّاة ؽوٓ ؿؤال ( .19
 ٌؿٖبً أعػ الأكؼاص. .أ 
 أّ يخأعؼث. ثتغء اهؾتّث يتنؼ .ة 
 أعػ الأكؼاص تغًّ خؼخٖة. .ر 
 خٌبّل أغّٖج لأعؼْ. .غ 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 153 
Appendix 2 
 
Available Oral Contraceptive Formulations in the Local Market (Bergman, 2008)  
 
NO. Product Name Type Category 
Ingredients & Concentrations Tablets 
NO. 
Comments 
Progesterone Estrogen 
1 Belara® COC* Monophasic 
Chlormadinone 
acetate 2 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
1
st
 tablet on 1
st
 day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
1st day of cycle. 
2 Cerazette® POOC** Monophasic 
Desogestrel 
0.075 mg 
____________ 28 Tablets 
 
One tablet daily. 
3 Feminet® COC* Monophasic 
Desogestrel 
0.150 mg 
Ethinylestradiol 
0.020 mg 
21 Tablets 
 
1
st
 tablet on 1
st
 day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
8
th
 day. 
4 Gynera® COC* Monophasic 
Gestodene 
0.075 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
Start on 1
st
 day of 
cycle: 1 tablet daily 
for 21 days. 
5 Harmonet® COC* Monophasic 
Gestodene 
0.075 mg 
Ethinylestradiol 
0.020 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
1st day of cycle. 
6 Lodene® COC* Monophasic 
Gestodene 
0.075 mg 
Ethinylestradiol 
0.020 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
1st day of cycle. 
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NO. Product Name Type Category 
Ingredients & Concentrations Tablets 
NO. 
Comments 
Progesterone Estrogen 
 
7 
 
 
Meliane® 
 
COC* 
 
Monophasic 
 
Gestodene 
0.075 mg 
 
Ethinylestradiol 
0.020 mg 
 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
same day of week 
as the 1st pack. 
8 Mercilon® COC* Monophasic 
Desogestrel 
0.150 mg 
Ethinylestradiol 
0.020 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
same day of week 
as the 1st pack. 
9 Microdiol® COC* Monophasic 
Desogestrel 
0.150 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
same day of week 
as the 1st pack. 
10 Microgynon® COC* Monophasic 
Levonorgestrel 
0.150 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days. 
11 Microlut® POOC** Monophasic 
Levonorgestrel 
0.20 mg 
____________ 35 Tablets 
 
1 tablet daily 
(without break) for 
35 days without 
regard to bleeding, 
then new pack 
started without 
interruption. 
12 Minesse® COC* Monophasic 
Gestodene 
0.060 mg 
Ethinylestradiol 
0.015 mg 
 
28 Tablets: 
(24 yellow 
 active 
tablets, 4 
white 
placebo 
tablets) 
1st tablet (yellow) 
on 1st day of 
menstrual cycle, 
ending cycle with 4 
placebo tablets. 
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NO. Product Name Type Category 
Ingredients & Concentrations Tablets 
NO. 
Comments 
Progesterone Estrogen 
 
13 
 
Minulet® COC* Monophasic 
Gestodene 
0.075 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 21 days, 
followed by 7 free 
days, then new 
pack started on the 
same day of week 
as the 1st pack. 
 
14 
 
Nordette® 
 
COC* 
 
Monophasic 
 
Levonorgestrel 
0.150 mg 
 
Ethinylestradiol 
0.030 mg 
 
28 Tablets 
 
1st tablet on 1st day 
of menstrual cycle 
for 28 days without 
interruption. 
15 Ortho-Cyclen® COC* Monophasic 
Norgestimate 
0.250 mg 
Ethinylestradiol 
0.035 mg 
21 Tablets 
 
1st tablet on 1st 
menstrual cycle for 
21 days. 
16 Postinor2® POOC** 
Emergency 
Contraceptiv
e 
Levonorgestrel 
0.75 mg 
____________ 2 Tablets 
 
One tablet within 
72 hours after 
unprotected 
intercourse, 2nd 
tablet taken 12 
hours after the 1st 
tablet. 
17 Yasmin® COC* Monophasic 
Drospirenone  
3 mg 
Ethinylestradiol 
0.030 mg 
21 Tablets 
 
1st tablet on 1st 
menstrual cycle for 
21 days, followed 
by 7 free days, then 
new pack started on 
the same day of 
week as the 1st 
pack. 
* COC: Combination Oral Contraceptive, ** POOC: Progestin-Only Oral Contraceptive 
 
 
 
 
 
 
 
 
 
 
 
 
